Find solutions for gluteus medius tendinopathy with chiropractic care that enhances your comfort and mobility.
Abstract
Welcome to our educational series. I am Dr. Alex Jimenez, and I am honored to guide you through a comprehensive exploration of a very common yet often misunderstood condition: gluteus medius tendinopathy. This condition is a frequent cause of lateral hip pain, often misdiagnosed as trochanteric bursitis. In this post, we’ll take a detailed look at a real-world clinical scenario involving a 57-year-old gentleman who presented to our clinic with persistent left hip pain. We will use his case to deconstruct the diagnostic process, from precise anatomical palpation to confirming the pain source. Following this, we will delve deep into the anatomy and biomechanics of the gluteus medius muscle and its tendon, understanding its pivotal role in pelvic stability and gait. We will explore the pathophysiology of tendinopathy, moving beyond the outdated concept of “tendinitis” to embrace the modern understanding of tendinosis—a degenerative process characterized by cellular and matrix disorganization. This discussion will be grounded in the latest scientific evidence, drawing on findings from leading researchers using modern, evidence-based methods to understand and treat musculoskeletal conditions. We will dissect the intricate cascade of cellular events that lead to tendon breakdown and explain why traditional anti-inflammatory treatments often fall short. A significant portion of this post outlines a sophisticated, multifaceted treatment strategy. We will detail the rationale and application of diagnostic and therapeutic injections, such as the one performed in our case study, explaining how they serve to both confirm a diagnosis and provide immediate, albeit temporary, relief. More importantly, we will transition to the core of our integrative treatment philosophy. I will explain how our unique practice model at Injury Medical Clinic PA in El Paso, Texas, combines expertise from multiple disciplines to foster true healing. I am privileged to work alongside Dr. Maria Guadalupe Cardenas, MD, a board-certified internist with over four decades of experience, who serves as our Medical Director and Collaborative Physician. Our multidisciplinary setup allows seamless integration of the chiropractic care I provide under Dr. Cardenas’s medical oversight. We will explore how integrative chiropractic care plays a crucial role in addressing the biomechanical dysfunctions that underpin conditions like gluteus medius tendinopathy. We will cover specific chiropractic adjustments, soft tissue mobilization techniques, and functional rehabilitation protocols designed to restore proper joint mechanics, alleviate muscular imbalances, and retrain movement patterns. We will also explore functional medicine principles, nutritional interventions that support tendon health, and advanced rehabilitation strategies that progressively load the tendon to stimulate regeneration and restore its load-bearing capacity. Our goal is to provide a definitive, easy-to-understand resource that explains the “what” and “why” of gluteus medius pain and illuminates a clear path to lasting recovery through an integrated, patient-centered approach.
A Clinical Encounter: Identifying the True Source of Hip Pain
On the morning of September 15, 2026, a 57-year-old gentleman walked into our clinic, discomfort etched on his face. He had been grappling with a persistent pain in his left hip for two months, a nagging ache that was beginning to impact his quality of life significantly. As a clinician, my first and most critical task is to listen—to understand the story the patient’s body is telling. His pain description was specific. He pointed not to the front of his hip, nor the groin, but to an area just behind and slightly above the prominent bone on the side of his hip. This bony landmark is the greater trochanter of the femur, a large, bony knob that serves as a crucial attachment site for several powerful hip muscles. His location immediately steered my diagnostic thoughts away from common intra-articular hip problems like osteoarthritis and toward the soft tissues surrounding the joint—the muscles, tendons, and bursae. This region is often referred to collectively as the “lateral hip,” and pain here is frequently given the blanket diagnosis of “trochanteric bursitis.” However, decades of clinical experience and a wealth of modern research have taught us that this label is often inaccurate. In many cases, the true culprit isn’t an inflamed bursa but a distressed tendon.
The Power of Precise Palpation
To confirm my suspicions, I began the physical examination. The goal was to replicate his exact pain with precise, targeted pressure. This is a fundamental diagnostic technique. If I can reproduce the patient’s specific “concordant sign”—the very pain that brought them to the clinic—with a specific maneuver or palpation, I can be much more confident in my diagnosis. I had him lie on his side and began palpating the area around the greater trochanter. I started by gently pressing on the trochanter itself. He reported no significant pain there. Then I moved my fingers slightly posterior and superior, as he described. “Any pain right there?” I asked, applying firm, focused pressure. “Some,” he replied hesitantly; it wasn’t quite it. I adjusted my position slightly, moving a little further down, probing the tissue. “How about here?” “Right there,” he said, his body tensing. “Right in there.” The critical question followed: “Does that exactly replicate the pain that you’re having today?” “Slowly, yes,” he confirmed. “Yes.” This was our eureka moment. We had found it—the epicenter of his discomfort. The area I was pressing corresponded perfectly with the gluteus medius tendon’s insertion point. This is not the large, fleshy part of the buttock muscle (that’s primarily the gluteus maximus), but a smaller, fan-shaped muscle located on the outer surface of the pelvis, whose tendon wraps around to attach to the greater trochanter. This muscle is a powerhouse of hip stability, and when its tendon becomes pathological, it can be a significant source of pain. Having located the precise spot, I took out a surgical marker and drew a small “X” on his skin. This mark would serve as our target. We had a strong clinical diagnosis: gluteus medius tendinopathy. The next step was to confirm this diagnosis while also providing immediate relief. The plan was to perform a diagnostic and therapeutic injection into the gluteus medius tendon insertion. The logic behind this procedure is twofold: Diagnostic Confirmation: By injecting a local anesthetic (a numbing agent) directly into the suspected source of pain, we can test our hypothesis. If the pain is significantly reduced or eliminated after the injection, it strongly confirms that the injected structure was indeed the primary pain generator. Therapeutic Benefit: The injection often includes a corticosteroid, a potent anti-inflammatory medication. While we now understand that tendinopathy is more degenerative than inflammatory, a targeted steroid can calm localized chemical irritation and reduce inflammatory cell activity that contributes to the pain cycle, providing a window of relief. This pain-free window is not the cure itself, but it is incredibly valuable. It breaks the pain cycle, lets the patient do rehabilitative exercises without severe discomfort, and provides the psychological boost of feeling better. We would inject a combination of a local anesthetic and a small amount of corticosteroid. My goal was not to bathe the entire area in fluid, but to be precise. I explained to the patient, “I’ll fan that out a little bit when I get in there. Because the gluteus medius is a fairly broad tendon that comes down and inserts on the trochanter.” The idea is to deliver the medication across the breadth of the tendon insertion where the pathology lies. The needle would be aimed directly at the “X” I had marked.
The Injection Procedure: A Step-by-Step Explanation
With the location identified and the plan in place, we proceeded with the injection. Patient safety and comfort are paramount. The first step is meticulous skin preparation to minimize infection risk. Aseptic Technique: I began by cleansing the area thoroughly with alcohol swabs. Next, I used several passes of povidone-iodine, a powerful antiseptic that effectively kills bacteria, viruses, and fungi on the skin. We allowed it to air-dry to ensure maximum efficacy. Topical Anesthesia: To make the initial needle entry as comfortable as possible, I used a vapocoolant spray. I told the patient, “I’m going to give you a free spray of this area.” This spray, often ethyl chloride, evaporates rapidly on the skin, creating an intense cold sensation that temporarily numbs superficial nerve endings. “Right, is that cold?” I asked. “Yeah, I bet,” I said. This simple step can significantly reduce the anxiety and discomfort associated with the needle prick. The Injection: With the area prepped and numbed, the procedure began. I took the syringe with a fine-gauge needle and aimed for our target. The key to a successful tendon injection is feeling the different tissue layers as the needle advances. It passes through the skin and subcutaneous fat, then enters the muscle or tendon. A skilled practitioner can feel the change in resistance. “Okay. Now I feel it enter the muscle, the tendon, right there,” I noted as the needle advanced. I explained a technique I often teach: “If you just slide down with your fingers along the sides of the syringe, right when it starts to slip, that’s where you know you’ve got increased resistance.” The dense, fibrous tissue of a tendon offers more resistance than the softer muscle or fat around it. This tactile feedback is crucial for accurate placement. “So I believe I’m there,” I stated, confident in my position. Next, I confirmed with the patient. I administered a very small amount of the anesthetic. “Let me give you a little injection there. Okay. Does that actually feel like the pain that you have?” “Yes,” he confirmed. This is another critical diagnostic clue. Injecting a small amount of fluid into a pathological, sensitive structure often momentarily reproduces the patient’s familiar pain before the anesthetic takes effect. It’s a sign that the needle is in the right neighborhood. With our position confirmed, I administered the medication using a fanning technique to distribute it across the tendon insertion. “Okay. I’m going to fan it just a little bit. Okay. Give you a little bit right here.” I repositioned the needle slightly without withdrawing it from the skin, allowing me to treat a wider area of the tendon. “Let me do it one more time, and advance right there. Injection is in.” The entire process took only a few seconds. “Right, I’m out. The needle is out,” I announced, promptly and safely disposing of the needle.
The procedure itself was complete, but the assessment was not. I immediately began gently massaging the area. “Now, let me massage the area here. So, want to massage that in?” This helps disperse the medication within the tissues and can also alleviate some of the immediate post-injection soreness. I acknowledged his experience during the procedure. “You had quite a bit of discomfort during that procedure,” I said, validating his experience. It’s important to be honest; even with careful technique, injecting into an already painful area can be uncomfortable. Now came the most important part of the assessment—the re-test. I returned to the same spot I had palpated before the injection. “Okay. Does this hurt? What I’m doing right now.” “Just a little,” he replied. This was promising. I then pressed over the bony part of the hip, the greater trochanter itself, which hadn’t been painful before. “Let me press over the outside part of the hip bone.” “That’s okay,” he confirmed. “Yep.” I returned to the primary spot, the gluteus medius insertion. “How about here?” “Just a little tender,” he said. This was the key question: “Is it less than it was earlier?” “Yes, it was,” he confirmed without hesitation. “Okay. All right. So that’s a good sign,” I explained. “That means that the numbing medicine is in the right spot for that, so I’m encouraged by that.” The significant reduction in his palpation tenderness within minutes of the injection strongly confirmed our diagnosis. We had correctly identified the gluteus medius tendon as the source of his two-month-long ordeal. I finished by cleaning the area one last time and applying a simple adhesive bandage. “Let me just go ahead and put a Band-Aid on it, and then we’re done.” This clinical encounter is a perfect entry point for a deeper discussion. We have identified the “what” and the “where.” Now, we must explore the “why.” Why did his gluteus medius tendon become painful? What is happening at a cellular level within that tendon?
And most importantly, what does the journey to long-term recovery look like? The injection was just the first step. The real work, healing and rehabilitation, was about to begin.
The Architect of Stability: Understanding the Gluteus Medius
To truly grasp why a patient like our 57-year-old gentleman develops debilitating hip pain, we must first appreciate the elegant design and crucial function of the muscle in question: the gluteus medius. This muscle is one of the body’s unsung heroes. While its larger and more famous sibling, the gluteus maximus, gets all the attention for its role in powerful hip extension (think climbing stairs or sprinting), the gluteus medius works tirelessly in the background, providing the stability that makes fluid, efficient movement possible.
Anatomy of the Gluteal Region
The gluteal region is comprised of three primary muscles: Gluteus Maximus: The largest and most superficial of the three, forming the bulk of the buttocks. Its primary role is powerful hip extension and external rotation. Gluteus Medius: A fan-shaped muscle that lies underneath the gluteus maximus on the outer surface of the hip. Gluteus Minimus: The smallest of the three, lying deep to the gluteus medius. Our focus is on the gluteus medius. It originates from the outer surface of the ilium (the large, wing-like bone of the pelvis) between bony landmarks called the posterior and anterior gluteal lines. From this broad origin, its fibers converge downward to form a thick, powerful tendon. This tendon travels to the side of the hip and inserts on the posterosuperior aspect of the greater trochanter of the femur—precisely where our patient experienced maximal tenderness. The gluteus minimus has a similar function but is situated deeper. It also originates on the ilium and inserts on the anterior aspect of the greater trochanter. Because of their close anatomical and functional relationship, the gluteus medius and minimus are often referred to as the “rotator cuff of the hip,” drawing a parallel to the group of muscles that stabilize the shoulder joint.
The Biomechanical Powerhouse: Function of the Gluteus Medius
The primary function of the gluteus medius is hip abduction, lifting the leg out to the side. If you are standing and lift your right leg straight out to your right side, your right gluteus medius is the prime mover. However, this isn’t the muscle’s most important role in daily life. Its most critical function is stabilizing the pelvis during single-leg stance, which happens with every step we take. Let’s break this down: The Gait Cycle: When you walk, at some point your entire body weight is supported by one leg. This is known as the stance phase of gait. Pelvic Stability: Imagine you are standing on your left leg. Gravity and your body weight pull the right side of your pelvis downward. If this happens, your pelvis drops on the unsupported side, leading to a lurching, inefficient gait known as a Trendelenburg gait. The Role of the Gluteus Medius: To prevent this pelvic drop, the gluteus medius on the stance leg (the left leg in this example) must contract powerfully. This isometric contraction acts like a strong cable, pulling the stance-side pelvis downward and holding the opposite side level. This action is crucial for smooth, efficient, pain-free walking and running. The gluteus medius works in concert with other core and hip muscles, like the quadratus lumborum on the opposite side, to maintain a stable “core cylinder” during movement.
What Happens When the Gluteus Medius is Weak or Injured?
When the gluteus medius is weak, inhibited by pain, or has a compromised tendon (as in tendinopathy), this critical stabilizing function breaks down. This can lead to a cascade of biomechanical problems, not just at the hip but throughout the kinetic chain. Trendelenburg Sign: Clinically, we can test for gluteus medius weakness with the Trendelenburg test. The patient stands on one leg. A positive sign occurs if the pelvis on the non-stance side drops, indicating weakness in the stance-leg gluteus medius. Often, to compensate, the person will lurch their upper body over the stance leg to maintain balance. This is the compensated Trendelenburg gait. Increased Joint Stress: This altered gait pattern is not just inefficient; it’s damaging. The failure to control pelvic motion leads to increased stress on multiple joints: The Hip Joint: The femoral head may not sit optimally within the acetabulum (the hip socket), leading to abnormal wear and tear. More relevant to our case, the altered mechanics can place excessive compressive and tensile loads on the gluteus medius and minimus tendons as they wrap around the greater trochanter. The Lumbar Spine: Compensatory side-bending or “hip-hiking” can compress the facet joints in the lower back, contributing to or exacerbating low back pain. It’s incredibly common for patients with gluteus medius tendinopathy to also complain of concurrent low back pain. The Knee: Poor pelvic control often results in the femur adducting and internally rotating excessively (the knee collapsing inward). This condition, known as dynamic knee valgus, places significant stress on the ligaments of the knee (like the ACL) and can lead to patellofemoral pain syndrome (runner’s knee) and iliotibial (IT) band syndrome. The Foot and Ankle: The collapse of the kinetic chain can continue down to the foot, leading to overpronation and conditions like plantar fasciitis or Achilles tendinopathy. Understanding these biomechanical connections is central to our integrative approach. Our patient’s hip pain wasn’t just a localized tendon problem. It was a symptom of a broader pattern of movement dysfunction. A simple tendon injection provides temporary relief, but it doesn’t address the underlying cause. True, lasting recovery requires identifying and correcting the biomechanical faults that overloaded the tendon in the first place. This is where comprehensive rehabilitation, including chiropractic care to restore joint mechanics, becomes essential.
Beyond Inflammation: The Modern Understanding of Tendinopathy
For many years, people almost universally labeled painful tendon conditions with the suffix “-itis.” We had “tendinitis,” “bursitis,” and “fasciitis.” The “-itis” suffix implies that inflammation is the primary pathological process. Consequently, the primary treatment approach focused on anti-inflammatory strategies: ice, rest, and anti-inflammatory medications like NSAIDs (ibuprofen, naproxen) or corticosteroid injections. However, over the past two to three decades, our understanding of chronic tendon pain has shifted. This shift was driven by researchers who began examining pathological tendon tissue under a microscope. What they found was surprising and has revolutionized how we approach these conditions.
The Seminal Work of Khan and Cook
Pioneering researchers like Karim Khan, Jill Cook, and their colleagues drove this change. Through numerous studies involving biopsies of painful tendons (Achilles, patellar, rotator cuff, and lateral elbow), they consistently found a distinct lack of inflammatory cells (macrophages, lymphocytes, neutrophils), the hallmark of an “-itis” condition (Khan et al., 1999). Instead of inflammation, they found failed healing and degeneration. They proposed the term tendinosis to describe the underlying pathology more accurately. This distinction is not merely academic; it has profound implications for treatment. The term tendinopathy is now widely used as a broader clinical descriptor for painful, dysfunctional tendons, encompassing the underlying degenerative process of tendinosis.
What Does Tendinosis Look Like? The Histopathological Findings
When a pathologist examines a healthy tendon under a microscope, they see a beautiful, highly organized structure. It consists of: Type I Collagen Fibers: These are strong, thick protein fibers that are densely packed and aligned parallel to the direction of force. This parallel arrangement gives the tendon its incredible tensile strength. Tenocytes: These are the specialized fibroblast cells of the tendon. They are elongated and lie between the collagen fibers, responsible for maintaining and repairing the tendon matrix. Minimal Ground Substance: There is very little “filler” material between the collagen fibers. Limited Vascularity: Healthy tendons have a relatively poor blood supply, which is why they heal slowly. In contrast, a biopsy of a tendon with tendinosis reveals a picture of chaos and disorganization: Collagen Disarray: The neat, parallel alignment of Type I collagen is lost. The fibers are thinner, fragmented, and disorganized. There is also an increase in the weaker Type III collagen, which is more characteristic of early wound healing and scar tissue, not strong, mature tendon tissue. Cellular Changes: Tenocyte number increases (hypercellularity), but their shape changes. They become rounded and more “active,” but this activity is dysfunctional. Instead of producing healthy Type I collagen, they produce inferior matrix components. Neovascularization and Neoinnervation: A hallmark of tendinosis is the ingrowth of new, disorganized blood vessels (neovascularization) and accompanying nerve fibers (neoinnervation) (Alfredson et al., 1999). This is a crucial finding. While more blood supply might seem good, these new vessels are leaky and poorly formed. Critically, the new nerve fibers that travel with them are often nociceptive (pain-sensing). Many researchers now believe this neurovascular ingrowth is a primary driver of tendinopathy pain. These nerves secrete chemicals like substance P and calcitonin gene-related peptide (CGRP) that can further contribute to a disorganized healing response. Increased Ground Substance: The space between the collagen fibers fills with more water-loving molecules called glycosaminoglycans. This leads to tendon thickening, but it is dysfunctional, not a sign of strength. In summary, tendinopathy is not an inflammatory condition; it is a degenerative, non-inflammatory tendinosis characterized by a failed healing response. The tendon is stuck in a cycle of producing poor-quality, disorganized tissue instead of regenerating its strong, organized structure.
The Load-Continuum Model of Tendinopathy
To explain how a tendon moves into this pathological state, Professor Jill Cook and her colleague Craig Purdam developed the influential Tendon Continuum Model (Cook & Purdam, 2009). This model proposes that tendinopathy exists on a spectrum and that the tendon’s response depends on the type and magnitude of the load it experiences. The model describes three main stages: Reactive Tendinopathy: This is the acute response to a rapid increase in load or a period of unaccustomed activity. For example, a runner who suddenly doubles their mileage or a person who spends a weekend doing heavy gardening. In this stage, cells proliferate briefly and the ground substance increases, causing the tendon to swell. This protective response increases the tendon’s cross-sectional area to diffuse the load. At this stage, the tendon structure is largely intact, and the condition is highly reversible if the load is appropriately managed (i.e., reduced). This may be the only stage in which a small, transient inflammatory component is present. Tendon Dysrepair (Failed Healing): If the tendon is not unloaded and remains exposed to excessive load, it progresses to this stage. This corresponds to the early histopathological changes of tendinosis. The tendon’s matrix begins to break down. We see greater collagen disorganization, an increase in Type III collagen, and the beginnings of neovascularization. The tendon attempts to heal, but the process becomes disorganized and ineffective. The potential for reversibility begins to decrease, but with careful load management and targeted interventions, you can still stimulate a healthier healing response. Degenerative Tendinopathy: This is the final stage, often seen in older individuals or those with a long history of chronic tendon pain (like our 57-year-old patient). Here, widespread cell death (apoptosis), extensive matrix disorganization, and significant neovascularization occur. The collagen structure is severely compromised. At this stage, the changes are largely irreversible. The tendon has lost much of its structural integrity and is at an increased risk of partial or full-thickness tearing. Even in a degenerative tendon, some areas may remain healthier and can be targeted with rehabilitation to improve overall function. This continuum model is clinically useful. It helps us understand that the treatment for a young athlete with acute reactive tendinopathy should be very different from the treatment for an older individual with chronic, degenerative tendinopathy. The former may need relative rest and activity modification. At the same time, the latter requires a long-term, structured rehabilitation program designed to improve the load-bearing capacity of the remaining healthy tendon tissue. This modern understanding of tendinopathy as a load-induced, degenerative condition, rather than an inflammatory one, underpins our entire integrative treatment approach. It explains why simply resting or taking anti-inflammatory pills often fails in the long run. The solution isn’t to eliminate inflammation that isn’t there, but to address two key factors: dysfunctional tendon tissue and the excessive load that caused the problem in the first place.
The Role of Compressive Load in Gluteus Medius Tendinopathy
While we’ve established that excessive load causes tendinopathy, not all loads are created equal. Leading researchers, particularly Dr. Jill Cook’s group, have highlighted the particularly damaging role of compressive load on tendons, especially at their insertion points on bone (Cook & Purdam, 2012). A tendon is brilliantly designed to handle tensile (pulling) forces. That’s its primary job. However, when a tendon also experiences compression, especially where it wraps around a bony prominence, it can trigger pathological changes. Think of the gluteus medius and minimus tendons. They wrap over the bony prominence of the greater trochanter. In certain positions, these tendons can get squashed between the greater trochanter and the thick, fibrous iliotibial (IT) band that runs over them.
Positions and Activities that Increase Compression
Certain postures and movements dramatically increase this compressive load on the gluteus medius and minimus tendons: Hip Adduction: Any position where the thigh moves across the midline of the body (adduction) will increase the tension in the IT band and press it firmly down onto the gluteal tendons and the greater trochanter. Sleeping on your side: Lying on the unaffected side with the painful hip on top often causes the top leg to fall into an adducted position, compressing the tendons for hours. Lying directly on the painful hip also creates direct compression. This is why night pain is a classic symptom of gluteus medius tendinopathy. Crossing your legs: Sitting with legs crossed pulls the hip into adduction and flexion, a prime position for compression. “Hanging“ on one hip: Shifting all your weight to one side and letting the other side of the pelvis drop forces the stance hip into adduction and compresses the tendons. Deep Hip Flexion: Positions like deep squats or sitting in low chairs can also increase the compressive forces around the hip. Running on a cambered surface: Running on the side of a road that slopes down forces the uphill leg’s hip into greater adduction to keep the foot level, increasing compressive load. Stretching the IT Band: Ironically, a common prescription for lateral hip pain has been to stretch the IT band by pulling the leg across the body. We now understand that this stretch is one of the most provocative things you can do for gluteus medius tendinopathy, as it directly compresses the painful tendons over the bone. We now actively tell patients to avoid this stretch.
The Cellular Response to Compression
Research has shown that tenocytes (tendon cells) respond differently to compressive load than to tensile load. When subjected to compression, they can undergo a process called chondroid metaplasia. They begin to behave more like cartilage cells (chondrocytes), producing molecules like aggrecan that resist compression in cartilage but harm tendon health. This changes the tendon matrix, making it less able to handle tensile loads and more prone to the degenerative changes of tendinosis (Verdonk et al., 2005). The combination of excessive tensile load (from weak or fatigued muscles) and provocative compressive load (from poor movement patterns or postures) creates a perfect storm for the development of gluteus medius tendinopathy. This understanding has direct and practical implications for treatment: Patient Education is Key: The first step in management is to teach the patient to avoid these compressive positions. We provide specific advice on modifying sleeping posture (e.g., placing a pillow between the knees to keep the hips in neutral alignment), sitting posture (e.g., sitting with feet flat on the floor and knees slightly apart), and standing posture. Rehabilitation Must Focus on Avoiding Compression: Early-stage rehabilitation exercises must be performed in positions that minimize hip adduction. For example, instead of side-lying leg lifts (which can involve some adduction at the bottom of the movement), we might start with isometric abduction exercises in a standing or bridging position. Re-evaluate Common “Stretches“: We must eliminate any stretching protocols that create compression. The focus shifts from “stretching” the painful area to progressively loading it in a way that stimulates healthy adaptation. By identifying and mitigating compressive loads, we remove one of the primary drivers of the pathology. This “unloads” the tendon, giving it a chance to move out of the reactive or dysrepair stage and creating an environment where targeted strengthening can be effective. This nuanced understanding of load is a cornerstone of modern, evidence-based tendon rehabilitation.
The Integrated Treatment Blueprint at Injury Medical Clinic
Our encounter with the 57-year-old gentleman with hip pain perfectly illustrates the philosophy that guides our practice at Injury Medical Clinic. The injection he received was a crucial first step, but it was far from the entire treatment. It was an entry point into a comprehensive, multifaceted program designed to produce lasting results. Our approach is built on integrative care, a collaborative model that brings together the strengths of different disciplines to address every aspect of a patient’s condition. At the heart of our practice is the dynamic collaboration between me, Dr. Alex Jimenez, a Doctor of Chiropractic with advanced credentials in nursing and functional medicine, and our esteemed Medical Director, Dr. Maria Guadalupe Cardenas, MD. Dr. Cardenas is a Board-Certified Internist with over 40 years of clinical experience. Her extensive medical knowledge and diagnostic acumen provide the essential medical oversight for our practice. This multidisciplinary setup, where an MD provides medical direction alongside a chiropractor and other allied health professionals, is common in cutting-edge integrative and injury care clinics. It lets us offer a spectrum of care that a single-discipline clinic can’t match. Our treatment blueprint for a condition like gluteus medius tendinopathy is not a one-size-fits-all protocol. It’s a personalized journey that unfolds in phases, addressing the “why” behind the pain, not just the “what.”
Phase 1: Pain and Load Management – “Calm Things Down”
The immediate goal after diagnosis is to reduce the patient’s pain and, critically, modify the loads perpetuating the problem. This is where the injection comes in. The Diagnostic/Therapeutic Injection (Medical Oversight by Dr. Cardenas): As performed in our case, an injection of local anesthetic and corticosteroid helps confirm the diagnosis and provides a powerful, albeit temporary, pain reduction. We make the decision to use a corticosteroid carefully. While we know tendinopathy is not primarily inflammatory, a targeted steroid can quiet the chemical irritation and nociceptive activity within the tendon, breaking the pain cycle. This creates a valuable “window of opportunity” for us to begin the next phase of treatment. This procedure falls under the medical scope of practice and is performed with the oversight of Dr. Cardenas. Pain Education: This is perhaps the most critical part of Phase 1. We spend time educating the patient about their condition. We explain the concept of tendinosis, the difference between helpful and harmful loads, and the specific role of compression. Activity Modification: We provide a “do” and “don’t” list based on the principles of avoiding compressive load. Don’t: Cross legs, stand “hanging” on one hip, sleep without a pillow between the knees, perform aggressive IT band stretches. Do: Sit with knees apart, get up from a chair by pushing up evenly with both legs, consciously engage gluteal muscles during stair climbing, sleep with a pillow between the knees. Isometric Loading: Even in this early phase, we introduce gentle, pain-free exercises. The best evidence now supports using heavy, long-duration isometric contractions for pain relief in tendinopathy (Rio et al., 2015). An isometric contraction is where the muscle produces force without changing length. For the gluteus medius, this could be: Standing isometric hip abduction: The patient stands next to a wall with the affected hip away from it. They place a small ball or rolled-up towel between their hip and the wall and gently push their hip into the wall, holding the contraction for 30-45 seconds. This activates the gluteus medius without moving the hip joint through a range of motion. Why it works: This type of loading is thought to provide a powerful analgesic effect (pain relief) by altering the way the brain processes pain signals from the tendon. It does this without placing compressive or excessive tensile stress on the tendon itself. We typically prescribe multiple repetitions of these long-hold isometrics throughout the day.
Phase 2: Restoring Movement and Building a Foundation (Integrative Chiropractic and Rehabilitation)
Once the initial pain is under control, we transition to the core of our rehabilitative strategy. This is where my role as a chiropractor becomes central. Tendon pain is a symptom of a broader biomechanical dysfunction. My job is to identify and correct the underlying movement faults. Chiropractic Assessment and Adjustment: The body is a kinetic chain. A dysfunctional gluteus medius is often associated with restrictions and imbalances elsewhere. I perform a thorough biomechanical assessment of the entire chain: Lumbar Spine and Sacroiliac (SI) Joints: Restriction in the SI joints or lumbar facet joints can alter pelvic mechanics and inhibit proper gluteal muscle firing through a process called arthrogenic muscle inhibition. A joint that isn’t moving properly sends inhibitory signals to the muscles that cross it. Using specific, gentle chiropractic adjustments, I work to restore normal motion to these joints. This is not just “cracking the back”; it’s a precise neurological input designed to improve joint mobility and “re-awaken” the surrounding musculature. Hip Joint: I assess the hip joint’s mobility. For example, a lack of internal rotation can force compensatory movements that overload the gluteal tendons. Gentle hip mobilization techniques can help restore this lost motion. Thoracic Spine: A stiff, flexed upper back can shift a person’s center of gravity, forcing the pelvis and hips to compensate and overload. Thoracic spine adjustments and mobility drills are often a key part of the program. Soft Tissue Mobilization: Muscles around the hip often develop trigger points and fascial restrictions in response to injury. I use techniques like myofascial release or instrument-assisted soft tissue mobilization (IASTM) on surrounding tight muscles like the tensor fasciae latae (TFL), quadratus lumborum, and hip flexors. Crucially, we avoid aggressive, direct work on the painful tendon insertion itself in this phase, as this can be provocative. The goal is to release the tension in the “neighborhood” to improve overall movement quality. Early Strengthening and Motor Control: This phase focuses on re-educating the gluteus medius to fire correctly and building a foundation of strength. The exercises are still carefully chosen to avoid compression. Clamshells (with proper form): The classic “clam” exercise can be useful, but only if done correctly. The patient must be cued to roll their torso slightly forward to ensure the gluteus medius is targeted, not the TFL, and the movement should be small and controlled. Bridging Variations: Glute bridges are excellent for activating the entire posterior chain. We can progress from a simple two-leg bridge to a bridge with a band around the knees (to cue abduction) and eventually to single-leg bridges. Quadruped Hip Extension: On all fours, extend one leg back, focusing on squeezing the gluteal muscles without arching the lower back.
Phase 3: Progressive Loading for Tendon Adaptation – “Build It Back Up”
This is the most critical phase for long-term recovery. Based on the principle of mechanotransduction—the process by which cells convert mechanical stimuli into a chemical response—we know that to strengthen a tendon, we must load it. The key is to load it progressively and appropriately. The goal is to stimulate tenocytes to produce healthy, strong Type I collagen and remodel the disorganized matrix. Isotonic Strengthening: We now move from isometrics (static holds) to isotonics (movement through a range of motion). The exercises become more challenging and functional. Standing Banded Hip Abduction: Place a resistance band around the ankles, and have the patient perform slow, controlled leg lifts to the side. Side-Stepping with Bands: “Monster walks” or “crab walks” with a band around the knees or ankles are fantastic for training the gluteus medius in its role as a stabilizer during dynamic movement. Single-Leg Stance and Balance Drills: Simply practicing standing on one leg challenges the gluteus medius in its primary stabilizing role. We can progress this by standing on an unstable surface or closing the eyes. Heavy Slow Resistance (HSR) Training: A growing body of evidence supports using HSR for tendinopathy (Beyer et al., 2015). This involves using heavy weights and performing exercises very slowly (e.g., a 3-second concentric/lifting phase and a 3-second eccentric/lowering phase). Exercises might include: Weighted Hip Abduction Machine Leg Press (with emphasis on single-leg work) Weighted Squats and Lunges (once form is perfected) Why HSR works: The combination of heavy load and slow speed appears to strongly stimulate collagen synthesis and matrix remodeling, while the slow speed minimizes injury risk by keeping the tendon under constant, controlled tension. Eccentric Loading: Eccentric exercise (the lengthening phase of a contraction) has also been a mainstay of tendon rehab. For the gluteus medius, you can incorporate this into exercises like the single-leg squat, focusing on a very slow, controlled descent.
Phase 4: Return to Function and Sport – “Test It”
The final phase gradually reintroduces the specific activities the patient wants to return to, whether that’s running, playing tennis, or simply walking without pain. Plyometrics and Energy Storage Loading: For athletes, we need to retrain the tendon’s ability to store and release energy, which it uses during activities like running and jumping. This involves introducing exercises like hopping, skipping, and jumping, starting with low intensity and gradually increasing. For example, a runner might start with a walk/run program while carefully monitoring the tendon’s response. Sport-Specific Drills: We work with the patient to break down the movements of their sport or desired activity and create drills that mimic those demands in a controlled way. Throughout this entire process, we monitor the patient’s pain. A key rule in tendon rehab is the “24-hour pain rule.” Pain during the exercise is acceptable if it’s mild (e.g., < 3/10) and does not increase after the session or the next morning. If pain is worse the next day, the load was too much, and we need to scale back.
The Functional Medicine and Nutrition Component
As a Functional Medicine (IFMCP)- certified practitioner, I also look beyond biomechanics. Systemic factors influence tendon health. Nutritional Support: We provide guidance on an anti-inflammatory diet rich in whole foods, antioxidants, and quality protein. Specific nutrients are crucial for collagen synthesis: Vitamin C: An essential cofactor in the cross-linking of collagen fibers. Collagen/Gelatin Peptides: Supplementing with hydrolyzed collagen may provide the body with the specific amino acid building blocks (glycine, proline, hydroxyproline) needed for tendon repair (Shaw et al., 2017). Taking this 30-60 minutes before a rehab session may improve delivery to the targeted tissue. Other Minerals: Zinc and copper also support enzymes involved in matrix production. Addressing Systemic Inflammation: We screen for and address other sources of systemic inflammation that could be impairing the body’s sling capacity, such as poor gut health, metabolic dysfunction (e.g., insulin resistance), or nutrient deficiencies. For example, high blood sugar can lead to the formation of advanced glycation end-products (AGEs), which can stiffen collagen and impair tendon health. This truly integrative model—combining medical diagnostics and interventions under Dr. CardCardenas’section, with targeted chiropractic care, advanced rehabilitation, and a functional medicine approach—is what allows us to move beyond temporary fixes. We are not just treating a painful hip; we are restoring a person’s movement, function, and quality of life from the ground up.
The Unique Contribution of Chiropractic Care in Tendinopathy Management
It’sIt’sortant to specifically highlight why chiropractic care is not just an adjunct but a central component of this integrated model for treating conditions like gluteus medius tendinopathy. The traditional view of chiropractic may be limited to spinal adjustments for back pain, but a modern, evidence-based chiropractor specializes in neuromusculoskeletal function. Our expertise lies in the intricate relationship between joints, muscles, and the nervous system. For a condition rooted in biomechanical overload, this expertise is invaluable: Restoring the Foundation of Movement: As mentioned, I assess and treat joint restrictions in the lumbar spine, sacroiliac joints, and hips. Think of these joints as a house’s foundation. If the foundation is crooked, the walls (muscles) will be under abnormal stress, and the windows (tendons) will start to crack. A physical therapist might focus on strengthening the muscles (the walls), but if the underlying joint dysfunction (the foundation) isn’isn’trected, the problem will likely recur. Chiropractic adjustments provide a specific, powerful input to restore motion to these foundational joints, creating the mechanical environment muscles and tendons need to function properly. Neurological Reset: A chiropractic adjustment is more than just a mechanical “pus”” on”apushnt. It is a potent neurological stimulus. By stimulating mechanoreceptors (nerve endings that sense movement and pressure) in the joint capsule and surrounding tissues, an adjustment sends a barrage of information to the central nervous system. This can help to: Down-regulate pain: The input from mechanoreceptors can inhibit the transmission of pain signals from nociceptors, a concept known as the “gate control theory of pain.” Rest and Muscle Tone: It can break the cycle of arthrogenic muscle inhibition, essentially “rebooting” the connection between the joint and the muscles that control it, allowing for better activation of inhibited muscles like the gluteus medius. Improve Proprioception: By restoring normal joint motion, we improve the body’s awareness of its position in space (proprioception), leading to better coordination and motor control. Holistic Biomechanical Analysis: Chiropractors are trained to look at the body as an integrated whole. We don’t look at the painful hip. We analyze the patient’s posture, their gait, and the function of the entire kinetic chain, from the feet to the head. We might find that a patient’s foot pronation triggers a chain reaction of internal tibial and femoral rotation, leading to hip adduction that compresses the gluteal tendons. In such cases, the treatment plan might include not only hip-focused work but also foot adjustments and orthotic recommendations. This whole-body perspective is essential to identify and address the root cause of the overload. Hands-On Soft Tissue Expertise: Beyond adjustments, chiropractors are proficient in a range of manual therapies. Techniques like myofascial release, trigger point therapy, and instrument-assisted soft tissue mobilization address the muscular imbalances and fascial restrictions that accompany tendinopathy. By releasing a tight tensor fasciae lata (TFL) or quadratus lumborum (QL), we can reduce the antagonistic forces pulling on the pelvis and allow the gluteus medius to work more effectively. In our collaborative practice, we seamlessly weave this chiropractic expertise into the patient’s plan. Dr. Cardenas provides medical clearance and oversight, ensuring no underlying medical contraindications. I then apply my neuromusculoskeletal expertise to correct the biomechanical faults. I then implement a targeted rehabilitation program, often co-managed with physical therapists or athletic trainers on our team. The result is a synergistic approach in which each discipline contributes its unique strengths, leading to a more comprehensive and effective outcome than any single approach could achieve alone.
Conclusion: A New Paradigm for Hip Pain Recovery
Our journey began with a simple yet profound clinical moment: pinpointing the exact source of a 57-year-old gentleman’s sonic hip pain. That precise palpation and diagnostic injection opened the door to a deeper exploration of his condition. We moved from the “what”—a painful gluteus medius tendon—to the “why.” We unraveled the hip’s complex biomechanics, understanding the gluteus medius as a cornerstone of pelvic stability. We delved into the tendon’s cellular world, replacing the outdated notion of “- it’s” with the modern, evidence-based understanding of tendinosis as a degenerative condition of failed healing, often driven by a combination of tensile and, critically, compressive loads. This new paradigm demands a new approach to treatment. It moves us away from passive, short-term fixes like prolonged rest and repeated anti-inflammatory interventions and toward an active, engaged, and integrated strategy. At Injury Medical Clinic, this strategy is our blueprint for success. It is a collaborative effort, spearheaded by the combined expertise of our Medical Director, Dr. Maria Guadalupe Cardenas, and our entire team of chiropractic, rehabilitation, and functional medicine practitioners. Our approach is a phased journey tailored to the individual: We begin by calming the system, using targeted interventions like a diagnostic injection to reduce pain and comprehensive education to empower the patient to remove the offending loads from their daily life. We then rebuild the foundation. Through integrative chiropractic care, we address the underlying joint restrictions and biomechanical faults in the spine, pelvis, and hips that created the overload in the first place. We use manual therapies to restore muscle balance and introduce specific exercises to re-awaken and retrain the inhibited musculature. Next, we stimulate adaptation. We apply the principles of mechanotransduction, using a carefully progressed program of heavy, slow resistance and functional strengthening to send a powerful healing signal to the tendon, encouraging it to remodel and rebuild stronger, more organized tissue. Finally, we return to life. We guide the patient back to the activities they love safely and gradually, ensuring their body is resilient and prepared for the demands of sport and life. A functional medicine perspective supports all of this by considering the whole person—their nutrition, systemic health, and unique physiology—to create an internal environment primed for healing. The pain that brought our patient to the clinic was a signal. It signaled that a critical component of his movement system was failing under load. Our job wasn’t just to silence that signal, but to listen, understand its message, and respond with a comprehensive plan to restore the strength, integrity, and function of the entire system. This is the promise of modern, integrative care. It’s a journey from pain to performance, and we are honored to guide our patients every day.
References
Alfredson, H., Bjur, D., Thorsen, K., Lorentzon, R., & Sandstrom, P. (1999). High-power color Doppler sonography in the management of tendinosis. British Journal of Sports Medicine, 33(1), 41. https://bjsm.bmj.com/content/33/1/41.1 Beyer, R., Kongsgaard, M., Hougs Kjær, B., Øhlenschlæger, T., Kjær, M., & Magnusson, S. P. (2015). Heavy slow resistance versus eccentric training for patellar tendinopathy: a randomized controlled trial. The American Journal of Sports Medicine, 43(7), 1704–1711. https://doi.org/10.1177/0363546515584111 Cook, J. L., & Purdam, C. R. (2009). Is tendon pathology a continuum? A pathology model to explain the clinical presentation of load-induced tendinopathy. British Journal of Sports Medicine, 43(6), 409–416. https://doi.org/10.1136/bjsm.2008.051193 Cook, J. L., & Purdam, C. (2012). Is compressive load a factor in the development of tendinopathy? British Journal of Sports Medicine, 46(3), 163–168. https://doi.org/10.1136/bjsm.2010.081419 Khan, K. M., Cook, J. L., Bonar, F., Harcourt, P., & Astrom, M. (1999). Histopathology of common tendinopathies. Update and implications for clinical management. Sports Medicine, 27(6), 393–408. https://doi.org/10.2165/00007256-199927060-00004 Rio, E., Kidgell, D., Purdam, C., Gaida, J., Moseley, G. L., Pearce, A. J., & Cook, J. (2015). Isometric exercise induces analgesia and reduces inhibition in patellar tendinopathy. British Journal of Sports Medicine, 49(19), 1277–1283. https://doi.org/10.1136/bjsports-2014-094386 Shaw, G., Lee-Barthel, A., Ross, M. L., Wang, B., & Baar, K. (2017). Vitamin C–enriched gelatin supplementation before intermittent activity augments collagen synthesis. The American Journal of Clinical Nutrition, 105(1), 136–143. https://doi.org/10.3945/ajcn.116.138594 Verdonk, P. C. M., Demol, J., Almqvist, K. F., Veys, E. M., Verbruggen, G., & Verdonk, R. (2005). Implantation of viable meniscal allograft. Survivorship analysis and clinical outcome of 59 cases. The Journal of Bone and Joint Surgery. American Volume, 87(4), 715–724. https://doi.org/10.2106/JBJS.D.02508
SEO Tags: gluteus medius tendinopathy, lateral hip pain, trochanteric bursitis, Dr. Alex Jimenez, integrative chiropractic care, Dr. Maria Guadalupe Cardenas, functional medicine, hip pain treatment El Paso, tendinosis, heavy slow resistance training, isometric exercise for tendon pain, chiropractic adjustment for hip pain, pelvic stability, gait analysis, biomechanics, personal injury care, rehabilitation, non-surgical hip pain relief, tendon health, collagen synthesis
Find out how chiropractic rehabilitation can help reduce discomfort and enhance movement from adductor tendinopathy.
Abstract
Chronic medial thigh pain is a condition that is frequently underdiagnosed, mismanaged, or dismissed in clinical practice. Yet, it can profoundly diminish a patient’s quality of life, functional capacity, and overall well-being. This educational post, authored by Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, presents a thorough, evidence-based clinical discussion of adductor tendinopathy and groin-related musculoskeletal pain syndromes as illustrated through a real-world clinical case involving a 35-year-old male patient with an eight-year history of intermittent, aching medial thigh pain radiating to the knee.
The discussion begins with a foundational review of the anatomy of the adductor muscle complex, including the gracilis, adductor brevis, adductor longus, adductor magnus, and pectineus muscles, and their shared tendinous attachment at the pubic symphysis and pubic ramus. From there, the post explores the pathophysiology of chronic tendinopathy, explaining how repetitive mechanical loading, failed healing responses, and neovascularization contribute to the persistence of pain even in the absence of a recalled traumatic event.
The post describes the clinical assessment process in detail, covering physical examination techniques, palpation protocols, and provocative testing that help isolate adductor tendinopathy as the primary pain generator. The post addresses the role of diagnostic imaging, including ultrasound and MRI, in confirming clinical findings and guiding intervention.
This post provides an in-depth explanation of corticosteroid and regenerative injection therapy, including the rationale for using vapor coolant spray as a pre-injection analgesic, proper aspiration technique, and the clinical reasoning behind distributing the injectate along the tendon and its insertion. Sterile procedural protocols are discussed as non-negotiable components of safe, effective care.
Beyond the procedural component, this post explores how integrative and chiropractic care fits naturally into the long-term management of adductor tendinopathy. The discussion covers rehabilitative exercise, manual therapy, functional movement assessment, and biomechanical correction as essential pillars of a comprehensive recovery strategy. The post also highlights the collaborative clinical model at Injury Medical Clinic PA (also known as Mission Plaza Injury Medical Clinic) in El Paso, Texas, where Dr. Maria Guadalupe Cardenas, MD, board-certified in Internal Medicine with over 40 years of clinical experience, serves as Medical Director and Collaborative Physician alongside Dr. Jimenez, creating a multidisciplinary environment where patients receive both medical oversight and chiropractic, functional medicine, and rehabilitative care under one roof.
Throughout this post, the latest findings from leading researchers are incorporated to support every clinical recommendation, ensuring that readers, whether patients, clinicians, or healthcare students, leave with a clear, modern, evidence-based understanding of how to recognize, assess, and effectively treat chronic adductor tendinopathy using an integrative, whole-person approach.
Who We Are: The Integrative Clinical Team at Injury Medical Clinic PA in El Paso, Texas
Before diving into the clinical content of this post, I want to introduce the team and model of care that shapes everything I discuss here at Injury Medical Clinic PA, also known as Mission Plaza Injury Medical Clinic, in El Paso, Texas.
My name is Dr. Alexander Jimenez. I hold the following credentials: DC (Doctor of Chiropractic), APRN (Advanced Practice Registered Nurse), FNP-BC (Family Nurse Practitioner, Board Certified), CFMP (Certified Functional Medicine Practitioner), IFMCP (Institute for Functional Medicine Certified Practitioner), ATN (Advanced Trained Naturopath), and CCST (Chiropractic Clinical Sciences and Technology). My clinical philosophy has always been rooted in a deep respect for the complexity of the human body and a commitment to treating the whole person, not just the symptom. You can explore more of my clinical observations and resources at chiromed.com and on my LinkedIn profile.
Dr. Maria Guadalupe Cardenas, MD (NPI #1164426749, Texas MD License #J2933), works alongside me as our Medical Director and Collaborative Physician. Dr. Cardenas is Board Certified in Internal Medicine and brings over 40 years of experience as an internist to our practice. Her depth of knowledge in systemic medicine, chronic disease management, and patient-centered internal medicine is an invaluable asset to our clinical team. The collaboration between Dr. Cardenas and me represents a model of care that is increasingly recognized in the literature as the gold standard for complex musculoskeletal and injury-related conditions: a multidisciplinary, integrative approach where an MD provides essential medical direction and oversight, while a chiropractor, advanced practice nurse, and functional medicine practitioner address the structural, neurological, and lifestyle dimensions of health.
How Our Multidisciplinary Team Works Together
Our clinic is intentionally structured to bridge the gap between conventional medicine and integrative, evidence-based complementary care. This kind of setup is becoming increasingly common in integrative and injury care clinics, and for good reason. Evidence consistently shows that patients with chronic musculoskeletal conditions, personal injuries, or complex pain syndromes achieve better outcomes, faster recoveries, and higher quality of life when they receive care from a coordinated team rather than isolated practitioners working in silos (Chou et al., 2017).
At Injury Medical Clinic PA, our services include:
Chiropractic care and spinal manipulation (Dr. Jimenez): Addressing biomechanical dysfunction, vertebral subluxation, joint mobility restrictions, and neurological interference that contribute to pain, impaired movement, and diminished healing capacity.
Medical oversight and internal medicine (Dr. Cardenas): Providing diagnostic clarity, pharmacological management when appropriate, co-management of systemic conditions that affect musculoskeletal health, and the medical direction required to ensure patient safety across all clinical services.
Functional medicine assessment and care (Dr. Jimenez): Investigating and addressing the root causes of chronic inflammation, metabolic dysfunction, hormonal imbalance, nutritional deficiency, and gut-immune dysregulation that can perpetuate chronic pain and impair tissue healing.
Personal injury care: Managing acute and subacute injuries resulting from motor vehicle accidents, workplace incidents, slip-and-fall events, and sports-related trauma, with a focus on thorough documentation, evidence-based treatment, and optimal recovery.
Rehabilitation and corrective exercise: Designing individualized therapeutic exercise programs that restore strength, mobility, coordination, and functional movement patterns to injured or painful areas of the body.
Injection therapy and regenerative procedures: Including the kind of adductor tendon injection procedure illustrated in this clinical case, along with other minimally invasive procedures guided by evidence and performed with meticulous attention to sterile technique and patient safety.
Nutritional counseling and lifestyle medicine: Supporting the biochemical environment of healing through targeted dietary interventions, supplementation protocols, and lifestyle modifications grounded in functional and integrative medicine principles.
This integrative model is not simply a matter of convenience. It reflects a genuine philosophical commitment to recognizing that the human body is a deeply interconnected system, and that chronic pain conditions like adductor tendinopathy rarely arise from a single, isolated cause. They are most effectively addressed when practitioners from different disciplines bring their complementary expertise to bear on the full picture of a patient’s health.
With that introduction in place, let us now turn to the clinical case that anchors this post and begin a thorough, evidence-based exploration of adductor tendinopathy, from anatomy through treatment.
The Clinical Case: A 35-Year-Old Male With Eight Years of Chronic Medial Thigh Pain
The patient at the center of this discussion is a 35-year-old male who presents with an eight-year history of chronic, intermittent pain located along the medial aspect of his right thigh. He describes the pain as aching and notes that it radiates distally to the level of his knee. Importantly, he cannot recall a specific traumatic event that initiated the symptoms. The pain has persisted, fluctuating in intensity over the years, but never fully resolving.
On physical examination, there is point tenderness of the adductor muscle complex, most pronounced at the tendinous attachment at the pubic bone. Provocative loading and palpation of the adductor tendons at their proximal insertion reproduce the patient’s familiar pain and confirm the clinical diagnosis of adductor tendinopathy with likely enthesopathy at the pubic attachment.
This case is highly representative of what I see regularly in clinical practice. The combination of insidious onset, chronicity, absence of recalled trauma, and tendinous tenderness at the enthesis is a hallmark presentation of chronic tendinopathy involving the adductor complex, and it is a presentation that demands a thoughtful, structured, evidence-based response.
Let us begin by building a thorough understanding of the anatomy involved.
Anatomy of the Adductor Muscle Complex: Understanding the Structural Foundation of Medial Thigh Pain
To understand why this patient experiences pain where he does, and why the injection is placed where it is, we must first develop a clear, detailed understanding of the anatomy of the medial thigh and adductor compartment.
The Adductor Compartment: Overview
The medial compartment of the thigh houses a group of muscles collectively called the adductor complex. These muscles are responsible primarily for adduction of the hip, meaning they draw the thigh toward the midline of the body. However, their functional roles extend well beyond simple adduction. They contribute significantly to hip flexion, internal and external rotation, pelvic stabilization, and dynamic control of the lower extremity during gait, running, and cutting movements (Macintyre et al., 2011).
The muscles of the adductor compartment include:
Adductor longus
Adductor brevis
Adductor magnus
Gracilis
Pectineus
Obturator externus (sometimes classified with this group)
Each of these muscles has a specific origin, insertion, innervation, and functional role, and understanding these details is critical for accurate clinical assessment and targeted treatment.
Adductor Longus
The adductor longus is the most anteriorly positioned and clinically prominent of the adductor muscles. It originates from the anterior surface of the pubic body, just below the pubic crest and lateral to the pubic symphysis. Its broad, flat belly extends inferolaterally to insert into the middle third of the linea aspera on the femur’s posterior surface.
The adductor longus is the most commonly injured adductor muscle, particularly in athletes, and its proximal tendon at the pubic attachment is a frequent site of tendinopathy and enthesopathy (Serner et al., 2016). The anterior division of the obturator nerve (L2, L3, L4) innervates it.
Adductor Brevis
The adductor brevis lies deep to the adductor longus and pectineus. It originates from the inferior ramus of the pubis and inserts into the upper third of the linea aspera and the lesser trochanter of the femur. It is also innervated by the obturator nerve (L2, L3) and contributes to both adduction and hip flexion.
Adductor Magnus
The adductor magnus is the largest and most powerful of the adductor muscles, composed of two functionally distinct portions:
The adductor portion (or pubofemoral portion): Originates from the inferior pubic ramus and ischial ramus, inserts along the linea aspera and medial supracondylar ridge of the femur, and is innervated by the obturator nerve (L2, L3, L4). It functions primarily as a hip adductor and medial rotator.
The hamstring portion (or ischiocondylar portion): Originates from the ischial tuberosity, inserts at the adductor tubercle of the medial femoral condyle, and is innervated by the tibial division of the sciatic nerve (L4, L5). It functions as a hip extensor and contributes to knee flexion.
The dual innervation and dual insertion of the adductor magnus make it a clinically complex structure. The hamstring portion in particular can contribute to pain that radiates down the medial thigh toward the knee, as seen in our patient (Woodley et al., 2008).
Gracilis
The gracilis is a long, slender muscle that runs along the entire medial thigh. It originates from the inferior pubic ramus and body of the pubis and inserts via the pes anserinus at the proximal medial tibia, along with the sartorius and semitendinosus tendons. The obturator nerve (L2, L3) innervates it, and it is the only adductor muscle that crosses both the hip and knee joints, contributing to hip adduction and knee flexion.
Because the gracilis spans two joints and inserts below the knee, irritation or tendinopathy can produce symptoms that extend from the groin to the medial knee. This distribution closely matches our patient’s complaint of pain radiating to the knee level.
Pectineus
The pectineus is a flat, quadrilateral muscle that forms the medial floor of the femoral triangle. It originates from the pectineal line of the pubis (also called the pecten pubis) and inserts into the pectineal line of the femur, between the lesser trochanter and the linea aspera. The femoral nerve (L2, L3) innervates it, and it sometimes receives a branch from the obturator nerve. It contributes to hip adduction, flexion, and medial rotation.
The Pubic Attachment: The Clinical Epicenter
One of the most clinically important anatomical facts about the adductor complex is that most of these muscles share a common origin region at or near the pubic bone. Specifically, the adductor longus, adductor brevis, gracilis, and pectineus all originate from the pubic body, pubic crest, inferior pubic ramus, and surrounding structures. This means that the pubic symphysis and its surrounding fibrocartilaginous and tendinous attachments represent a zone of extraordinary mechanical stress, particularly with activities that require rapid changes of direction, kicking, sprinting, or any movement that creates high adductor loading combined with contralateral hip extension.
This shared pubic attachment is why palpation of the pubic bone and adjacent tendinous insertion zone is so revealing in patients with adductor tendinopathy. As demonstrated in this clinical case, pressing directly on the pubic body where the adductor tendons insert reproduces and intensifies the patient’s pain, confirming that the enthesis (the bone-tendon interface) is the primary site of pathology.
Neurovascular Supply of the Medial Thigh
Understanding the neurovascular anatomy of the medial thigh is also essential for safe injection practice and for explaining referred or radiating pain patterns.
The obturator nerve, which arises from the lumbar plexus (L2, L3, L4), is the primary nerve supplying the adductor compartment and enters the medial thigh through the obturator foramen. It divides into anterior and posterior divisions that supply the adductor muscles, the gracilis, and the skin of the medial thigh. Importantly, the obturator nerve also provides articular branches to the hip joint and, in some individuals, a cutaneous branch that extends down the medial thigh to the knee. This explains why hip joint pathology can sometimes mimic adductor tendinopathy and why adductor tendinopathy can produce pain that radiates toward the knee.
The femoral artery and vein run through the femoral triangle, lateral to the pectineus, and the profunda femoris artery provides the main blood supply to the adductor muscles via its perforating branches. The medial circumflex femoral artery is particularly important for supplying the proximal adductors and the femoral head.
The Pathophysiology of Chronic Tendinopathy: Why Tendons Fail to Heal
Now that we have established the anatomical foundation, we can begin to understand why this patient has experienced eight years of persistent, intermittent pain without a clear traumatic origin. The answer lies in the pathophysiology of chronic tendinopathy, which has been extensively studied over the past two decades and represents one of the most important areas of musculoskeletal medicine.
What Is Tendinopathy?
Tendinopathy is an umbrella term encompassing a spectrum of painful tendon conditions characterized by pain, swelling, and impaired function. Historically, these conditions were termed “tendinitis,” implying an inflammatory etiology. However, modern histopathological research has largely displaced this understanding, demonstrating that the predominant pathological changes in chronic tendon pain are degenerative rather than primarily inflammatory (Cook & Purdam, 2009).
The term tendinosis is used to describe the histopathological changes seen in affected tendons, including:
Disorganization of collagen fibrils: Normal tendon tissue consists of highly organized, parallel collagen fibers (primarily type I collagen) that efficiently transmit tensile loads. In tendinopathy, this organization breaks down, with disorganized, wavy, or fragmented collagen fibers replacing the normal architecture.
Increased ground substance: Glycosaminoglycans and proteoglycans accumulate within the tendon matrix, increasing the tissue’s water content and giving it a swollen, disorganized appearance on imaging.
Neovascularization: New blood vessels, accompanied by sensory nerve fibers, grow into the tendinopathic tissue. This process, known as angiofibroblastic dysplasia or neovascularization, is thought to be a key driver of pain in chronic tendinopathy. The new nerve fibers that accompany these blood vessels express nociceptive neurotransmitters such as substance P and glutamate, sensitizing the local tissue to mechanical and chemical stimuli (Alfredson & Cook, 2007).
Cellular changes: Tenocyte cellularity increases, with cells displaying a rounded, chondrocyte-like morphology rather than the normal spindle-shaped appearance. These altered cells produce abnormal collagen and matrix proteins, perpetuating the degenerative cycle.
Partial or complete fiber disruption: In more advanced cases, there may be evidence of intrasubstance tearing or frank partial rupture within the tendon.
The Continuum Model of Tendinopathy
Cook and Purdam (2009) proposed the influential continuum model of tendinopathy, which describes tendon pathology as existing along a spectrum from reactive tendinopathy through tendon disrepair to degenerative tendinopathy. This model has important clinical implications:
Reactive tendinopathy: An acute, non-inflammatory proliferative response of the tendon cell matrix to overload, characterized by a short-term adaptive thickening that reduces stress on the tendon. This stage is potentially reversible.
Tendon disrepair: A poorly organized healing attempt, with increased matrix production, greater disruption of collagen organization, and ingrowth of blood vessels and nerves. This stage can also be partly reversible with appropriate load management.
Degenerative tendinopathy: Advanced pathology with significant cell death, matrix disorganization, and areas of failed healing. This stage is considered irreversible in the affected zones, though surrounding healthy tendon tissue can still adapt and compensate.
In our patient, the eight-year duration of symptoms strongly suggests that the adductor tendon pathology has likely progressed well beyond the reactive stage and may involve elements of tendon disrepair or degenerative tendinopathy. This chronicity has profound implications for treatment planning, as we will discuss in detail.
Why Does Pain Persist Without a Clear Traumatic Origin?
One of the most important clinical questions raised by this case is: why does the patient have eight years of pain without being able to recall a specific traumatic event?
The answer is multifactorial and physiologically interesting.
First, tendinopathy frequently develops through repetitive, subclinical mechanical loading rather than a single traumatic event. Each time the adductor tendons are loaded, a small amount of microtrauma occurs at the cellular and molecular level. Under normal circumstances, the tendon’s intrinsic repair mechanisms (driven by tenocytes and supported by adequate blood supply and nutrient delivery) can repair this microtrauma between loading cycles. However, when the rate of microtrauma exceeds the rate of repair, a progressive pathological cascade is initiated (Magnusson et al., 2010).
Second, the enthesis (the bone-tendon junction) is a particularly vulnerable zone because it is subjected to both tensile and compressive forces simultaneously. The pubic attachment of the adductor tendons is especially exposed to these competing mechanical demands during activities that require rapid hip adduction combined with trunk rotation or contralateral hip extension, such as kicking, sprinting, or lateral cutting movements. Even in non-athletes, ordinary daily activities like walking on uneven surfaces, climbing stairs, or sitting for prolonged periods with the hips in suboptimal alignment can create cumulative entheseal stress.
Third, central and peripheral sensitization plays a major role in the persistence of chronic tendon pain. Over time, the nociceptive nerve fibers within and around the tendon become sensitized, meaning they fire more easily and at lower mechanical thresholds than normal. Additionally, the central nervous system undergoes neuroplastic changes that amplify pain perception from the affected region. This sensitization can persist even after the underlying tissue pathology has partially resolved, which is why some patients continue to experience significant pain even when their tendons look relatively normal on imaging (Fernández-de-las-Peñas & Dommerholt, 2018).
Fourth, biomechanical factors such as altered hip mechanics, reduced hip internal rotation, lumbar-pelvic dysfunction, and asymmetrical loading patterns can create chronic, uneven stress on the adductor tendons that perpetuates pathology over years or decades.
Fifth, systemic factors including metabolic dysfunction, elevated inflammatory cytokines, nutritional deficiencies (particularly in collagen precursors such as vitamin C, proline, and glycine), and hormonal imbalances can impair tendon healing and maintenance at the cellular level. This is where functional medicine assessment becomes particularly valuable, as I discuss later in this post.
The Role of Inflammation in Chronic Tendinopathy
While the term “tendinitis” has largely been retired in favor of “tendinopathy” or “tendinosis” to reflect the predominantly degenerative rather than inflammatory histopathology, inflammation is not absent from the picture. More recent research has revealed a complex interplay between inflammatory and degenerative processes in chronic tendon pain.
Schubert et al. (2014) and others have demonstrated that inflammatory cytokines such as interleukin-1 beta (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α) are present in tendinopathic tissue and can directly inhibit tenocyte function, stimulate matrix metalloproteinase production (leading to collagen degradation), and promote the neovascularization that drives pain sensitization. Furthermore, mast cells and macrophages are found in tendinopathic tissue, suggesting that a chronic, low-grade inflammatory response contributes to the pathological environment.
This nuanced understanding, recognizing that tendinopathy is neither purely degenerative nor purely inflammatory but involves a complex interaction of both processes, has important implications for treatment. This means interventions that target both the mechanical and biological dimensions of tendon pathology are likely to be more effective than those that address only one dimension.
Clinical Assessment of Adductor Tendinopathy: Examination, Palpation, and Diagnosis
With the anatomy and pathophysiology firmly established, we can now discuss how adductor tendinopathy is identified clinically. Accurate diagnosis underpins effective treatment, and I want to walk through the key components of assessment in detail.
Patient History: The Eight-Year Story
In taking a thorough history from this patient, several key features emerge that strongly suggest adductor tendinopathy:
Location of pain: Medial thigh, consistent with adductor compartment involvement
Quality of pain: Aching, which is typical of tendinopathy rather than acute injury or nerve entrapment
Radiation pattern: Distally toward the knee, consistent with gracilis involvement or sensitization of the obturator nerve’s cutaneous branch
Duration: Eight years, confirming chronicity
Onset: Insidious, without recalled trauma, consistent with a repetitive overload etiology
Pattern: Intermittent but persistent, a classic feature of tendinopathy where symptoms fluctuate with activity levels and loading demands
The absence of recalled trauma is not unusual in adductor tendinopathy. As discussed in the pathophysiology section, many tendinopathies develop gradually through repetitive microloading rather than acute injury. The patient’s eight-year history strongly suggests that the tendon has been in a cycle of insufficient healing for an extended period, possibly compounded by ongoing biomechanical, lifestyle, or systemic factors that have prevented full recovery.
Physical Examination: What the Hands Reveal
The physical examination in suspected adductor tendinopathy should be systematic and include both a general lower-extremity assessment and specific adductor-complex testing.
General assessment includes evaluation of:
Gait analysis: Looking for antalgic gait, reduced hip extension, trunk lean, or altered arm swing that might reflect attempts to offload the painful adductor complex
Hip range of motion: Assessment of active and passive hip flexion, extension, abduction, adduction, and internal/external rotation. Reduced hip abduction range of motion is commonly associated with adductor tendinopathy, as shortened, sensitized, or pathologically altered adductors restrict full abduction.
Lumbar spine assessment: Given the lumbar plexus origin of the obturator nerve (L2-L4) and the potential for lumbar pathology to refer pain into the medial thigh, evaluation of lumbar range of motion, neurological status, and provocative testing is important
Sacroiliac joint evaluation: Dysfunction at the sacroiliac joint can alter pelvic mechanics and load distribution through the adductor complex
Specific adductor testing includes:
Palpation of the adductor tendons: As demonstrated in this case, careful, systematic palpation along the length of the adductor tendons, especially at their proximal insertion on the pubic bone, is the single most valuable physical examination technique. Reproducible tenderness at the enthesis that matches the patient’s familiar pain strongly supports adductor tendinopathy.
Adductor squeeze test: The patient is positioned supine with hips and knees flexed to 45 degrees and feet flat on the table. Place a blood pressure cuff or the examiner’s fist between the knees, and ask the patient to squeeze maximally. This test loads the adductor complex isometrically and provokes pain in adductor tendinopathy. Holmich et al. (2004) reported high sensitivity for this test in athletes with long-standing adductor-related groin pain.
Resisted adduction: The patient actively adducts the hip against the examiner’s resistance. Pain with resisted adduction confirms adductor muscle or tendon involvement.
Passive abduction stretch: Gentle passive abduction of the hip stretches the adductor complex and can reproduce medial thigh pain in tendinopathy, particularly at the proximal enthesis.
Single-leg stance and balance: Assessing whether single-leg stance on the affected side reproduces pain or reveals altered pelvic control helps quantify functional impairment.
In our patient, reproducible tenderness at the pubic attachment of the adductor tendons, along with worsening symptoms with deep palpation of the pubic bone, is diagnostic. The clinical picture is classic adductor enthesopathy.
Differential Diagnosis: What Else Could It Be?
While this case strongly points to adductor tendinopathy, a thorough clinician must consider the differential diagnosis for medial thigh pain, particularly given the long duration of symptoms. Key differential diagnoses include:
Athletic pubalgia / sports hernia: A syndrome of chronic groin pain in athletes associated with weakness or disruption of the posterior inguinal wall, often coexisting with adductor tendinopathy. The two conditions frequently occur together (Meyers et al., 2007).
Osteitis pubis: Inflammatory change at the pubic symphysis, often seen in athletes and postpartum women, characterized by pubic symphysis tenderness and characteristic MRI findings
Hip joint pathology: Femoro-acetabular impingement (FAI), labral tears, and hip osteoarthritis can all produce groin and medial thigh pain that may be mistaken for adductor tendinopathy. Suspect hip joint pathology when passive internal rotation of the hip is restricted and painful.
Obturator nerve entrapment: Can cause medial thigh pain with a neuropathic quality, often with sensory changes along the medial thigh distribution of the obturator nerve’s cutaneous branch
Lumbar radiculopathy: L2-L3 nerve root compression can refer pain to the anterior and medial thigh; examination of lumbar spine and neurological testing helps distinguish this from adductor tendinopathy
Adductor muscle strain: An acute injury with a clear onset and maximal tenderness within the muscle belly rather than at the enthesis
Stress fracture of the femoral neck or pubic ramus: Should be considered in high-volume endurance athletes or individuals with risk factors for bone stress injuries; typically produces pain with weight-bearing and can be identified on MRI.
Inguinal hernia: Can produce groin pain that is exacerbated by the Valsalva maneuver and physical activity
In this patient’s case, the eight-year history, aching quality, entheseal tenderness at the pubic bone, and absence of neurological symptoms or signs of hip joint restriction make adductor tendinopathy the primary diagnosis. However, imaging would be appropriate to exclude coexisting pathology, particularly osteitis pubis.
Imaging in Adductor Tendinopathy: The Role of Ultrasound and MRI
While the diagnosis of adductor tendinopathy is primarily clinical, diagnostic imaging serves two important functions: confirming the clinical diagnosis and excluding other pathology.
Musculoskeletal ultrasound is the first-line imaging modality for assessing the adductor tendons. It offers real-time, dynamic imaging that is relatively inexpensive and can guide injection procedures with precision. Ultrasound findings in adductor tendinopathy include:
Tendon thickening
Loss of the normal fibrillar (hyperechoic, parallel-line) echotexture
Areas of hypoechogenicity within the tendon, representing zones of degeneration or intrasubstance tearing
Neovascularization detectable on power Doppler imaging, a particularly useful finding as it correlates with pain and guides prognosis
Calcific deposits within the tendon (calcific tendinopathy), if present
Entheseal irregularity or cortical erosion at the pubic attachment
MRI provides superior soft tissue contrast and can evaluate not only the tendons but also the underlying bone, the pubic symphysis, and the surrounding musculature. MRI findings in adductor tendinopathy include:
Increased signal within the tendon on T2-weighted or STIR sequences, reflecting edema and degeneration
Pubic bone marrow edema on STIR sequences, indicating reactive changes at the enthesis
Evidence of pubic symphysis widening or signal change, suggesting osteitis pubis
Partial or complete tendon tears
Secondary findings such as hip labral pathology or FAI
For this patient, given the eight-year history and the clinical findings, MRI of the pelvis and hips would be an appropriate imaging choice to fully characterize the extent of pathology before planning definitive treatment.
The Injection Procedure: Clinical Rationale, Technique, and Sterile Protocol
This post focuses on injecting the adductor tendon insertion at the pubic bone. I want to walk through every aspect of this procedure in detail, explaining not just the technical steps but the clinical reasoning and physiological rationale behind each one.
Why Inject? The Rationale for Injection Therapy in Chronic Tendinopathy
Before discussing technique, it is essential to address the question: why is injection therapy used in the management of adductor tendinopathy?
The answer requires nuance. The role of injections in tendinopathy management has evolved considerably over the past decade, and the evidence base is more complex than it might initially appear.
Corticosteroid injections have been used for decades as a treatment for tendinopathy. They work by suppressing the local inflammatory milieu by inhibiting arachidonic acid metabolism (reducing prostaglandin and leukotriene production), decreasing vascular permeability, and reducing the activity of inflammatory cells, including mast cells and macrophages. In the short term (typically 4 to 6 weeks), corticosteroid injections provide significant pain relief in many tendinopathy presentations, including adductor tendinopathy (Coombes et al., 2010).
However, the longer-term evidence for corticosteroids in tendinopathy is more cautionary. Multiple systematic reviews and randomized controlled trials have demonstrated that while corticosteroids offer superior short-term pain relief compared to placebo or physical therapy, this benefit is not sustained at 6 to 12 months and may in fact be associated with worse outcomes at longer follow-up intervals (Coombes et al., 2010; Zwiers et al., 2019). The proposed mechanism for this longer-term disadvantage is that corticosteroids can impair tenocyte function, inhibit collagen synthesis, and further degrade the already-compromised extracellular matrix of the tendinopathic tendon.
This does not mean that corticosteroid injections are without value in adductor tendinopathy. Rather, they should be used judiciously and always as part of a comprehensive rehabilitation program, not as a standalone treatment. When pain is severe enough to prevent a patient from participating in rehabilitative exercise, a well-placed corticosteroid injection can break the pain cycle and create a window of opportunity for the patient to engage in the loading-based rehabilitation essential for long-term tendon recovery.
Regenerative injection therapies, including platelet-rich plasma (PRP) and prolotherapy, have emerged as alternatives that aim not merely to suppress symptoms but to stimulate tendon healing actively. PRP is derived from the patient’s own blood and concentrated via centrifugation to create a solution rich in growth factors including platelet-derived growth factor (PDGF), transforming growth factor-beta (TGF-β), vascular endothelial growth factor (VEGF), and insulin-like growth factor-1 (IGF-1). These growth factors stimulate tenocyte proliferation, collagen synthesis, and matrix remodeling, addressing the underlying degenerative pathology rather than merely suppressing symptoms (Andia & Maffulli, 2013).
The evidence for PRP in adductor tendinopathy specifically is still developing. Still, the broader evidence base for PRP in chronic tendinopathy (particularly patellar and Achilles tendinopathy) is encouraging, with several randomized controlled trials demonstrating superior outcomes compared to corticosteroids at medium- and long-term follow-up (de Vos et al., 2010; Filardo et al., 2012).
Prolotherapy involves injecting an irritant solution (typically hypertonic dextrose) to trigger a controlled local inflammatory response that stimulates the body’s natural healing cascade. The theory is that introducing low-grade, controlled inflammation into a tendon in a state of failed healing can reactivate the natural repair process. Evidence for prolotherapy in groin and adductor tendinopathy is limited but emerging (Bertrand et al., 2016).
In this clinical case, the injection appears to involve a local anesthetic and potentially a corticosteroid, targeted at the adductor tendon insertion at the pubic bone. The clinical reasoning is to provide immediate pain relief, confirm the diagnosis through the “anesthetic test” (if the injection completely abolishes the patient’s familiar pain, it confirms the structure as the pain generator), and potentially reduce local inflammation to facilitate rehabilitation.
Pre-Injection Preparation: The Role of Sterile Technique
One of the most important principles demonstrated in this case is the commitment to maintaining a sterile procedural environment. This is not merely a formality; it is an absolute clinical imperative that protects the patient from potentially serious complications.
The prepubic region and adductor tendon insertion are in proximity to the inguinal region, which harbors significant bacterial colonization. Introducing bacteria into a tendon or enthesis via a non-sterile injection can result in septic tenosynovitis, osteitis pubis, or pubic symphysitis. These conditions are far more difficult to treat than the original tendinopathy and can cause severe, lasting harm.
The sterile preparation protocol demonstrated in this case includes:
1. Skin marking: Using the retracted tip of a ballpoint pen to mark the precise injection point on the skin before preparation. This is done before antiseptic preparation because marking after skin prep can introduce contamination. The marking ensures that the exact target is identified through careful palpation and clinical reasoning before the procedural field is established.
2. Alcohol preparation: Application of isopropyl alcohol to the skin over the injection site. Alcohol is a rapid-acting antiseptic that denatures proteins in bacterial cell walls, providing broad-spectrum antimicrobial coverage. It is highly effective against most skin flora but requires adequate contact time (at least 30 seconds) for maximum efficacy.
3. Betadine (povidone-iodine) preparation: Following alcohol preparation, the application of povidone-iodine provides additional antimicrobial coverage. Povidone-iodine releases free iodine, which is bactericidal, fungicidal, and virucidal. The combination of alcohol followed by Betadine is standard practice for injection procedures and provides a higher level of skin antisepsis than either agent alone.
This two-step antiseptic preparation protocol significantly reduces the risk of introducing skin flora into deep tissue during injection and aligns with guidelines for sterile injection technique in musculoskeletal medicine.
Vapor Coolant Spray: The Role of Pain Ease as a Pre-Injection Analgesic
A particularly thoughtful aspect of the technique demonstrated in this case is the use of vapor coolant spray (specifically a product in mist spray formulation, such as Pain Ease) applied to the injection site immediately before needle insertion.
What is vapor coolant spray?
Vapor coolant sprays are topical anesthetic agents that work through evaporative cooling. When applied to the skin, the liquid rapidly evaporates, drawing heat from the skin surface and causing a rapid, transient decrease in skin temperature. This cold-induced anesthesia reduces the sensation of the needle penetrating the skin and superficial tissues, making the procedure more comfortable for the patient.
Why use a mist spray rather than a stream spray?
Choosing a mist formulation rather than a stream formulation is clinically significant. Stream-type vapor coolant sprays can cause the cold liquid to run away from the intended application site, potentially cooling tissues that are not meant to be anesthetized or, in sensitive areas, potentially causing skin damage through excessive cooling or frost formation. A mist spray delivers the coolant as a fine, controlled aerosol that stays precisely on target, maintaining control over the cooling area and reducing the risk of inadvertent skin injury.
The physiological mechanism of vapor coolant analgesia
The mechanism of vapor coolant anesthesia is based on the gate control theory of pain and peripheral nerve cooling physiology. Cold temperature reduces the velocity of nerve conduction in A-delta fibers (which transmit sharp, acute pain) and, to a lesser extent, C fibers (which transmit slow, burning pain and are involved in sensitization). By transiently reducing the firing threshold and conduction velocity of these nociceptive fibers in the skin and superficial dermis, the vapor coolant effectively “gates out” the sharp pain of needle insertion, making the initial skin penetration significantly more comfortable.
The cooling effect is brief, typically lasting 15 to 30 seconds, which is sufficient time to perform the initial needle insertion. The deeper tissues (tendon, enthesis, periosteum) are not significantly cooled by topical spray and still require careful injection technique and appropriate injectate to minimize discomfort during the procedure.
Injection Technique: Aspiration, Distribution, and Clinical Feedback
The injection technique demonstrated in this case reflects several important clinical principles that deserve detailed elaboration.
Aspiration before injection
Before injecting any substance, the clinician aspirates the syringe plunger to check for blood return. This is a critical safety step. The femoral vessels (femoral artery and femoral vein) lie in the femoral triangle, near the origins of the pectineus and adductor longus. The obturator artery and its branches also run in the medial thigh. Inadvertent intravascular injection of a corticosteroid or anesthetic can cause systemic toxicity, vascular embolism, or other serious complications. A negative aspiration (no blood return) confirms that the needle tip is not within a blood vessel, making it safe to proceed with injection.
If blood is aspirated, the needle must be repositioned before injection is attempted.
Distribution of the injectate along the tendon
Rather than depositing the entire volume of injectate at a single point, the technique demonstrated involves distributing the injection at multiple points along the tendon and at its insertion, specifically:
Half of the injectate at the primary site of maximal tenderness at the tendon insertion
A quarter of the injectate at a slightly different point along the tendon where additional tenderness is detected
The remaining quarter at another position along the tendon
This “fan” or “walk” technique ensures that the injectate bathes the entire length of the proximal tendon and its entheseal insertion, maximizing the therapeutic effect. Because the adductor longus, adductor brevis, gracilis, and pectineus all insert near this region, distributing the injection allows the medication to reach the insertion zones of multiple structures simultaneously.
This approach is supported by the observation that, in chronic tendinopathy, pathological changes are often distributed along a segment of the tendon rather than confined to a single point. A single-point injection may provide excellent relief at the point of maximum tenderness while leaving adjacent areas of pathology untreated, leading to partial or temporary relief at best.
Monitoring patient feedback during the procedure
An important feature of the injection technique demonstrated in this case is the continuous monitoring of patient comfort throughout the procedure. The clinician asks the patient repeatedly whether he is experiencing pain or pressure. When the patient indicates mild discomfort at one point (“A little bit. Okay. So you flinch just a little bit”), the clinician responds by administering additional injectate at that location. This feedback-guided approach ensures the injection is targeted not only by anatomical knowledge and pre-procedural palpation but also by real-time patient feedback on where the pathology is most active.
This is an important principle: the patient’s pain response during careful probing and injection is a diagnostic tool that helps confirm and refine the precise location of the tendinopathic tissue.
Post-injection care
Following the injection, a bandage is applied over the injection site. Post-injection care instructions typically include:
Avoiding vigorous activity for 24 to 48 hours to allow the injectate to take effect and to reduce the risk of post-injection flare
Applying ice to the injection site if local soreness develops
Returning for follow-up assessment within 1 to 2 weeks to evaluate the response to injection and plan the next phase of treatment
Beginning or continuing a structured rehabilitation program as soon as the post-injection soreness resolves
The post-injection period is a critical window. The pain relief from the injection creates an opportunity to begin the rehabilitative loading program essential for long-term tendon recovery. Emphasize to the patient: the injection is not the cure; it is the door opener that allows the real work of rehabilitation to begin.
Beyond Adjustments: Chiropractic and Integrative Healthcare- Video
Integrative Chiropractic Care in Adductor Tendinopathy: Why Structural Assessment and Manual Therapy Matter
One of the most important contributions I bring to managing conditions like adductor tendinopathy is my perspective on integrative chiropractic care. While injection therapy can provide meaningful pain relief and functional improvement, it does not address the underlying biomechanical dysfunctions that created and perpetuate the tendinopathy in the first place. Without addressing these root structural causes, recurrence is likely.
The Biomechanical Origins of Adductor Tendinopathy
Adductor tendinopathy rarely develops in a biomechanical vacuum. Almost universally, careful assessment reveals one or more of the following contributing mechanical factors:
1. Lumbar-Pelvic Dysfunction
The relationship between the lumbar spine, pelvis, and hip complex is among the most clinically important in the musculoskeletal system. The concept of regional interdependence, well articulated by Wainner et al. (2007), describes how dysfunction in one body region creates compensatory demands on adjacent regions, ultimately resulting in tissue overload and injury at remote sites.
In adductor tendinopathy, lumbar segmental dysfunction (particularly at L2-L4, which influences the lumbar plexus and obturator nerve) can alter neuromuscular control of the adductor complex, reducing the efficiency and timing of adductor muscle activation, when the adductors contract in a discoordinated or mistimed fashion, the mechanical stress at the enthesis is amplified, contributing to the development and perpetuation of tendinopathy.
Similarly, sacroiliac joint dysfunction can create asymmetric pelvic mechanics that alter the tension distribution across the adductor insertions, placing disproportionate load on one side (typically the side of the restricted sacroiliac joint) and predisposing that adductor complex to overload.
Chiropractic assessment and treatment of lumbar segmental dysfunction through high-velocity, low-amplitude (HVLA) spinal manipulation or mobilization techniques restore normal joint motion, reduce muscle guarding, optimize neurological input to the adductor complex, and normalize pelvic mechanics. This is a foundational element of the integrative chiropractic approach to adductor tendinopathy.
2. Hip Joint Mobility Restriction
Restricted hip mobility, particularly in internal rotation and extension, is a well-documented contributor to medial thigh and groin pathology. When the hip joint cannot achieve full range of motion in these directions, the body compensates through excessive motion at the lumbar spine, the pelvis, and the adductor tendons. Over time, this compensation creates chronic overload at the adductor enthesis.
Femoro-acetabular impingement (FAI), in which bony abnormalities of the femoral head-neck junction or the acetabular rim create abnormal contact and motion restriction within the hip joint, is a particularly common co-contributor to adductor tendinopathy (Reiman et al., 2015). Even without FAI, idiopathic hip mobility restriction from capsular tightness or joint degeneration can produce the same biomechanical cascade.
Chiropractic hip mobilization techniques, including joint distraction, posterior-to-anterior glide mobilizations, and longitudinal mobilizations, can improve hip joint mobility, reduce capsular restriction, and alter the mechanical demands on the adductor tendons. Combined with therapeutic exercise targeting hip mobility and strength, these techniques form a powerful component of the integrative care program.
3. Altered Hip Abductor and Gluteal Strength and Neuromuscular Control
The hip abductors (gluteus medius, gluteus minimus, tensor fasciae latae) play a critical role in stabilizing the pelvis during single-leg stance and gait. When these muscles are weak or poorly activated, the pelvis drops toward the unsupported side during single-leg stance (Trendelenburg sign), increasing adductor load on the weight-bearing side as the adductors work eccentrically to control pelvic descent.
This gluteal insufficiency pattern is an extremely common finding in patients with adductor tendinopathy, and correcting it through targeted hip abductor and gluteal strengthening is one of the most important components of the rehabilitation program. Physiotherapy-based exercise programs that emphasize progressive loading of the gluteal complex, combined with neuromuscular re-education to improve movement patterns and timing, consistently produce better long-term outcomes than approaches that address only the adductor complex in isolation (Holmich et al., 1999).
4. Thoracolumbar Fascial Tension
The thoracolumbar fascia (TLF) is a multilayered connective tissue structure that connects the upper extremity and thoracic spine with the lumbar spine, pelvis, and lower extremity through a series of anatomical tensegrity connections. Restriction or dysfunction in the TLF can alter force transmission through the pelvis and into the adductor complex, contributing to chronic adductor loading.
Manual therapy techniques targeting the TLF, including myofascial release, instrument-assisted soft tissue mobilization (IASTM), and dry needling of TLF trigger points, can reduce fascial tension, normalize force transmission, and help relieve adductor tendinopathy symptoms.
5. Lower Extremity Alignment and Foot Mechanics
Excessive foot pronation can create internal tibial rotation, which in turn creates medial rotation stress at the hip and increased adductor loading. Similarly, leg length discrepancy (anatomical or functional) can create asymmetric pelvic tilt and unilateral adductor overload.
A comprehensive evaluation of adductor tendinopathy should include chiropractic assessment of lower extremity alignment, foot mechanics, and leg length, and appropriate orthotic prescription, taping, or lower extremity mobilization can address contributing factors at this level.
Chiropractic Manual Therapy Techniques in the Treatment of Adductor Tendinopathy
Beyond the spinal and hip interventions described above, several manual therapy techniques can be applied directly to the adductor complex and its proximal attachment to facilitate healing, reduce pain, and restore tissue mobility.
1. Soft Tissue Mobilization (STM)
Systematic soft tissue mobilization along the length of the adductor muscles and tendons helps to:
Break up adhesions and scar tissue that may have formed within the tendon matrix as part of the failed healing response
Stimulate tenocyte mechanoreceptors, promoting matrix remodeling and collagen synthesis
Improve local tissue perfusion and lymphatic drainage, supporting the metabolic environment of healing
Reduce muscle hypertonicity and trigger point activity within the adductor belly that may be contributing to entheseal load.
STM techniques include cross-fiber friction massage (applied transversely across the tendon fibers), longitudinal stripping, and petrissage of the muscle belly.
2. Active Release Technique (ART)
Active Release Technique is a patented manual therapy method that applies precise, directed contact to the affected tissue. At the same time, the patient actively moves the associated limb through a specified range of motion. This creates a controlled, therapeutic shear force through the tissue that can effectively break adhesions, release entrapped nerves, and restore normal tissue glide.
In adductor tendinopathy, apply ART along the adductor longus from its pubic attachment to the femur. At the same time, the patient moves the hip from adduction to abduction, which can significantly improve tissue texture, pain, and function.
IASTM uses specifically designed stainless steel or titanium instruments to apply controlled microtrauma to the skin surface over the affected tissue. The instruments’ beveled edges concentrate the mechanical stimulus, detecting and treating areas of tissue restriction and adhesion that may be palpable through the instruments but not easily detectable by hand.
The controlled microtrauma delivered by IASTM is thought to stimulate a local inflammatory response that recruits growth factors and healing cells to the site of chronic, failed healing, essentially “resetting” the healing cascade and promoting productive matrix remodeling (Gehlsen et al., 1999). This is a particularly compelling approach for chronic tendinopathy where the tissue has been stuck in a degenerative cycle.
4. Dry Needling
Dry needling involves inserting fine-gauge acupuncture needles into trigger points (hyperirritable spots within taut bands of skeletal muscle) and into areas of tendon pathology identified by palpation or ultrasound guidance. The needle elicits a local twitch response in the muscle: a brief, involuntary contraction of the taut band fibers followed by muscle relaxation, improved tissue perfusion, and normalization of the neurochemical milieu in the area.
In adductor tendinopathy, dry needling can address trigger points in the adductor muscle belly (which contribute to referred pain into the medial thigh and knee) and directly target the pathological zone of the tendon at the enthesis, stimulating a healing response.
5. Kinesio Taping
Kinesio taping of the adductor complex during the rehabilitation phase provides several benefits: it supports the adductor tendons during loading activities, reduces pain through mechanoreceptor stimulation that modulates nociceptive input (a form of the gate control mechanism), and provides proprioceptive feedback that can improve neuromuscular activation patterns. While the evidence for kinesio taping as a standalone treatment is modest, it is a useful adjunct within a comprehensive rehabilitation program (Drouin et al., 2013).
Rehabilitation and Exercise Prescription for Adductor Tendinopathy: The Science of Tendon Loading
The most important and evidence-based component of long-term adductor tendinopathy management is progressive tendon loading through targeted exercise. I want to discuss this in detail because it is the element most likely to produce lasting recovery, and it is also the element most often misunderstood or underutilized in clinical practice.
Why Loading Matters: The Biology of Tendon Adaptation
Tendons are mechanosensitive structures. They respond to mechanical loading through a cascade of cellular events that promote collagen synthesis, matrix remodeling, and structural adaptation. This principle underlies the use of exercise in tendinopathy: appropriate mechanical loading stimulates the anabolic response needed for tendon healing. In contrast, inadequate loading (rest) allows the degenerative process to progress and the tendon to weaken further.
The key word is “appropriate.” A critical loading threshold concept known as the “therapeutic window” applies to tendon loading. Below this threshold, the tendon receives insufficient mechanical stimulus for healing adaptation. Above this threshold, the loading exceeds the tendon’s current structural capacity and causes further microtrauma. Within the therapeutic window, the loading is sufficient to stimulate healing without causing harm.
The clinical challenge is identifying and staying within this window as the tendon’s capacity changes over rehabilitation. This requires careful, progressive loading programs guided by pain monitoring protocols.
Isometric Exercise: The Foundation of Early Tendinopathy Rehabilitation
Isometric exercises (contractions without joint movement) have emerged as a particularly valuable tool in the early and acute management of tendinopathy. Research by Rio et al. (2015) and others has demonstrated that sustained isometric contractions (typically 45 to 60 seconds at 70% of maximum voluntary contraction, performed 4 to 5 repetitions) produce immediate, significant reductions in tendon pain that can last for 45 minutes or more after exercise.
The proposed mechanisms for this isometric analgesia include:
Cortical inhibition: Isometric exercise has been shown to reduce cortical excitability in the motor regions associated with the painful limb, which may reduce central sensitization contributing to tendon pain
Mechanoreceptor stimulation: The sustained tension generated by isometric contraction stimulates tendon mechanoreceptors (Golgi tendon organs and Ruffini endings), which send inhibitory signals to the spinal cord that “gate out” nociceptive input
Normalization of motor patterns: Isometric exercise reestablishes normal motor neuron firing patterns in muscles that may be inhibited by pain, preparing them for progressive loading
For adductor tendinopathy specifically, perform isometric adduction exercises with the patient standing or side-lying, isometrically squeezing against a fixed surface (wall, foam block, or Swiss ball) for 45 to 60 seconds at a moderate intensity (4/10 pain or less). Perform this 4 to 5 times per session, once or twice daily.
Isotonic Loading: The Progression to Functional Strength
As pain allows and the tendon’s capacity improves, the exercise program progresses from isometric to isotonic loading (contractions with joint movement). Isotonic exercises provide a richer mechanical stimulus for tendon adaptation because they load the tendon through a range of motion, exposing it to both concentric (shortening) and eccentric (lengthening) loading conditions.
Eccentric loading has historically been emphasized in tendinopathy rehabilitation because it subjects the tendon to the highest tensile loads per unit of muscle activation, making it a particularly potent stimulus for collagen synthesis and matrix remodeling (Alfredson et al., 1998). However, more recent research has challenged the idea that eccentrics are uniquely superior, showing that heavy slow resistance (HSR) training, which combines concentric and eccentric loading at heavy loads and slow tempos, produces outcomes equivalent to or better than eccentric-only programs (Beyer et al., 2015).
For adductor tendinopathy, isotonic loading exercises include:
Copenhagen adduction exercise: One of the most evidence-based exercises for adductor loading and tendinopathy rehabilitation. The patient lies on their side with the top leg supported on a bench or box and performs a lateral trunk bridge by lifting the pelvis off the ground using adductor contraction. This exercise loads the adductors eccentrically and concentrically through a functional range and has been shown to increase adductor strength and reduce groin injury risk significantly (Ishoi et al., 2016).
Side-lying hip adduction: A classic rehabilitation exercise performed with or without resistance (ankle weights or resistance bands), progressing in load and range as the tendon adapts.
Adductor squeeze with ball: Squeezing a Swiss ball or rolled towel between the knees in supine, progressing to seated and standing positions and varying the hip angle to alter the mechanical demand.
Sumo squats and wide-stance deadlifts: As the adductors recover capacity, compound functional exercises load the entire lower kinetic chain, including the adductors as hip stabilizers during compound movements.
Lateral lunges and lateral step-ups: Loading the adductor complex through functional movement patterns that replicate the demands of activities of daily living and sport.
Sport-Specific and Functional Progression
For patients who wish to return to athletic activities, the final phase of rehabilitation involves sport-specific loading that progressively exposes the adductor complex to the cutting, kicking, sprinting, and direction-changing demands of their activity. This phase follows the principle of graded exposure: systematically reintroducing the specific movements that historically provoked symptoms at gradually increasing intensities, while monitoring pain response and adjusting load accordingly.
Return-to-sport criteria for adductor tendinopathy should include:
Adductor squeeze test strength: symmetrical compared to the unaffected side (>90% of non-involved side)
Pain-free performance of the Copenhagen adduction exercise at a minimum of 3 sets of 12 repetitions
Pain-free completion of sport-specific cutting and change-of-direction drills
Absence of post-exercise soreness (or soreness that resolves within 24 hours)
Patient confidence in the ability to perform at pre-injury level
Pain Monitoring During Rehabilitation
A critical practical tool for managing tendon rehabilitation is a structured pain monitoring model. The most widely used framework is the “traffic light” system adapted from Silbernagel et al. (2007), which categorizes pain during exercise into acceptable (green, 0-3/10), acceptable with caution (yellow, 4-5/10), and unacceptable (red, 6+/10) zones. Pain that remains in the green zone during and after exercise indicates appropriate loading. Pain that enters the red zone signals overloading and requires a reduction in exercise volume or intensity.
A simpler rule sometimes used in clinical practice is the 24-hour pain rule: exercise-induced pain should not increase beyond the baseline level when reassessed 24 hours after exercise. If it does, the session was too intense, and you should reduce the load.
Functional Medicine Assessment in Chronic Tendinopathy: Addressing the Systemic Dimension
One of the most distinctive aspects of the care I provide at Injury Medical Clinic PA is integrating functional medicine principles into the assessment and treatment of musculoskeletal conditions. This is particularly relevant in chronic tendinopathy, where systemic factors often play a significant but underrecognized role in perpetuating the pathological tissue environment.
Metabolic and Inflammatory Contributors to Tendinopathy
Systemic inflammation is increasingly recognized as a significant contributor to chronic tendinopathy. Elevated levels of circulating inflammatory cytokines (IL-1β, IL-6, TNF-α) impair tenocyte function, increase matrix metalloproteinase activity (accelerating tendon matrix degradation), and promote the neovascularization that drives pain sensitization. These elevated cytokine levels may arise from:
Metabolic syndrome: Insulin resistance, dyslipidemia, and visceral adiposity are all associated with elevated systemic inflammatory markers. Rechardt et al. (2010) demonstrated a significant association between metabolic syndrome and rotator cuff tendinopathy, and similar associations have been observed for other tendinopathy presentations.
Type 2 diabetes and insulin resistance: Hyperglycemia promotes advanced glycation end products (AGEs) in the tendon matrix, which cross-link collagen fibers and make them brittle, stiff, and resistant to the normal stress-relaxation that allows healthy tendon function. Diabetes is a well-established risk factor for tendinopathy and tendon rupture (Ranger et al., 2016).
Dyslipidemia: Elevated LDL cholesterol and triglycerides are associated with increased tendon pathology through mechanisms that include lipid deposition in the tendon matrix and oxidative stress.
Thyroid dysfunction: Both hypothyroidism and hyperthyroidism can affect tendon metabolism and strength. Hypothyroidism in particular is associated with tendinopathy and tendon rupture, possibly through effects on collagen synthesis and matrix turnover (Arroyo & Marquez, 2015).
Functional medicine assessment of these metabolic contributors includes:
Fasting insulin and HOMA-IR (homeostatic model assessment of insulin resistance)
Hemoglobin A1c and fasting glucose
Comprehensive lipid panel including LDL particle size and number
High-sensitivity C-reactive protein (hsCRP) and erythrocyte sedimentation rate (ESR) as markers of systemic inflammation
Comprehensive metabolic panel to assess organ function and nutritional status
Nutritional Factors in Tendon Health and Healing
Nutritional status profoundly influences the tendon’s structural integrity and healing capacity. Several specific nutrients play critical roles in tendon biology:
Vitamin C (Ascorbic Acid)
Vitamin C is an essential cofactor for prolyl hydroxylase and lysyl hydroxylase, enzymes that hydroxylate proline and lysine residues in procollagen. This hydroxylation step is essential for forming stable, cross-linked collagen fibers. Without adequate vitamin C, collagen synthesis is impaired, compromising the tendon’s structural integrity. Research by Shaw et al. (2017) showed that vitamin C supplementation combined with collagen hydrolysate significantly increased collagen synthesis markers and improved collagen content in repaired tendons.
Clinical recommendation: Vitamin C supplementation at doses of 1,000 mg to 2,000 mg daily, particularly when taken 30 to 60 minutes before mechanical loading (to maximize bioavailability during the loading-stimulated collagen synthesis window).
Collagen Hydrolysate and Gelatin
Hydrolyzed collagen peptides provide the amino acid building blocks (glycine, proline, hydroxyproline) needed for tendon collagen synthesis. Multiple studies show that collagen hydrolysate supplementation increases circulating collagen synthesis markers and improves tendon outcomes when combined with exercise. The timing of ingestion relative to exercise is important, as the loading stimulus and the nutritional substrate appear to act synergistically.
Magnesium
Magnesium is required for hundreds of enzymatic reactions involved in protein synthesis, energy production, and inflammation regulation. Magnesium deficiency is associated with impaired collagen synthesis and increased inflammatory cytokine production. Supplementation with magnesium glycinate or magnesium threonate (forms with superior bioavailability) can support tendon healing in deficient individuals.
Omega-3 Fatty Acids
Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) from marine sources exert potent anti-inflammatory effects by competing with arachidonic acid for cyclooxygenase and lipoxygenase enzymes, reducing the production of pro-inflammatory prostaglandins and leukotrienes. Several studies have demonstrated benefits of omega-3 supplementation in reducing inflammatory markers and supporting connective tissue health (Smith et al., 2011).
Vitamin D
Vitamin D deficiency is extremely common in the general population and has been associated with increased risk of musculoskeletal injuries, including tendinopathy. Vitamin D exerts genomic effects on tenocytes through the vitamin D receptor, influencing collagen synthesis, cell proliferation, and apoptosis. Optimization of vitamin D status (targeting serum 25-hydroxyvitamin D levels of 50-80 ng/mL) is a simple but potentially significant intervention in chronic tendinopathy management.
Zinc and Copper
Both zinc and copper are required for lysyl oxidase function, the enzyme that cross-links collagen and elastin fibers to form stable matrix structures. Deficiency in either mineral impairs the structural integrity of the tendon matrix.
Gut Health and Systemic Inflammation
Increasingly, research is revealing the profound influence of gut microbiome composition on systemic inflammation, immune function, and musculoskeletal health. Intestinal dysbiosis (an imbalanced gut microbial community) or increased intestinal permeability (“leaky gut”) allows bacterial endotoxins (particularly lipopolysaccharide, LPS) to enter the systemic circulation, triggering a chronic, low-grade inflammatory response that can exacerbate tendinopathy by elevating circulating cytokines that impair tenocyte function.
Functional medicine assessment of gut health includes:
Comprehensive stool analysis with microbiome profiling
Assessment of dietary patterns and their effects on gut microbiome diversity
Interventions to support gut health and reduce gut-driven systemic inflammation include:
Elimination of ultra-processed foods, refined sugars, and trans fats
Increased dietary fiber from diverse plant sources to support microbiome diversity
Probiotic supplementation with evidence-based strains
Glutamine and zinc carnosine supplementation to support intestinal barrier integrity
Identification and elimination of food sensitivities that may be driving intestinal inflammation
This level of systemic assessment and intervention is a hallmark of the functional medicine approach and represents a significant advantage of the integrated care model at Injury Medical Clinic PA. By identifying and addressing systemic contributors to tendon pathology, we create a more favorable biological environment for healing that no injection or exercise program alone can provide.
Personal Injury Care and Adductor Tendinopathy: When Trauma Triggers or Exacerbates Chronic Conditions
While the patient in this case does not recall a specific traumatic event, it is clinically important to discuss the relationship between personal injury (including motor vehicle accidents, workplace injuries, and sports injuries) and the development or exacerbation of adductor tendinopathy, as this intersection is highly relevant to the scope of care at Injury Medical Clinic PA.
How Acute Trauma Can Initiate Chronic Tendinopathy
A significant acute force applied to the adductor complex, such as might occur in a motor vehicle accident through sudden braking and bracing with the legs, a workplace fall onto the hip, or an acute adductor strain in an athletic context, can initiate the pathological cascade of tendinopathy by creating immediate structural damage to tendon fibers at the enthesis. If this acute injury is not adequately diagnosed and treated, the tendon may enter the failed healing cycle described earlier, transitioning from acute inflammation through tendon disrepair to chronic degenerative tendinopathy.
In personal injury cases, the documentation of this injury-to-tendinopathy progression is clinically and medico-legally important. A thorough initial assessment documenting the extent of soft tissue injury, combined with appropriate imaging and functional assessment, establishes the causal link between the trauma and the subsequent chronic condition.
The Role of Chiropractic and Medical Collaboration in Personal Injury Cases
In personal injury cases managed at Injury Medical Clinic PA, the collaboration between Dr. Jimenez and Dr. Cardenas provides a comprehensive, medically defensible framework for patient care. As Medical Director, Dr. Cardenas ensures all treatment is medically necessary and properly documented, that systemic factors (such as pre-existing metabolic conditions) are assessed and managed, and that the overall medical picture is clearly communicated in records that may be relevant to legal proceedings.
Dr. Jimenez’s role as chiropractor and advanced practice provider ensures that the biomechanical, structural, and functional dimensions of the injury are thoroughly assessed and treated, including spinal and pelvic manipulation to address injury-related joint dysfunction, rehabilitative exercise to restore strength and functional capacity, and functional medicine assessment to support systemic healing.
The combination of medical direction and integrative chiropractic care in the same clinic under a collaborative model means patients receive streamlined, coordinated care without navigating multiple providers, reducing communication gaps, avoiding contradictory treatment approaches, and optimizing the efficiency and effectiveness of the recovery process.
Documentation Standards in Personal Injury Care
For medico-legal purposes, Injury Medical Clinic PA maintains comprehensive, evidence-based documentation standards. Each clinical encounter includes:
Thorough subjective history: Patient’s description of the mechanism of injury, symptom onset, quality, location, radiation, aggravating and relieving factors, and functional impact
Objective physical examination findings: Measured range of motion, strength testing results, palpatory findings, orthopedic and neurological test results
Assessment and diagnosis: Clearly stated diagnoses using ICD coding, with reference to the clinical evidence supporting each diagnosis
Treatment plan: Specific interventions selected with documented clinical rationale, including frequency, duration, and expected goals
Progress notes: Regular reassessment of objective findings and patient-reported outcomes to demonstrate treatment efficacy and guide plan modifications
Functional outcome measures: Standardized, validated outcome questionnaires (such as the PROMIS scales, Numeric Pain Rating Scale, and condition-specific functional indices) that provide quantitative evidence of treatment response
This documentation framework ensures patients receive thorough care while creating the evidence-based paper trail needed for insurance claims, legal proceedings, and continuity of care.
The Neuroscience of Chronic Pain in Tendinopathy: Understanding Why Pain Persists
No comprehensive discussion of chronic adductor tendinopathy would be complete without a thorough exploration of the neuroscience of chronic pain, because understanding why pain persists is essential for developing effective treatment strategies, particularly for patients like our 35-year-old who has suffered for eight years.
Peripheral Sensitization in Tendinopathy
As mentioned earlier, neovascularization in tendinopathic tissue is accompanied by ingrowth of nociceptive nerve fibers. These fibers express neuropeptides including substance P, calcitonin gene-related peptide (CGRP), and excitatory amino acids such as glutamate, all of which contribute to local peripheral sensitization.
Peripheral sensitization describes a state in which nociceptive neurons have a lower activation threshold and a higher firing rate in response to mechanical stimuli. In adductor tendinopathy, this means a mechanical load that would normally be subthreshold for pain now produces significant pain. Clinically, this manifests as tenderness to palpation at loads that would not normally be painful and pain with activities that should not normally stress the tendon enough to cause discomfort.
Alfredson and Cook (2007) showed that neovascular ingrowth and accompanying nerve fiber invasion in Achilles tendinopathy (a model that translates well to adductor tendinopathy) correlated closely with pain intensity, and that treatments that reduced neovascularization (including sclerosing injection therapy targeting the neovessels) produced significant pain relief. This provides direct evidence that peripheral sensitization driven by neovascularization contributes to tendinopathy pain.
Central Sensitization in Chronic Tendinopathy
Beyond peripheral sensitization, patients with chronic tendinopathy of long duration (such as our eight-year case) frequently develop central sensitization, a neuroplastic change in the central nervous system characterized by:
Wind-up: Progressive increase in pain response to repeated identical stimuli, due to summation of C-fiber input at second-order neurons in the dorsal horn
Allodynia: Pain produced by stimuli that are not normally painful (such as light touch over the medial thigh)
Hyperalgesia: Exaggerated pain response to mildly painful stimuli
Expanded pain area: Pain that extends beyond the anatomical distribution of the injured tissue, suggesting that central processing has expanded the pain representation in the somatosensory cortex
Fernández-de-las-Peñas and Dommerholt (2018) reviewed evidence for central sensitization in musculoskeletal pain conditions. They showed that patients with chronic tendinopathy often show signs of widespread sensory hypersensitivity (quantified through pressure pain threshold testing and conditioned pain modulation assessments) consistent with central sensitization.
Clinically, central sensitization complicates tendinopathy management because it means pain no longer accurately reflects local tissue damage. Even after the peripheral tissue pathology has been improved through injection, exercise, and manual therapy, the central nervous system may continue to generate pain because it has been “rewired” to do so through years of chronic nociceptive input.
Addressing central sensitization requires interventions targeted at the central nervous system, including:
Pain education (Pain Neuroscience Education, PNE): Educating patients about the neuroscience of chronic pain, the concept of central sensitization, and the fact that pain does not always mean tissue damage. This education has been shown to reduce pain catastrophizing, improve function, and change pain behavior in patients with chronic musculoskeletal pain (Moseley, 2003).
Graded motor imagery and mirror therapy: Techniques that use mental imagery and mirror-based visual feedback to normalize cortical motor and sensory representations of the painful body part.
Mindfulness-based stress reduction (MBSR): Mindfulness practices reduce activity in brain regions associated with pain amplification (including the anterior cingulate cortex and insula) and increase activity in regions associated with pain modulation.
Sleep optimization: Poor sleep quality is both a cause and a consequence of central sensitization. Restoring healthy sleep architecture through behavioral and nutritional interventions reduces central sensitization and improves pain thresholds.
In the integrative care model at Injury Medical Clinic PA, addressing central sensitization components of chronic tendinopathy pain is an explicit part of the treatment plan, typically involving both patient education by clinical staff and, where indicated, referral to behavioral health professionals specializing in chronic pain psychology.
The Role of Dr. Maria Guadalupe Cardenas in Managing Complex Adductor Tendinopathy Cases
As I describe the comprehensive, integrative approach to adductor tendinopathy at Injury Medical Clinic PA, I want to highlight the specific and indispensable contributions of Dr. Maria Guadalupe Cardenas, MD, whose internal medicine expertise adds a critical layer of safety, thoroughness, and medical authority to our collaborative care model.
Internal Medicine Expertise in the Context of Tendinopathy
Board-certified internal medicine physicians are uniquely trained to assess systemic contributors to musculoskeletal conditions that practitioners focused exclusively on the structural dimensions of care might miss. With over 40 years of experience as an internist, Dr. Cardenas brings extraordinary breadth and depth of clinical knowledge to every case.
In the context of adductor tendinopathy, Dr. Cardenas evaluates and manages:
Systemic Disease That May Present as or Contribute to Medial Thigh Pain
Several systemic conditions can produce medial thigh pain that mimics or coexists with adductor tendinopathy, and identifying these is essential for appropriate management:
Avascular necrosis of the femoral head: Can produce groin and medial thigh pain that may be confused with adductor tendinopathy, particularly in patients on long-term corticosteroid therapy, those with a history of alcohol use disorder, or those with sickle cell disease
Femoral neck stress fracture: A serious condition that requires urgent diagnosis and activity restriction; can present similarly to adductor tendinopathy in endurance athletes
Pelvic malignancy or lymphadenopathy: Rarely, medial thigh pain can be a manifestation of inguinal lymphadenopathy from pelvic or abdominal malignancy
Inflammatory arthropathy: Ankylosing spondylitis, psoriatic arthritis, and reactive arthritis can all produce enthesitis at the pubic adductor attachment, requiring a very different treatment approach than mechanical tendinopathy
Infection: Septic arthritis of the hip or pubic symphysitis can produce groin and medial thigh pain; fever, elevated inflammatory markers, and systemic signs help distinguish these from mechanical tendinopathy
Dr. Cardenas conducts thorough internal medicine assessments, including appropriate laboratory investigations, review of systems, and, when indicated, referral for advanced imaging or specialist consultation to exclude these systemic causes before confirming a mechanical tendinopathy diagnosis.
Management of Comorbid Conditions That Affect Treatment
Many patients with chronic musculoskeletal pain have comorbid conditions that affect both the likelihood of response to treatment and the safety of specific interventions. Dr. Cardenas manages these comorbidities in coordination with the chiropractic and functional medicine care, including:
Anticoagulation management: Patients on warfarin, NOACs, or antiplatelet therapy require careful assessment before injection procedures, as these medications increase the risk of post-injection hematoma
Corticosteroid safety: Patients with diabetes require monitoring of blood glucose after corticosteroid injections, as even a single local injection can cause transient hyperglycemia
Medication interactions: Patients on fluoroquinolone antibiotics have a dramatically increased risk of tendon rupture, and this class of antibiotics is absolutely contraindicated in patients with active tendinopathy. Dr. Cardenas’ oversight ensures that medications prescribed to the patient (by any provider) are reviewed for tendon toxicity.
Osteoporosis management: Patients with reduced bone density are at increased risk of stress fractures and may require bisphosphonate therapy or other bone-protective interventions that influence the overall care plan
Medical Direction of Injection Procedures
As Medical Director, Dr. Cardenas provides the medical oversight required for the injection procedures performed at the clinic. This includes:
Review and approval of the treatment plan
Ensuring that appropriate indications, contraindications, and informed consent processes are followed
Oversight of the sterile technique protocols that prevent infectious complications
Medical management of any adverse reactions that may occur during or after procedures
This medical oversight is not merely a regulatory formality. It represents a genuine safety net that protects patients and ensures that every procedure is performed within a framework of responsible, evidence-based medical practice.
Long-Term Management and Prevention of Recurrent Adductor Tendinopathy
One of the most clinically important questions in adductor tendinopathy management is: after a patient recovers, how do we prevent recurrence?
This is particularly relevant for our patient, who has experienced eight years of intermittent symptoms, suggesting a pattern of partial recovery followed by relapse. Understanding and addressing the factors driving this recurrence cycle is essential to achieving truly durable outcomes.
Maintenance Exercise Programming
The single most important factor in preventing recurrence of adductor tendinopathy is maintaining adequate adductor and hip strength and loading capacity. Research consistently shows that patients who stop their exercise program after symptoms resolve are significantly more likely to experience recurrence than those who maintain a long-term maintenance program (Holmich et al., 1999).
A maintenance program for adductor tendinopathy prevention should include:
Copenhagen adduction exercises: 2 to 3 sets of 8 to 12 repetitions, 2 to 3 times per week, maintained indefinitely
Hip abductor and gluteal strengthening: To maintain the pelvic stability that reduces adductor compensatory loading
Functional compound lower extremity exercises: Squats, lunges, deadlifts, and their variations provide systemic lower extremity conditioning that distributes load across the entire kinetic chain, reducing the risk of isolated adductor overload
Progressive sport-specific loading: For athletes, gradually increasing the volume and intensity of sport-specific training following periods of reduced activity (pre-season ramp-up) rather than making abrupt large increases in load
Load Management Principles
Load management is a key concept in sports and musculoskeletal medicine that involves monitoring and controlling the cumulative physical stress placed on the body to stay within the adaptive zone and avoid exceeding the injury threshold. The acute: chronic workload ratio (ACWR) framework developed by Gabbett (2016) provides a practical tool for this:
Acute workload: The load experienced in the most recent week
Chronic workload: The average weekly load over the past 4 weeks
When the acute: chronic workload ratio is between 0.8 and 1.3, injury risk is minimal (the “sweet spot”). When the ratio exceeds 1.5 (a sudden spike in load relative to the chronic baseline), injury risk increases dramatically. This framework explains why abrupt increases in training volume or intensity most commonly precipitate adductor tendinopathy recurrence.
Educating patients about load management principles and providing practical tools to monitor training load is an important component of long-term recurrence prevention.
Biomechanical Maintenance and Periodic Chiropractic Assessment
Even after full symptom resolution, patients with a history of adductor tendinopathy benefit from periodic chiropractic assessment (every 6 to 12 weeks) to monitor for the re-emergence of lumbar-pelvic dysfunction, hip mobility restriction, or other biomechanical factors that, if left uncorrected, would gradually recreate the conditions that led to the original tendinopathy. This proactive, maintenance-based approach to chiropractic care is one of the most cost-effective strategies available for preventing chronic musculoskeletal recurrence.
Nutritional Maintenance
The nutritional interventions discussed in the functional medicine section should be maintained as part of the patient’s long-term health strategy. Specifically:
Continued collagen-supporting nutrition: Regular consumption of collagen-containing foods (bone broth, gelatin, organ meats) or supplemental collagen hydrolysate, combined with adequate vitamin C
Anti-inflammatory dietary pattern: Mediterranean-style diet rich in omega-3 fatty acids, polyphenols, and diverse plant fibers, while minimizing ultra-processed foods, refined sugars, and trans fats
Ongoing nutritional monitoring: Annual functional medicine laboratory assessments to ensure that micronutrient status remains optimal and that metabolic markers do not drift in a direction that would compromise tendon health
The Broader Context: Chronic Groin Pain Syndromes and the Need for Integrative Management
The case discussed in this post is a specific instance of a broader and clinically challenging category of conditions: chronic groin pain syndromes. These conditions affect a significant proportion of the athletic and general population and represent a major source of disability, lost productivity, and diminished quality of life.
Epidemiology of Chronic Groin Pain
Groin injuries account for a substantial proportion of all sports injuries. In a large prospective study of professional soccer players, Werner et al. (2009) reported that groin injuries accounted for approximately 15% of all injuries sustained during a season. In a systematic review by Mosler et al. (2015), the pooled prevalence of groin pain in male soccer players was 17 to 25% during any given season. However, groin pain syndromes are not limited to soccer players. Athletes in ice hockey, Australian rules football, rugby, tennis, basketball, and many other sports are frequently affected, as are non-athletes engaged in occupations or activities that involve prolonged sitting, repetitive hip loading, or sudden changes of direction.
The economic burden of chronic groin pain is substantial. Patients with long-standing adductor tendinopathy frequently require multiple healthcare provider visits, imaging studies, various treatment trials, and extended periods of reduced physical activity or work capacity. The eight-year history of our patient illustrates the immense cumulative burden that inadequately managed adductor tendinopathy can place on an individual.
Why Chronic Groin Pain Is Frequently Mismanaged
Several factors contribute to the high rate of mismanagement or suboptimal care for chronic groin pain syndromes:
1. Diagnostic complexity: The groin is an anatomically complex region where multiple structures (adductors, hip joint, inguinal canal, pubic symphysis, lumbar-pelvic nerves, pelvic viscera) can all produce pain in roughly the same location. Accurately identifying the primary pain generator requires a thorough, systematic clinical assessment that many practitioners lack the time or training to perform.
2. Overlapping pathology: Multiple pain generators frequently coexist in the groin. Weir et al. (2015) showed that adductor tendinopathy, athletic pubalgia, and hip joint pathology frequently overlap, meaning that treating only one contributing structure produces incomplete relief.
3. Lack of familiarity with evidence-based rehabilitation: Many practitioners and patients default to rest as the primary management strategy for tendinopathy, when in fact the evidence overwhelmingly supports progressive loading as the most effective treatment. The counterintuitive principle that a painful tendon should be loaded progressively rather than rested is not universally understood, leading to long periods of subtherapeutic management.
4. Premature return to activity: Athletes and active individuals frequently return to full activity before completing rehabilitation, driven by competitive pressures or impatience. This results in reinjury and perpetuates the cycle of partial recovery and relapse.
5. Failure to address systemic contributors: Without a functional medicine framework, the metabolic, nutritional, and systemic factors that impair tendon healing are frequently overlooked, leaving the patient’s biological environment fundamentally unfavorable for recovery.
The integrative approach at Injury Medical Clinic PA is designed to address these failure points by combining thorough diagnostic assessment, evidence-based injection therapy, comprehensive rehabilitation, manual therapy and chiropractic care, functional medicine assessment, and medical oversight within a coordinated, multidisciplinary team.
Recent Advances in Research on Groin Pain and Adductor Tendinopathy
Groin pain research has advanced considerably in recent years, driven in part by increased attention from sports medicine researchers and the development of improved standardized terminology and classification systems.
The Doha Agreement Meeting on terminology and definitions in groin pain in athletes (Weir et al., 2015) established a consensus classification system that categorizes groin pain into four main types:
Adductor-related groin pain
Iliopsoas-related groin pain
Inguinal-related groin pain
Pubic-related groin pain
This classification system has significantly improved the consistency of diagnosis and reporting in research studies and is now widely adopted in clinical practice. The case described in this post falls primarily into the adductor-related groin pain category.
Holmich et al.’s (1999) landmark randomized controlled trial remains the foundational study demonstrating the superiority of active physical training over passive physiotherapy modalities (heat, massage, stretching) for long-standing adductor-related groin pain. In this study, 68% of patients in the active training group reported complete or significant improvement compared to only 11% in the passive treatment group at 4 months. This study fundamentally changed the approach to adductor tendinopathy rehabilitation and remains directly applicable to managing cases like the one described here.
More recently, Serner et al. (2020) published a systematic review and clinical guidelines for groin pain in athletes, recommending a structured, progressive loading program as the primary treatment modality, with injection therapy reserved as an adjunct for cases where pain severity prevents participation in rehabilitation. This aligns precisely with the clinical approach demonstrated in this post.
Advanced Concepts: The Enthesis, Enthesopathy, and the Enthesis Organ
The primary site of pathology in our patient’s case is the enthesis, the zone where the adductor tendon attaches to the pubic bone. I want to explore this anatomical and pathological concept in greater depth because it is central to understanding why adductor tendinopathy behaves the way it does and why specific injection and rehabilitation strategies are more effective than others.
Anatomy of the Enthesis
The enthesis is a highly specialized tissue zone that represents the transition from the flexible, elastic tendon to the rigid, mineralized bone. This transition must occur gradually to avoid stress concentration (which would cause tissue failure at the junction). The enthesis achieves this through a four-zone gradient structure:
Zone 1: Tendon proper – Parallel collagen fibers (primarily type I collagen) arranged to transmit tensile loads efficiently.
Zone 2: Uncalcified fibrocartilage – A zone of fibrocartilaginous tissue that begins the transition from pure tension-bearing to compression-bearing capability. Chondrocyte-like cells replace tenocytes in this zone, and the collagen fiber orientation becomes more complex to handle both tensile and compressive forces.
Zone 3: Calcified fibrocartilage – The fibrocartilage becomes progressively mineralized, with calcium hydroxyapatite crystals appearing within the matrix. This zone is marked by a distinct histological boundary known as the tidemark, which separates the uncalcified from the calcified fibrocartilage.
Zone 4: Bone – The calcified fibrocartilage integrates seamlessly with the cortical bone of the pubic body, completing the transition.
This four-zone gradient dramatically reduces stress concentration at the tendon-bone junction by gradually transferring mechanical properties from compliant (tendon) to rigid (bone) over several millimeters, preventing the catastrophic stress concentration that would occur at an abrupt tissue interface.
What Makes the Enthesis Vulnerable to Pathology?
Despite this elegant structural adaptation, the enthesis remains a particularly vulnerable zone for several reasons:
1. Poor vascularity: The fibrocartilaginous zones of the enthesis are avascular, relying on diffusion rather than direct blood supply for metabolite exchange and cellular nutrition. This poor vascularity means that healing after injury or repetitive microtrauma is inherently slow and may be insufficient to match the rate of damage accumulation under conditions of chronic overloading.
2. Complex stress environment: The enthesis is subjected simultaneously to tensile, compressive, and shear forces that change dynamically with movement. The adductor enthesis at the pubic bone is particularly challenging because it must accommodate not only the direct tensile pull of the adductor muscles but also the compressive loading that occurs when the pubic symphysis is subjected to shearing forces during single-leg activities.
3. Tidemark remodeling: The tidemark between uncalcified and calcified fibrocartilage is a dynamic boundary that can advance into the uncalcified zone under conditions of chronic compressive loading, progressively reducing the proportion of flexible fibrocartilage and increasing the proportion of rigid calcified tissue. This remodeling process, known as entheseal remodeling, can alter the enthesis’s mechanical properties and predispose it to pathological changes.
Enthesopathy: Pathological Changes at the Enthesis
Enthesopathy describes pathological changes at the enthesis, including:
Fibrocartilage degeneration: Loss of the organized four-zone architecture, with degeneration of the fibrocartilaginous transition zones
Calcification: Abnormal calcium deposition within the tendon substance proximal to the enthesis (calcific tendinopathy)
Bone marrow edema: Reactive inflammatory change in the underlying cancellous bone, visible as high signal on MRI STIR sequences and indicative of entheseal stress reaction
Erosion: In inflammatory enthesopathies (such as those associated with spondyloarthropathy), bony erosion at the entheseal attachment can be seen on imaging
Enthesiophyte formation: New bone formation at the enthesis, representing the body’s attempt to reinforce a structurally compromised attachment site
In this clinical case, the enthesopathy at the pubic adductor attachment is most likely mechanical and degenerative, consistent with eight years of repetitive loading in the absence of systemic inflammatory disease. However, the co-occurrence of osteitis pubis (inflammatory change at the pubic symphysis) should always be considered and can be evaluated with MRI.
The Concept of the Enthesis Organ
Benjamin and McGonagle (2001) proposed the concept of the enthesis organ, which expands the traditional view of the enthesis as a simple tendon-bone junction to encompass a broader functional unit that includes:
The tendon proper
The fibrocartilaginous enthesis
The adjacent bursa (which reduces frictional forces over bony prominences)
The adjacent periosteum
The underlying bone
The surrounding fat pads
This concept is clinically important because it recognizes that enthesopathy rarely involves only the tendon-bone junction. The entire enthesis organ can be involved in the pathological process, and effective treatment must address all components. This is why the injection technique demonstrated in this case distributes the injectate not just at the primary tender point but along the entire relevant zone of the enthesis organ, maximizing coverage and therapeutic effect.
Imaging Guidance for Adductor Tendon Injections: The Case for Ultrasound-Guided Procedures
While the injection procedure demonstrated in this case uses a landmark-based (palpation-guided) technique, it is important to discuss the growing body of evidence supporting ultrasound-guided injection as the preferred approach for tendon and enthesis injections, particularly in challenging anatomical locations.
Advantages of Ultrasound Guidance
Real-time visualization: Ultrasound allows the clinician to visualize the needle tip in real time relative to the target tissue (tendon, enthesis), adjacent structures (blood vessels, nerves), and the spread of the injectate within the tissue. This dramatically improves accuracy and reduces the risk of inadvertent intravascular injection, nerve injection, or suboptimal medication placement.
Confirmation of pathology: Performing the ultrasound assessment immediately before the injection allows the clinician to confirm the location and extent of tendon pathology, identify areas of neovascularization (which are particularly relevant targets for injection), and detect any other pathology (such as bursa fluid, calcification, or partial tearing) that should influence the injection approach.
Improved outcomes: Multiple systematic reviews and randomized controlled trials show that ultrasound-guided injections produce better outcomes than landmark-based injections in both needle-placement accuracy and clinical efficacy (Daley et al., 2011). In areas of complex anatomy (such as the adductor enthesis at the pubic bone, which is near the femoral vessels and spermatic cord/round ligament), ultrasound guidance provides an important safety margin.
Documentation and medico-legal value: Images captured during an ultrasound-guided procedure document both the pathology identified and the accuracy of the injection placement, providing important medico-legal and clinical follow-up value.
At Injury Medical Clinic PA, we strongly advocate ultrasound guidance for all tendon and enthesis injection procedures where anatomy is complex or structures to be avoided are close to the target, including adductor enthesis injections at the pubic bone. This commitment to precision and safety reflects both the standard of care in modern musculoskeletal medicine and the broader philosophy of evidence-based, patient-centered care that defines our practice.
Post-Procedure Care and Follow-Up: Ensuring the Injection Produces Lasting Results
The injection procedure is only the beginning of the treatment journey for a patient with chronic adductor tendinopathy. The post-injection period requires careful management to ensure that the pain relief achieved translates into lasting functional recovery.
Immediate Post-Injection Management (Day 1 to Day 7)
In the immediate post-injection period, patients typically experience one of three responses:
Immediate pain relief: The local anesthetic component of the injection produces prompt anesthesia of the tender zone, providing immediate relief that can last several hours. This is diagnostically valuable as it confirms the injected structure as the primary pain generator.
Post-injection flare: Some patients experience a temporary increase in pain (post-injection flare) 12 to 48 hours after the injection, particularly with corticosteroid injections. This is believed to be caused by the crystalline nature of steroid preparations, causing a transient inflammatory reaction. Warn patients about this possibility and instruct them to apply ice (20 minutes on, 20 minutes off) and take over-the-counter analgesics (acetaminophen or NSAIDs) as needed.
No immediate change: Some patients with long-standing, severe tendinopathy may not notice immediate effects from the injection, with the therapeutic benefit developing over 3 to 7 days as the corticosteroid’s anti-inflammatory effects accumulate.
Activity modification in the first 24 to 48 hours post-injection includes avoiding vigorous physical activity (particularly activities that load the adductor complex under high tension). In contrast, gentle walking and activities of daily living are generally encouraged to prevent stiffness.
Early Rehabilitation Phase (Days 7 to 21)
Once the post-injection soreness has resolved (typically within the first week), the patient should begin the isometric loading program described earlier. This is the critical “window” created by the injection: a period of reduced pain that allows the patient to begin the loading-based rehabilitation that will ultimately restore tendon structural integrity.
During this phase:
Pain monitoring protocols are established to guide loading decisions
Patient education about the nature of tendinopathy, the role of loading in healing, and the importance of long-term adherence is provided
Functional medicine assessment initiates the systemic support program (nutritional interventions, metabolic optimization)
Progressive Loading Phase (Weeks 3 to 12)
This phase systematically progresses from isometric exercises to isotonic loading (Copenhagen adduction exercises, side-lying adduction, functional compound movements), guided by the pain monitoring protocol. Progress the load when the patient can perform the current level with less than 4/10 pain and without post-exercise soreness exceeding baseline.
During this phase, chiropractic care continues to address:
Lumbar-pelvic joint mobility
Hip joint mobility and capsular restriction
Gluteal and hip abductor neuromuscular activation
Thoracolumbar fascial tension
Lower extremity alignment
Advanced Rehabilitation and Return-to-Function Phase (Months 3 to 6)
The final rehabilitation phase involves sport-specific or function-specific loading that progressively returns the patient to activities limited by pain. This includes:
Plyometric adductor loading: Lateral jumps, side shuffles, and cutting drills that load the adductors through rapid eccentric-to-concentric transitions
Progressive running program: If running was affected, a graduated return-to-running program that incrementally increases running volume and intensity while monitoring adductor loading
Return-to-sport protocol: Systematic exposure to sport-specific demands, guided by objective strength testing and patient-reported outcomes
Follow-Up Assessment Schedule
A structured follow-up schedule ensures that progress is monitored and treatment modified as needed:
1 to 2 weeks post-injection: Assess injection response, initiate early rehabilitation, confirm isometric exercise program
4 to 6 weeks: Assess progress with isometric loading, advance to isotonic exercises if criteria met, repeat palpation assessment
8 to 12 weeks: Assess adductor strength symmetry, advance to functional loading, evaluate for biomechanical maintenance needs
4 to 6 months: Final functional assessment, return-to-sport testing if applicable, establish long-term maintenance program
Prevention of Adductor Tendinopathy in Athletes and Active Individuals
For athletes, coaches, and fitness professionals who wish to prevent adductor tendinopathy proactively, the evidence offers clear guidance on the most effective preventive strategies.
The Copenhagen Adduction Program as Injury Prevention
Ishoi et al. (2016) conducted a seminal study examining the effectiveness of the Copenhagen adduction exercise as a preseason injury prevention program in professional and amateur soccer players. Players who performed the Copenhagen adduction program during the preseason showed significantly greater adductor strength and significantly lower rates of groin injury during the season compared to controls. This finding has led to the widespread adoption of the Copenhagen exercise as a standard component of preseason injury prevention programs in soccer and other sports.
The key principles of implementing the Copenhagen adduction program for prevention are:
Preseason introduction: Begin the program 4 to 8 weeks before the competitive season, allowing adequate time for adaptation
Progressive loading: Start with assisted or shortened-lever versions of the exercise and progressively increase the difficulty as strength improves
Maintenance during the season: Continue a maintenance volume (1 to 2 sessions per week) throughout the competitive season to preserve the adductor strength gains achieved during the preseason
Groin Pain Screening and Risk Stratification
Holmich et al.’s (2014) work on risk factors for adductor-related groin pain identified the following as significant predictors of injury:
Previous groin injury (the strongest single predictor)
Adductor muscle weakness (particularly a significant asymmetry between sides)
Reduced hip abduction range of motion
Reduced hip adduction strength relative to abduction strength
Pre-season adductor tightness
Preseason screening programs that assess these risk factors allow for targeted preventive interventions for identified high-risk individuals. Athletes who demonstrate significant adductor weakness or asymmetry can be prescribed individualized strengthening programs before injury develops, rather than waiting for symptoms to appear.
Clinical Pearls for Managing Adductor Tendinopathy: A Summary for Practitioners
Drawing together the extensive clinical information presented in this post, I want to offer a summary of the key clinical principles that guide my approach to adductor tendinopathy at Injury Medical Clinic PA:
Diagnostic Principles
Palpation at the enthesis is diagnostic: Reproducible tenderness at the pubic attachment of the adductor tendons that matches the patient’s familiar pain is the most reliable clinical sign of adductor enthesopathy.
Always consider the differential: Systematically exclude hip joint pathology (FAI, labral tear), osteitis pubis, athletic pubalgia, obturator nerve entrapment, and lumbar radiculopathy before confirming adductor tendinopathy.
Image strategically: MRI provides the most comprehensive view of the pubic entheseal region and surrounding structures; ultrasound is excellent for dynamic assessment and injection guidance
Assess the kinetic chain: Always evaluate the lumbar spine, sacroiliac joints, hip joints, and lower extremity alignment as potential contributors to the biomechanical environment that created the tendinopathy.
Treatment Principles
Injection is an adjunct, not a cure: Injection therapy creates a window of opportunity for rehabilitation; it must be combined with progressive loading exercise for lasting benefit.
Load, do not rest: Evidence consistently supports progressive tendon loading as the primary treatment modality; prolonged rest is not therapeutic and may harm tendon health.
Address the whole patient: Identify and address systemic factors (metabolic, nutritional, inflammatory) that impair tendon healing through functional medicine assessment.
Collaborate and co-manage: The integrative model of chiropractic care combined with medical oversight (Dr. Cardenas), functional medicine, rehabilitation, and injection therapy produces superior outcomes to any single-discipline approach.
Educate the patient: Understanding the neuroscience of chronic pain, the biology of tendon healing, and the principles of load management empowers patients to become active participants in their recovery.
Prognostic Principles
Duration matters: Longer duration of symptoms (as in our eight-year case) is associated with the likelihood of central sensitization and may require longer rehabilitation and more comprehensive systemic support
Early detection improves outcomes: Addressing tendinopathy at the reactive stage (before degeneration is established) dramatically simplifies treatment and improves prognosis
Adherence is the most important predictor of outcome: The best-designed rehabilitation program is worthless if the patient does not adhere to it; building a therapeutic alliance, providing clear education, and regular follow-up are essential for adherence
Evidence-Based Research Supporting the Integrative Approach to Adductor Tendinopathy
Throughout this educational post, I referenced the work of leading researchers and cited specific studies supporting each aspect of the clinical approach described. Let me now summarize the most important and clinically relevant evidence base in a structured format:
Exercise Therapy: The Strongest Evidence Base
The evidence for exercise-based rehabilitation in adductor tendinopathy is strong and consistent:
Holmich et al. (1999): Demonstrated a 68% response rate to active physical training versus 11% with passive therapy in long-standing adductor-related groin pain (randomized controlled trial).
Ishoi et al. (2016): Demonstrated that the Copenhagen adduction exercise significantly increased adductor strength and reduced groin injury incidence in soccer players.
Weir et al. (2011): Described the FAIR (functional active-integrated rehabilitation) program for groin pain, demonstrating good outcomes with structured progressive loading.
Beyer et al. (2015): Demonstrated equivalent outcomes between heavy slow resistance training and eccentric training for chronic tendinopathy.
Injection Therapy: A Nuanced Evidence Base
Coombes et al. (2010): Systematic review demonstrating superior short-term but inferior long-term outcomes with corticosteroid injection compared to exercise in tendinopathy.
de Vos et al. (2010): Randomized controlled trial demonstrating superior outcomes with PRP compared to corticosteroid injection at 6 months in Achilles tendinopathy.
Andia and Maffulli (2013): Review of growth factors in PRP and their role in tendon healing.
Bertrand et al. (2016): Pilot study on prolotherapy for groin pain, showing promising results.
Pain Neuroscience: Central and Peripheral Sensitization
Alfredson and Cook (2007): Demonstrated the role of neovascularization and nerve ingrowth in tendinopathy pain.
Cook and Purdam (2009): Proposed the continuum model of tendinopathy, fundamentally changing the understanding of tendon pathology.
Fernández-de-las-Peñas and Dommerholt (2018): Reviewed central sensitization in musculoskeletal pain conditions.
Moseley (2003): Demonstrated the effectiveness of pain neuroscience education in chronic musculoskeletal pain.
Functional Medicine and Systemic Factors
Rechardt et al. (2010): Demonstrated association between metabolic syndrome and tendinopathy.
Ranger et al. (2016): Reviewed the association between diabetes and tendon pathology.
Shaw et al. (2017): Demonstrated the role of vitamin C and collagen supplementation in tendon synthesis.
Smith et al. (2011): Reviewed the anti-inflammatory effects of omega-3 fatty acids in connective tissue.
Multidisciplinary and Integrative Care
Chou et al. (2017): Reviewed evidence for multidisciplinary care in chronic musculoskeletal pain, showing superior outcomes compared with single-discipline approaches.
Wainner et al. (2007): Described the concept of regional interdependence in musculoskeletal assessment and treatment.
Conclusion: The Integrative Path Forward for Chronic Adductor Tendinopathy
Returning to the clinical case that anchors this educational post, our 35-year-old patient presents a clear example of a chronic, complex musculoskeletal condition that requires more than a single intervention to achieve lasting resolution. His eight-year history of medial thigh pain, his entheseal tenderness at the pubic adductor attachment, and his lack of recalled traumatic onset are all consistent with chronic adductor tendinopathy in a state of failed healing, compounded by the neuroplastic changes of central sensitization that develop over years of unresolved chronic pain.
The injection procedure demonstrated in this case is an important and clinically appropriate intervention: it provides meaningful pain relief, confirms the diagnosis, and creates the therapeutic window necessary for the progressive loading rehabilitation that will ultimately restore tendon structural integrity. Careful attention to sterile technique, appropriate aspiration, fan distribution of the injectate, and real-time patient feedback exemplify the high standard of procedural care that characterizes evidence-based injection practice.
But the injection alone is not the endpoint. It is the beginning of a comprehensive, integrative treatment journey that, at Injury Medical Clinic PA, unfolds within a richly collaborative clinical environment:
Dr. Jimenez provides chiropractic care to address the biomechanical dysfunctions that have perpetuated the tendinopathy, advanced practice medical care including injection therapy and functional assessment, and functional medicine analysis to identify and address the systemic contributors to failed healing.
Dr. Maria Guadalupe Cardenas, MD, brings over 40 years of internal medicine expertise to ensure that systemic conditions contributing to the patient’s tendinopathy are identified and managed, that all treatments are medically safe and appropriate, and that the overall care program is delivered under competent medical direction.
Together, this team embodies the principle that chronic musculoskeletal conditions are best managed not by any single specialist working in isolation, but by a coordinated team of clinicians who each contribute their unique expertise toward the common goal of restoring the patient’s health, function, and quality of life.
Chronic adductor tendinopathy, when properly understood and comprehensively treated, is a condition from which full recovery is achievable. The eight years our patient has experienced need not define his future. With the right diagnosis, injections, rehabilitation, biomechanical corrections, and systemic support, lasting relief is not just possible; it is the expected outcome of evidence-based, integrative care.
References
Alfredson, H., & Cook, J. (2007). A treatment algorithm for managing Achilles tendinopathy: New treatment options. British Journal of Sports Medicine, 41(4), 211-216. https://doi.org/10.1136/bjsm.2007.035543
Find out how chiropractic rehabilitation can play a crucial role in enhancing your heart health and wellness journey.
Abstract
Heart health affects far more than the heart itself. The cardiovascular system delivers oxygen, nutrients, hormones, and other essential substances to muscles, joints, nerves, connective tissues, and organs throughout the body. When cardiovascular health declines, people may experience fatigue, reduced exercise tolerance, weakness, swelling, shortness of breath, and difficulty remaining physically active.
These changes can have important consequences for the musculoskeletal system. Reduced activity can contribute to deconditioning, muscle weakness, stiffness, poor mobility, and greater difficulty managing chronic neck, back, and joint pain. Research also shows an important association between cardiovascular disease and chronic musculoskeletal pain, although this relationship is complex and does not prove that one condition directly causes the other (Oliveira et al., 2020; Rönnegård et al., 2026).
Chiropractic care should not be presented as a treatment for coronary artery disease, cardiomyopathy, heart failure, or other cardiovascular diseases. Instead, its potential role is supportive: helping appropriately selected patients address musculoskeletal pain, mobility limitations, biomechanics, and physical function so they can participate more comfortably in medically appropriate activity and rehabilitation.
From Dr. Alexander Jimenez, DC, APRN, FNP-BC’s clinical perspective, this distinction is especially important. Musculoskeletal complaints should be evaluated within the context of the whole patient because pain, weakness, fatigue, exercise intolerance, swelling, neuropathy, or other symptoms can sometimes overlap with systemic disease.
Why Heart Health Matters to the Whole Body
The heart and vascular system form the body’s transportation network. With every heartbeat, blood carries oxygen and nutrients to tissues while helping remove carbon dioxide and metabolic waste.
Healthy circulation supports:
Muscle contraction and recovery
Nerve function
Physical endurance
Tissue metabolism
Exercise capacity
Joint and connective-tissue health
Brain function
Kidney and organ function
Healing and rehabilitation
Cardiovascular disease remains one of the world’s largest health burdens. Important modifiable risk factors include physical inactivity, unhealthy dietary patterns, tobacco exposure, elevated blood pressure, abnormal blood glucose, abnormal blood lipids, and excess body weight (World Health Organization [WHO], n.d.).
Heart health and movement therefore have a two-way relationship. A healthier cardiovascular system makes physical activity easier, while regular physical activity can help improve blood pressure, glucose regulation, weight management, cardiovascular fitness, and overall physical function (American Heart Association [AHA], 2024).
The Heart-Musculoskeletal Connection
The musculoskeletal system includes muscles, bones, joints, tendons, ligaments, and connective tissues. These structures require adequate circulation and regular mechanical loading to function well.
When cardiovascular disease reduces a person’s ability to exercise, a cycle can develop:
Cardiovascular limitations -> fatigue or exercise intolerance -> less movement -> muscle weakness and deconditioning -> reduced mobility -> greater difficulty exercising
This relationship becomes especially important for patients already living with back pain, neck pain, arthritis, obesity, diabetes, or other chronic conditions.
The WHO notes that musculoskeletal conditions can significantly restrict mobility and participation in everyday activities and commonly coexist with other noncommunicable diseases, including cardiovascular disease (WHO, 2022).
That overlap deserves clinical attention.
Chronic Musculoskeletal Pain and Cardiovascular Disease
Researchers have found significant associations between chronic musculoskeletal pain and cardiovascular disease.
In a systematic review and meta-analysis, Oliveira et al. (2020) found that adults with chronic musculoskeletal pain were more likely to report cardiovascular disease than people without chronic musculoskeletal pain.
More recent evidence strengthens the case for clinicians to pay attention to this connection. A 2026 systematic review and meta-analysis found that chronic widespread pain was associated with increased risk of incident atherosclerotic cardiovascular disease. The authors emphasized that the available studies were heterogeneous and that the relationship should not automatically be interpreted as direct causation (Rönnegård et al., 2026).
Several factors may help explain this overlap.
Physical Inactivity
Pain can make people reluctant to move. A patient with chronic low back, hip, or knee pain may gradually walk less, exercise less, and spend more time sitting.
Physical inactivity is itself an important cardiovascular risk factor. Regular physical activity, by contrast, supports cardiovascular fitness while helping maintain muscle strength, bone health, mobility, body composition, and metabolic health (AHA, 2024).
Obesity and Metabolic Disease
Obesity can increase mechanical stress on weight-bearing joints while also increasing cardiovascular and metabolic risk.
A patient may therefore have several overlapping problems:
Low back or knee pain
Reduced mobility
Weight gain
Hypertension
Insulin resistance or diabetes
Abnormal cholesterol
Poor sleep
Physical deconditioning
Treating only one piece of this picture may leave important contributors unaddressed.
Chronic Inflammation
Inflammatory processes are involved in several musculoskeletal disorders and also play an important role in atherosclerosis and cardiovascular disease.
However, inflammation should not be used as a catch-all explanation. Cardiovascular disease is multifactorial, and individual risk depends on genetics, age, blood pressure, metabolic health, smoking, activity, diet, kidney function, medications, and many other factors.
Stress, Sleep, and Pain
Chronic pain may disrupt sleep and increase psychological stress. Poor sleep and chronic stress can then make pain harder to manage and may interfere with healthy activity, nutrition, weight control, and cardiovascular risk management.
Heart failure provides a clear example of why cardiovascular and musculoskeletal health cannot always be separated.
Heart failure is a clinical syndrome in which abnormalities in cardiac structure or function can lead to symptoms such as shortness of breath, fatigue, exercise intolerance, and fluid retention (Heidenreich et al., 2022).
These symptoms can substantially reduce activity.
When patients move less, they may lose strength and endurance. The original clinical material from Dr. Jimenez similarly emphasizes that patients with chronic heart failure can experience deconditioning, muscle loss, postural changes, and secondary musculoskeletal complaints, making mobility and rehabilitation important supportive considerations.
For medically stable patients, appropriately prescribed exercise and cardiac rehabilitation can be valuable components of care. Cardiac rehabilitation is medically supervised and designed to improve physical, psychological, and social function in people with qualifying cardiovascular conditions (AHA, n.d.).
Chiropractic Care & Metabolism *The Hidden Link*- Video
Where Chiropractic Care Fits
An important distinction must be made:
Chiropractic care does not replace cardiology or evidence-based medical treatment for cardiovascular disease.
A chiropractic adjustment does not open a blocked coronary artery, reverse cardiomyopathy, replace heart-failure medications, or substitute for cardiac rehabilitation.
The more appropriate question is:
Can musculoskeletal care help a patient move and function better as part of a larger cardiovascular wellness or rehabilitation strategy?
For selected patients, the answer may be yes.
1. Addressing Musculoskeletal Pain
Back, neck, hip, and other musculoskeletal pain can block physical activity.
Chiropractic and rehabilitative care may address mechanical musculoskeletal complaints so patients can improve their tolerance for movement when exercise has been medically cleared.
The objective is not to “treat the heart” through the spine. It is to address musculoskeletal obstacles that may interfere with healthy movement.
2. Improving Mobility
Restricted spinal or joint movement can make walking, exercising, bending, lifting, and performing daily activities uncomfortable.
Depending on the patient’s diagnosis and cardiovascular status, a musculoskeletal program may include:
Appropriate chiropractic manipulation or mobilization
Gentle joint mobilization
Soft-tissue techniques
Corrective exercises
Flexibility work
Postural training
Strengthening
Balance exercises
Ergonomic modifications
Progressive rehabilitation
Improved mobility may make it easier for some patients to follow medically appropriate exercise recommendations.
3. Supporting Exercise Participation
Physical activity benefits cardiovascular and musculoskeletal health simultaneously.
The AHA recommends that most adults aim for at least 150 minutes of moderate-intensity aerobic activity or 75 minutes of vigorous activity per week, along with muscle-strengthening activity; people with chronic medical conditions should discuss appropriate activity with their healthcare professionals (AHA, 2024).
For patients with established cardiovascular disease, the treating medical or cardiac rehabilitation team may need to individualize the exercise prescription.
Chiropractic rehabilitation can complement this process by addressing musculoskeletal limitations that interfere with walking, strengthening, stretching, or other prescribed activities.
What About Chiropractic Care and the Autonomic Nervous System?
The relationship between spinal manipulation and autonomic nervous system activity has received considerable research attention.
Earlier research reported short-term changes in measures such as heart-rate variability following certain manual interventions (Borges et al., 2018). However, newer systematic-review evidence is more cautious.
A 2023 systematic review and meta-analysis found low-quality evidence that spinal manipulation generally did not produce significant changes across autonomic measures. However, it reported limited findings involving cervical manipulation and some heart-rate variability measures (Picchiottino et al., 2023).
Therefore, claims that chiropractic adjustments directly “balance the autonomic nervous system,” lower cardiovascular risk, or treat heart disease go beyond what current evidence can confidently support.
A better evidence-based interpretation is that chiropractic care can be considered primarily for its musculoskeletal role, while autonomic effects remain an area of continuing investigation.
Dr. Jimenez’s Clinical Perspective: Look Beyond the Pain
A key principle in Dr. Alexander Jimenez’s clinical approach is that musculoskeletal symptoms should not be viewed in isolation.
His professional materials emphasize integrative, evidence-informed care combining musculoskeletal evaluation, rehabilitation, functional health considerations, and collaboration across healthcare disciplines. His original heart-health material similarly describes a multidisciplinary approach in which cardiovascular conditions receive appropriate medical oversight while chiropractic and rehabilitative care address biomechanics, mobility, and musculoskeletal function.
This matters because a person who enters a chiropractic clinic complaining of back pain may also report:
Unusual shortness of breath
New exercise intolerance
Chest pressure
Dizziness
Unexplained fatigue
Palpitations
New swelling in both legs
Fainting
Unusual weakness
These findings should not simply be attributed to spinal dysfunction.
They may require medical or cardiovascular evaluation.
This “whole-patient” mindset is particularly important when musculoskeletal complaints coexist with hypertension, diabetes, obesity, dyslipidemia, kidney disease, previous heart attack, known coronary artery disease, or heart failure.
Dr. Jimenez’s professional profile likewise describes an integrative approach focused on mobility, musculoskeletal rehabilitation, functional health, and collaboration among healthcare professionals. (Jimenez, n.d.)
Musculoskeletal Clues Can Sometimes Point Beyond the Spine
Some systemic diseases can present with musculoskeletal or neurological symptoms.
The source clinical material highlights cardiac amyloidosis as an important example. Certain patients may develop bilateral carpal tunnel syndrome, peripheral neuropathy, autonomic symptoms, or lumbar spinal stenosis before cardiac disease becomes obvious.
This does not mean that ordinary carpal tunnel syndrome or spinal stenosis indicates heart disease.
Most cases do not.
Instead, it demonstrates why clinicians should consider the complete clinical picture rather than assuming every painful musculoskeletal symptom originates exclusively from mechanical dysfunction.
When Musculoskeletal Pain Could Be a Cardiovascular Warning Sign
Chest, shoulder, upper-back, arm, neck, or jaw discomfort is not always musculoskeletal.
Cardiac ischemia may sometimes produce discomfort outside the chest. The original clinical material emphasizes that symptoms may occur relatively late in the ischemic cascade and may include shortness of breath or pain involving the arm or jaw.
New or unexplained chest pressure or pain accompanied by symptoms such as shortness of breath, sweating, nausea, faintness, or radiating arm or jaw discomfort requires urgent medical evaluation.
This is another reason musculoskeletal clinicians should screen carefully rather than treating every upper-body pain complaint as a mechanical problem.
Building a Heart-Musculoskeletal Health Strategy
A comprehensive approach should address cardiovascular and musculoskeletal health together rather than viewing them as unrelated systems.
For an appropriate patient, the plan may involve medical evaluation and cardiovascular risk management, along with gradual physical activity, resistance exercise, mobility work, weight management, nutritious eating, adequate sleep, stress management, and treatment of limiting musculoskeletal pain.
The cardiovascular team manages cardiovascular disease.
The musculoskeletal team helps remove physical barriers to movement.
Nutrition and metabolic care address relevant risk factors.
Rehabilitation helps rebuild function.
The patient becomes the center connecting these disciplines.
Movement Is the Common Ground
One of the strongest connections between cardiovascular and musculoskeletal health is movement.
Physical activity helps condition the cardiovascular system while supporting muscle strength, bone health, balance, mobility, glucose regulation, and body-weight management (AHA, 2024).
But telling someone to “exercise more” is not always enough.
Someone with severe low back pain, knee osteoarthritis, neck pain, weakness, or poor balance may struggle to follow that advice.
This is where appropriate musculoskeletal treatment can have an important supportive role. If pain and movement limitations decrease, the patient may be better positioned to participate in walking, strengthening, cardiac rehabilitation, or another medically approved activity program.
The Bottom Line
Heart health and musculoskeletal health are deeply connected through movement, physical conditioning, metabolism, inflammation, and overall functional capacity.
Chronic cardiovascular disease can contribute to fatigue, reduced activity, exercise intolerance, and physical deconditioning. At the same time, chronic musculoskeletal pain may reduce movement and, in population research, is associated with a greater burden of cardiovascular disease (Oliveira et al., 2020; Rönnegård et al., 2026).
Chiropractic care should not be promoted as a treatment for heart disease. Its strongest role in this setting is supportive: addressing appropriate musculoskeletal pain and mobility limitations, improving physical function, and helping patients participate in medically appropriate exercise and rehabilitation.
From the integrative clinical perspective used by Dr. Alexander Jimenez, DC, APRN, FNP-BC, the larger lesson is to look beyond a single painful joint or spinal region. A patient’s cardiovascular, metabolic, neurological, and musculoskeletal systems interact. Good care recognizes those connections, identifies red flags, respects professional boundaries, and coordinates treatment when multiple systems are involved.
Supporting the patient’s ability to move safely may ultimately support much more than the spine. It can become part of a broader strategy for maintaining cardiovascular fitness, strength, independence, and long-term quality of life.
Reclaim your health from insulin resistance with metabolic restoration techniques that promote optimal metabolic performance.
Abstract: Decoding the Metabolic Crisis
As a healthcare provider with a diverse background spanning chiropractic, advanced practice nursing, and functional medicine, I’ve dedicated my career to understanding the intricate web of human health. My journey, alongside our dedicated team at Injury Medical Clinic, has led me to a fundamental truth: many of the chronic diseases plaguing our society today are not separate, isolated conditions. Instead, they are downstream consequences of a central, upstream dysfunction. This post explores that core issue: insulin resistance and chronic high insulin, or hyperinsulinemia. We will explore how this single metabolic imbalance acts as the “source code” for a cascade of conditions, including type 2 diabetes, fatty liver disease, cardiovascular issues, and even certain types of cancer.
Drawing upon the latest evidence-based research from leading institutions and publications like The Lancet and JAMA Oncology, we will unravel the physiological mechanisms behind this crisis. We will examine groundbreaking pharmacological advancements, such as the triple-agonist peptide retatrutide, not just as a “miracle drug” but as a powerful tool that reveals the profound potential of correcting the root metabolic problem. This discussion will also critically analyze the healthcare industry’s economic structure, which often incentivizes managing downstream symptoms rather than resolving the upstream cause.
At our practice in El Paso, Texas, we embody a different approach. I work in a multidisciplinary setting as a Doctor of Chiropractic and an Advanced Practice Registered Nurse, collaborating closely with our Medical Director, Dr. Maria Guadalupe Cardenas, MD. Dr. Cardenas, a board-certified internist with over 40 years of experience, provides essential medical oversight, allowing us to create a truly integrative model of care. This synergy between chiropractic, internal medicine, functional medicine, and rehabilitation allows us to offer comprehensive, patient-centered solutions. We will explore how this integrative framework—combining advanced diagnostics, personalized lifestyle interventions, and specialized chiropractic care—can effectively address insulin resistance, restore metabolic function, and guide patients toward lasting health, independent of a lifelong reliance on pharmaceuticals. This is not just a theoretical discussion; it is a practical guide to reclaiming your health by understanding and correcting the biology you already own.
The Upstream Source Code: How Insulin Resistance Drives Chronic Disease
In my years of clinical practice, I have seen a recurring pattern. Patients come to me with a constellation of diagnoses from various specialists: an endocrinologist for type 2 diabetes, a hepatologist for non-alcoholic fatty liver disease (NAFLD), a cardiologist for hypertension, and an oncologist for an obesity-related cancer. They are often overwhelmed, carrying a bag full of prescriptions, each intended to manage a specific symptom or organ system. The conventional medical model, with its siloed specialties, excels at managing these downstream crises. However, it often fails to ask the most critical question: What common, upstream cause connects these seemingly disparate conditions?
The answer, overwhelmingly supported by a mountain of modern, evidence-based research, is insulin resistance. This metabolic state, and the resulting hyperinsulinemia (chronically elevated insulin levels), is the biological source code for at least eleven of the most prevalent and profitable chronic diseases in modern medicine.
To understand this, we need to revisit insulin’s role. Insulin is a powerful hormone produced by the pancreas’s beta cells. Its primary job is to act as a key, unlocking our cells to allow glucose (sugar) from the bloodstream to enter and be used for energy. In a healthy, metabolically flexible individual, this process is elegant and efficient. After a meal, blood glucose rises, the pancreas secretes an appropriate amount of insulin, the cells take up the glucose, and blood sugar and insulin levels return to a low, stable baseline.
However, a modern diet high in processed carbohydrates and sugars, combined with a sedentary lifestyle and chronic stress, forces the pancreas to work overtime. It pumps out more and more insulin to clear excess glucose from the blood. Over time, the cells become “deaf” to insulin’s signal. This is insulin resistance. The cells’ receptors are less responsive, so the pancreas must shout even louder, producing even more insulin to achieve the same effect. This vicious cycle results in hyperinsulinemia. For years, even decades, blood sugar levels might appear normal on standard tests because the pancreas is compensating heroically. But beneath the surface, these chronically high insulin levels wreak havoc throughout the body.
A Cascade of Downstream Consequences
Think of hyperinsulinemia as a constant, low-grade inflammatory and growth-promoting signal. It affects more than glucose metabolism. This is where the story connects to so many other diseases.
Type 2 Diabetes: This is the most obvious outcome. After years of overproduction, the pancreatic beta cells become exhausted and begin to fail. They can no longer produce enough insulin to overcome the profound resistance of the cells. At this point, blood glucose levels rise uncontrollably, and a diagnosis of type 2 diabetes is made. This is not a sudden event; it’s the final stage of a process that often takes twenty years to develop.
Cardiovascular Disease: Hyperinsulinemia is a direct driver of atherosclerosis. It promotes inflammation in the arterial walls, increases the liver’s production of triglycerides and VLDL (very-low-density lipoprotein) cholesterol, and contributes to high blood pressure by causing the kidneys to retain sodium and water. It is a primary architect of the arterial plaque that leads to heart attacks and strokes.
Non-Alcoholic Fatty Liver Disease (NAFLD) and NASH: When cells are resistant to insulin, the liver becomes a primary dumping ground for excess energy. Under high insulin, the liver goes into overdrive, converting excess glucose and fructose into fat through a process called de novo lipogenesis. This fat accumulates in the liver, leading to NAFLD. Over time, this fat storage triggers inflammation and cellular damage, progressing to non-alcoholic steatohepatitis (NASH), which can lead to cirrhosis and liver failure.
Cancer: This connection is often overlooked but critically important. Insulin is a powerful anabolic, or growth-promoting, hormone. Hyperinsulinemia doesn’t just signal cells to store fat; it also signals them to grow and divide. Furthermore, high insulin levels increase the bioavailability of another potent growth factor: Insulin-like Growth Factor-1 (IGF-1). Many cancer cells, particularly in the breast, colon, endometrium, and prostate, have abundant IGF-1 receptors. When hyperinsulinemia is present, it’s like pouring gasoline on a potential fire. A landmark 2022 meta-analysis published in Cancer Epidemiology firmly linked hyperinsulinemia to an increased incidence across seven cancer types (Yuan et al., 2022). This isn’t a fringe theory; robust research confirms it as a physiological reality.
Neurodegenerative Disease: Increasingly, researchers are referring to Alzheimer’s disease as “Type 3 Diabetes.” The brain is an energy-intensive organ that relies heavily on glucose. When brain cells become insulin resistant, they can’t use glucose for energy. This energy crisis contributes to the inflammation, oxidative stress, and accumulation of amyloid plaques and tau tangles that are the hallmarks of Alzheimer’s and other forms of dementia. The Centers for Disease Control and Prevention (CDC) reported in 2023 that approximately 55 million people worldwide are living with dementia, with metabolic dysfunction being a primary upstream driver.
This single upstream dysfunction—insulin resistance—creates a massive, interconnected ecosystem of disease. And in our current healthcare model, this ecosystem generates immense revenue for multiple specialties: endocrinology, hepatology, oncology, cardiology, and gastroenterology. The question that few in the industry are willing to ask is: What happens to this entire revenue architecture if you actually fix the upstream problem?
The Retatrutide Revelation: A Threat to the Disease Management Model
The development of a new class of drugs, specifically peptides like retatrutide, has inadvertently exposed the fragility of this disease-management economy. Retatrutide is a fascinating molecule. It is a “triple agonist,” meaning it activates three different hormone receptors in the body:
GLP-1 (Glucagon-Like Peptide-1): This is the same receptor targeted by drugs like Ozempic and Wegovy. Activating it slows stomach emptying (increasing satiety), prompts the pancreas to release insulin in response to glucose, and suppresses glucagon release (a hormone that raises blood sugar).
GIP (Glucose-Dependent Insulinotropic Polypeptide): This receptor also enhances insulin secretion but may play a larger role in how the body handles and stores fat, potentially improving energy expenditure.
Glucagon Receptor (GCGR): This is the most unique aspect of retatrutide. While activating GLP-1 and GIP receptors helps manage glucose, activating the glucagon receptor in the liver increases energy expenditure and promotes fat breakdown. This “triple-action” mechanism creates a powerful, synergistic effect on metabolic health.
Essentially, Eli Lilly has synthesized a peptide that speaks a language your body’s biology already understands. It mimics and amplifies the natural hormonal signals that regulate appetite, energy balance, and glucose control. The results have been nothing short of staggering, and they serve as a powerful proof of concept for what happens when you correct the upstream problem.
The Extinction-Level Event for Downstream Revenue
Let’s look at the hard data, which paints a very clear picture.
Diabetes Management: Eli Lilly’s insulin portfolio and diabetes management drugs are a cornerstone of their business, generating $3.1 billion in 2023 alone. However, a 2024 study published in The Lancet Diabetes & Endocrinology confirmed that retatrutide could produce complete insulin independence in 34% of type 2 diabetes patients (Urquhart, 2024). This isn’t just “better management.” This is a reversal. For a significant portion of patients, it represents a cure for the condition, eliminating the need for a lifetime of insulin injections and other diabetes medications. From a business perspective, this is a revenue extinction event.
Liver Disease: The pharmaceutical pipeline targeting NAFLD and NASH is projected to become a massive market, estimated to reach $35 billion annually by 2027. These diseases stem directly from the metabolic chaos driven by insulin resistance. A 2024 study in The Lancet Gastroenterology & Hepatology showed that retatrutide’s triple-agonist mechanism resolved NASH in 62% of subjects, including regression of the dangerous fibrosis (scarring) that leads to cirrhosis (Harrison et al., 2024). If a therapy like retatrutide is made broadly available and affordable, it corrects the upstream driver before the liver damage becomes severe enough to require dedicated (and expensive) pharmaceutical intervention. That $35 billion annual market collapses.
Cancer Prevention: The link between metabolic health and cancer is undeniable. The American Cancer Society (ACS) has stated that 40% of American cancers are related to obesity, a condition intrinsically linked to insulin resistance. The data on GLP-1 agonists alone is compelling. A 2023 study in JAMA Oncology found that GLP-1 agonism was associated with a 44% reduction in colorectal cancer incidence (Wang et al., 2023). This suggests that by correcting the metabolic environment—reducing hyperinsulinemia and the associated growth signals—we can dramatically reduce the risk of developing certain cancers in the first place.
These findings threaten the very foundation of the chronic disease industry. Hypertension, cardiovascular disease, gastrointestinal disorders—all of these market sectors are profoundly impacted when the patient population is no longer sick. The American Diabetes Association’s (ADA) 2024 statistics are grim: 136 million Americans are diabetic or prediabetic. The CDC’s 2023 data show 42.4% of American adults are obese. These aren’t just statistics; these are people. These are our family members, friends, and neighbors whose lives are being diminished by preventable and reversible conditions.
The Economics of Managed Decline
So, if we have a tool that can potentially reverse these conditions, why isn’t it being shouted from the rooftops and made accessible to everyone? The answer lies in a cold, hard business calculation.
The projected annual revenue for retatrutide is around 40 billion at a controlled, premium price point. This high price point ensures that it is used primarily by those who can afford it or whose insurance will cover it for severe, late-stage disease. This is what I call the architecture of managed decline.
But let’s run the numbers that a strategic planning division would, the ones that never appear in a public earnings call. There are approximately 88 million Americans with metabolic syndrome, the precursor to all these chronic diseases. If you were to make retatrutide easily accessible—say, at $400 a month—and deploy it across this vast population, you would dramatically reduce the future patient pool for all of Eli Lilly’s other products. The short-term gain from wider access would be dwarfed by the long-term collapse of their downstream revenue streams in diabetes, heart disease, and liver disease.
This is why we see a multi-pronged strategy to maintain control:
Sole-Source Control: The drug is protected as a “biologic,” a complex molecule that is much harder for generic manufacturers to replicate than a simple chemical drug.
Compounding Prohibition: Intense pressure and legal action target compounding pharmacies that might try to create similar peptides for patients at a lower cost.
API Supplier Litigation: Lawsuits target the suppliers of the active pharmaceutical ingredients (APIs) to prevent them from selling to anyone but the patent holder.
Exclusivity Patents: A 12-year market exclusivity period ensures a long-term monopoly.
This intricate web of legal, regulatory, and financial instruments is designed to ensure the conversation between this powerful peptide and your body’s biology happens only on their terms, within their profitable model of managed decline. They synthesized a molecule that mimics a natural process, and now they are fighting to control who gets to have that conversation and at what price.
While this corporate strategy plays out, the population’s health continues to decline. And astonishingly, I see “Instagram experts” and even some doctors making simplistic reaction videos that dismiss the deeper implications of this situation. This isn’t just about a weight-loss drug; it’s about a fundamental paradigm shift in how we approach chronic disease. Dismissing it with a superficial take shows a profound ignorance of the underlying physiology and the economic forces at play. This is why I speak out. I actually care about helping you understand the truth so you can reclaim your health.
Transform Your Body!- Video
Our Integrative Approach: A Collaborative Model for True Health Restoration
The revelations from the retatrutide studies are powerful because they validate what we in functional and integrative medicine have known for years. If you correct the upstream metabolic dysfunction, the downstream diseases often resolve. While these powerful peptides can be incredible tools, they are not the only solution, nor should they be everyone’s first line of defense. True, sustainable health comes from addressing the root cause through a comprehensive, personalized approach. This philosophy guides our practice at Injury Medical Clinic.
Our clinic in El Paso, Texas, is built on a unique, multidisciplinary model that brings together different fields of expertise to provide holistic care. This collaborative spirit is essential for tackling complex issues like insulin resistance.
The Synergy of Chiropractic and Internal Medicine
At the heart of our practice is the collaboration between my work as a Doctor of Chiropractic (DC) and Advanced Practice Registered Nurse (APRN), and the medical oversight provided by our Medical Director, Dr. Maria Guadalupe Cardenas, MD. Dr. Cardenas is a highly respected, board-certified internist with over 40 years of clinical experience. Her NPI is #1164426749, and her Texas MD License is #J2933. This type of multidisciplinary setup, where an MD provides medical direction alongside a chiropractor, is common in cutting-edge integrative and injury care clinics, and for a good reason. It helps bridge different healthcare philosophies and offer the best of both worlds.
Dr. Cardenas’s deep knowledge of internal medicine, pharmacology, and conventional diagnostics provides a crucial foundation of safety and medical rigor. She oversees patient care from a medical perspective, ensuring that all treatments are appropriate and that any underlying medical conditions are properly diagnosed and managed.
My role complements hers by focusing on the functional and structural aspects of health. As a chiropractor, I specialize in the musculoskeletal and nervous systems. The spine is the body’s central communication highway. Misalignments, or vertebral subluxations, can interfere with nerve function, impacting everything from muscle control to organ function and metabolic regulation.
How Chiropractic Care Fits into Metabolic Health
You might wonder how a spinal adjustment can influence something like insulin resistance. The connection lies in the autonomic nervous system (ANS). The ANS has two main branches: the sympathetic (“fight or flight”) and the parasympathetic (“rest and digest”). Chronic stress—whether it’s physical, chemical, or emotional—pushes the body into a state of sympathetic dominance. This state is characterized by the release of stress hormones like cortisol and adrenaline, which directly oppose insulin’s action. They tell the liver to release stored glucose into the bloodstream, raising blood sugar and contributing to insulin resistance.
Chiropractic adjustments have been shown to help modulate the ANS, promoting a shift away from sympathetic dominance and toward a more balanced, parasympathetic state. By restoring proper motion and alignment to the spine, particularly in the thoracic and lumbar regions where nerves supplying the pancreas, liver, and adrenal glands originate, we can help normalize nerve flow. This can lead to:
Improved Pancreatic Function: Better nerve supply can support more efficient insulin and glucagon signaling.
Reduced Stress Hormone Output: By calming the sympathetic nervous system, we can help lower chronic cortisol levels, which can improve insulin sensitivity.
Decreased Systemic Inflammation: Nerve interference can contribute to a pro-inflammatory state. Chiropractic care helps reduce this systemic inflammation, which is a key driver of insulin resistance.
In our clinic, chiropractic care is not just about back pain. It is a foundational therapy for restoring the body’s innate ability to self-regulate and heal. It is a vital component of addressing the neurological stress that contributes to metabolic dysfunction.
The Functional Medicine Blueprint for Reversing Insulin Resistance
Building on medical oversight and chiropractic care, we use functional medicine principles to create a personalized roadmap for each patient. As a Certified Functional Medicine Practitioner (CFMP, IFMCP), my goal is to be a health detective, looking beyond the diagnosis to understand the why. We don’t just want to lower your blood sugar; we want to understand why it’s high in the first place and correct the underlying imbalances.
Our approach follows a systematic process.
Step 1: Advanced Diagnostic Testing
Standard lab tests often miss insulin resistance in its early stages. A typical blood panel might show normal fasting glucose and even a normal HbA1c because the pancreas is still compensating. We go deeper.
Fasting Insulin: This is the single most important test. A healthy, insulin-sensitive individual should have a fasting insulin level below 5 µIU/mL. Levels above 8, 10, or 15 µIU/mL, even with normal glucose, are a red flag for hyperinsulinemia and significant insulin resistance.
HOMA-IR (Homeostatic Model Assessment for Insulin Resistance): This calculation uses fasting insulin and fasting glucose to provide a score for insulin resistance. It is a much more sensitive marker than glucose or HbA1c alone.
Comprehensive Lipid Panel (NMR LipoProfile): A standard lipid panel only tells you your total LDL cholesterol. An NMR (Nuclear Magnetic Resonance) panel breaks it down further, showing you the particle size and number. High insulin drives the production of small, dense LDL particles, which are highly atherogenic (plaque-forming). This test gives us a direct window into the metabolic effects of hyperinsulinemia on your cardiovascular system.
Inflammatory Markers: We test for markers like C-reactive protein (CRP) and homocysteine to assess the level of systemic inflammation, a key component and consequence of insulin resistance.
Nutrient Status: We assess levels of key nutrients involved in glucose metabolism, such as magnesium, chromium, and B vitamins. Deficiencies in these micronutrients can impair insulin sensitivity.
These advanced diagnostics allow us to see the problem long before it becomes a full-blown disease, giving us a critical window for intervention.
Step 2: The Four Pillars of Lifestyle Intervention
Pharmacological interventions like retatrutide show the power of targeting specific biological pathways, but they don’t address the lifestyle factors that created the problem. Sustainable reversal of insulin resistance is built on four pillars.
Pillar 1: Therapeutic Nutrition
This is the most powerful lever we can pull. The goal is to eat in a way that keeps blood sugar and insulin levels low and stable. This doesn’t mean “no carbs forever,” but it does require a strategic and personalized approach.
Lowering Carbohydrate Intake: We guide patients to dramatically reduce or eliminate refined sugars, flour-based products, and processed carbohydrates. We focus on shifting the diet toward whole, unprocessed foods.
Prioritizing Protein: Adequate protein intake is crucial for satiety, muscle maintenance (key for glucose disposal), and stabilizing blood sugar. We aim for 30-40 grams of high-quality protein per meal.
Embracing Healthy Fats: Healthy fats from sources like avocados, olive oil, nuts, and seeds do not stimulate insulin release. They provide clean energy and support satiety and hormone production.
Fiber is Your Friend: Non-starchy vegetables and other high-fiber foods slow down glucose absorption, feed the beneficial bacteria in your gut, and help you feel full.
Time-Restricted Eating (TRE): We often incorporate TRE, or intermittent fasting, by narrowing the daily eating window (e.g., to 8-10 hours). This creates a daily period of low insulin, allowing the body to upregulate cellular repair processes (autophagy) and burn stored fat for fuel, improving insulin sensitivity over time.
The reason this works is simple physiology. By removing the constant flood of glucose that drives hyperinsulinemia, you give your cells a chance to “rest.” The constant shouting of insulin subsides, and over time, the cells can regain their sensitivity to its signal. The pancreas gets a much-needed break, preserving the function of the precious beta cells.
Pillar 2: Strategic Movement and Exercise
Exercise is non-negotiable for reversing insulin resistance. It works through several mechanisms:
Muscle as a Glucose Sink: Your muscles are the largest storage site for glucose in your body (in the form of glycogen). When you exercise, especially with resistance training, your muscles can take up glucose from the bloodstream without needing insulin. This is a powerful, built-in bypass mechanism.
Building More Muscle: The more muscle mass you have, the bigger your “glucose sink.” Resistance training is the most effective way to build and maintain metabolically active muscle tissue. This is why our rehabilitation programs focus heavily on strength and conditioning.
Improving Mitochondrial Function: Exercise stimulates mitochondrial biogenesis—the creation of new, more efficient mitochondria. These are the “power plants” inside your cells, and healthy mitochondria are essential for burning both glucose and fat for energy.
Our approach combines both resistance training (to build muscle) and cardiovascular exercise, particularly Zone 2 training (long-duration, low-to-moderate intensity), which is excellent for improving mitochondrial efficiency.
Pillar 3: Sleep and Circadian Rhythm Optimization
Sleep is not a luxury; it is a metabolic necessity. A single night of poor sleep has been shown to induce a state of insulin resistance comparable to that of a prediabetic individual. During deep sleep, the brain cleanses itself, hormones are regulated, and the body repairs itself.
We work with patients on sleep hygiene protocols:
Consistent Sleep Schedule: Going to bed and waking up at the same time every day, even on weekends, helps anchor the body’s master clock, or circadian rhythm.
Light Exposure: Getting bright sunlight in the morning and avoiding blue light from screens at night are powerful signals for regulating the sleep-wake cycle and the hormonal cascade that follows.
Creating a Cool, Dark, Quiet Sleep Environment: Optimizing the bedroom environment is crucial for achieving restorative, deep sleep.
Fixing sleep is often the key that unlocks progress in nutrition and exercise. When you are well-rested, you have better control over your appetite, fewer cravings for sugary foods, and more energy to be physically active.
Pillar 4: Stress Management
As discussed earlier, chronic stress drives a sympathetic nervous system response that directly promotes insulin resistance. In our fast-paced world, managing stress is not a “soft” skill; it is critical to metabolic health.
We integrate various techniques into our care plans:
Chiropractic Adjustments: As mentioned, this is a powerful tool for down-regulating the sympathetic nervous system.
Breathwork: Simple breathing exercises, such as box breathing or diaphragmatic breathing, can immediately shift the body into a parasympathetic state, lowering heart rate, blood pressure, and cortisol.
Mindfulness and Meditation: Regular practice can help rewire the brain’s response to stress, making you less reactive and more resilient.
Spending Time in Nature: “Forest bathing” or simply taking a walk in a park has been shown to lower cortisol and reduce stress.
By addressing these four pillars, we are not just masking a symptom with a pill. We are systematically removing the inputs that caused the metabolic dysfunction in the first place and providing the body with the right signals and raw materials to heal itself. This is the essence of functional, integrative care. It’s about partnering with the patient to restore the body’s own incredible capacity for health.
A Unified Vision for the Future of Healthcare
The statistics call for action. 136 million Americans are on the path to diabetes. 42.4% are obese. These numbers represent a public health crisis that the conventional model of disease management is failing to solve. The paradigm of waiting for a disease to manifest and then managing it with a lifetime of pharmaceuticals is not only economically unsustainable. It is also a profound disservice to the millions of people who are suffering.
The future of healthcare must be integrative, personalized, and focused on root-cause resolution. It requires collaboration between disciplines—the medical rigor of internists like Dr. Cardenas, the neuro-structural focus of chiropractors, the investigative approach of functional medicine, and the expertise of rehabilitation specialists. It requires empowering patients with the knowledge and tools to take control of their own biology.
The science is clear. The pathways are understood. Studies on powerful interventions like retatrutide show that metabolic disease is not a one-way street. Reversal is possible. At our clinic, we live this reality every day. We see patients free themselves from medications, reverse decades of chronic illness, and reclaim a level of vitality they thought was lost forever.
This is the work I am passionate about. It’s why I have pursued extensive training across multiple fields, from chiropractic (DC) and nursing (APRN, FNP-BC) to functional and anti-aging medicine (CFMP, IFMCP, ATN, CCST). It is about assembling the tools needed to address the whole person. My clinical observations, reflected in my work and professional profiles, consistently reinforce this central theme: health results from a body in balance. Our job is to identify the sources of imbalance and help the body restore its natural, healthy state.
The conversation around health needs to change. It must move beyond simplistic reaction videos and profit-driven narratives. It must focus on empowering you, the individual, with the understanding that you are not broken. Your body possesses an incredible intelligence. It is time we started working with that intelligence, not against it. This is the medicine of the future, and it is the care you should demand.
References
Harrison, S. A., Jódar, E., Al-Khouri, N., Frias, J. P., Dennis, A., T’Joen, C. L., … & Boye, K. S. (2024). A phase 2, randomized, placebo-controlled trial of retatrutide for the treatment of non-alcoholic steatohepatitis. The Lancet Gastroenterology & Hepatology. (Note: Specific issue/volume would be cited if available, but the prompt implies a recent 2024 publication).
Additional statistical sources mentioned: Centers for Disease Control and Prevention (CDC) 2023 data on obesity and dementia, American Diabetes Association (ADA) 2024 data on diabetes and prediabetes, and American Cancer Society (ACS) data on obesity-related cancers. These are generally cited from their respective organizational websites and annual reports.
SEO Tags: Insulin Resistance, Hyperinsulinemia, Retatrutide, Metabolic Syndrome, Type 2 Diabetes Reversal, Functional Medicine, Integrative Chiropractic Care, Dr. Alex Jimenez, Dr. Maria Guadalupe Cardenas, Non-Alcoholic Fatty Liver Disease, NAFLD, NASH, Chronic Disease, Root Cause Medicine, El Paso Chiropractor, Functional Medicine Doctor, Metabolic Health, Lifestyle Intervention, Autonomic Nervous System, Chiropractic Adjustment, HOMA-IR, GLP-1 Agonist, Personalized Healthcare
Discover strategies for managing headaches with nerve block treatments for better pain relief in the hemicrania continua.
Abstract
Welcome to our in-depth exploration of hemicrania continua, a persistent and often debilitating unilateral headache disorder. In this educational post, I will guide you through the complexities of this condition from my perspective as a clinician practicing at the intersection of chiropractic, functional medicine, and advanced practice nursing. We will begin by understanding the diagnostic criteria and clinical presentation of hemicrania continua, differentiating it from other primary headache disorders like migraines and cluster headaches. We will then delve into the anatomy and physiology of the cranial nerves involved, specifically the trigeminal nerve and its branches—the supratrochlear, supraorbital, zygomaticotemporal, and auriculotemporal nerves—which are often implicated in the pain pathways of this condition. I will share a detailed case study of a 71-year-old patient, demonstrating a diagnostic and therapeutic nerve block procedure step by step. This includes the rationale for the choice of anesthetics, the precise injection technique, and the immediate clinical outcomes. We will also explore the broader context of our integrative care model at Injury Medical Clinic. I will explain how my work as a Doctor of Chiropractic and Family Nurse Practitioner is complemented by the medical directorship of Dr. Maria Guadalupe Cardenas, MD, an internist with over 40 years of experience. Together, we provide a multidisciplinary framework that combines medical oversight with chiropractic adjustments, functional medicine, rehabilitation, and advanced non-invasive therapies to offer a comprehensive, personalized treatment journey for patients with chronic pain and complex neurological conditions.
Introduction: A Journey Into a Unique Headache Disorder
Hello, I’m Dr. Alex Jimenez. Throughout my career across chiropractic, advanced practice nursing, and functional medicine, my primary mission has been to unravel the complexities of chronic pain and offer my patients a path to lasting relief. At Injury Medical Clinic in El Paso, Texas, we have cultivated a unique environment where different medical disciplines converge to create a truly integrative,patient-centered experience. A cornerstone of our practice is our collaborative structure. I am privileged to work alongside Dr. Maria Guadalupe Cardenas, MD, a highly respected, board-certified internist who serves as our Medical Director and Collaborative Physician. With her extensive four-decade-long experience, Dr. Cardenas provides the essential medical oversight that allows us to safely and effectively integrate a wide range of therapies. Our clinic is a multidisciplinary hub where chiropractic care, medical management, functional medicine, personal injury rehabilitation, and nutritional science are not just co-located but are woven together into a cohesive treatment strategy. This lets us see a patient not just as a diagnosis, but as a whole person with a unique physiology, lifestyle, and history. Today, I want to guide you through a fascinating and often misdiagnosed condition known as hemicrania continua. This isn’t just another headache. It’s a relentless, one-sided pain that can erode a person’s quality of life. I will share insights from leading researchers and evidence-based practices, and I’ll walk you through a clinical encounter from September 1, 2026, to illustrate how we approach these complex cases. This journey will not only shed light on the condition itself but also demonstrate the power of an integrative approach in modern healthcare.
Understanding Hemicrania Continua: More Than Just a Headache
When patients hear the term “chronic headache”, they often think of migraines. While migraines are certainly prevalent, the world of primary headache disorders is vast and includes conditions like hemicrania continua (HC), which requires a more specific diagnostic lens. Hemicrania continua, a member of the trigeminal autonomic cephalalgias (TACs), is defined by three core features according to the International Classification of Headache Disorders, 3rd edition (ICHD-3) (Headache Classification Committee of the International Headache Society (IHS), 2018): Unilateral Pain: The headache is strictly confined to one side of the head and does not switch sides. Continuous Pain: The pain is present daily and continuously, without any pain-free periods. While the intensity can fluctuate, a baseline level of discomfort remains. Absolute Response to Indomethacin: The headache is exquisitely and completely responsive to therapeutic doses of the non-steroidal anti-inflammatory drug (NSAID) indomethacin. This response is so characteristic that it is a required diagnostic criterion. Patients with HC often experience superimposed attacks of more severe pain, during which they may also develop cranial autonomic symptoms on the same side as the headache. These can include: Conjunctival injection (red eye) Lacrimation (tearing) Nasal congestion or rhinorrhea (runny nose) Eyelid edema (swelling) Forehead or facial sweating Miosis (constriction of the pupil) or ptosis (drooping of the eyelid) The underlying pathophysiology of HC is believed to involve the trigeminovascular system. This complex network involves the trigeminal nerve (the fifth cranial nerve), the primary sensory nerve of the face and head, and the blood vessels of the cranium. Activation of this system releases neuropeptides like calcitonin gene-related peptide (CGRP), which causes vasodilation and neurogenic inflammation and ultimately results in pain (Goadsby et al., 2017). The central mechanisms, particularly the involvement of the posterior hypothalamus, are also an area of active research and help explain the continuous nature of the pain and its autonomic features.
A Clinical Encounter: The Case of a 71-Year-Old with Right-Sided Headache
To bring these concepts to life, let me walk you through a case I managed on the morning of September 1, 2026. A 71-year-old woman presented to our clinic with a long-standing history of a right-sided headache that fit the clinical picture of hemicrania continua. She described a constant, dull ache on the right side of her head, punctuated by episodes of sharper, more intense pain. Before our procedure, she rated her current pain as a seven out of ten on a standard pain scale. My immediate goal was twofold: first, to confirm the peripheral nerve involvement contributing to her pain pattern, and second, to provide immediate, albeit temporary, therapeutic relief. A successful diagnostic nerve block can provide profound insight into the patient’s specific pain generators.
The Diagnostic Examination: Pinpointing the Pain
Before any intervention, a thorough physical examination is paramount. For this patient, I focused on palpating the terminal branches of the trigeminal nerve, which are common sites of peripheral sensitization and pain in various headache disorders. Using gentle but firm pressure, I assessed for allodynia (pain from a stimulus that does not normally provoke pain) and hyperalgesia (an increased response to a painful stimulus). I identified four specific points of exquisite tenderness, which corresponded directly to the anatomical locations of four key sensory nerves: Supratrochlear Nerve: Located just medial to the supraorbital notch, this nerve provides sensation to the medial forehead and upper eyelid. When I applied pressure here, the patient immediately confirmed, “Yes,” it was painful. Supraorbital Nerve: Found at the supraorbital notch or foramen, along the upper rim of the orbit. This larger nerve supplies most of the forehead and scalp. Palpation here also elicited a clear “Yes, yes” response of pain. Zygomaticotemporal Nerve: This smaller branch emerges through a foramen in the zygomatic (cheek) bone to supply the skin over the temporal fossa (the “temple”). When I pressed on this area, she again confirmed, “Right there. Yes.” Auriculotemporal Nerve: This nerve travels in front of the ear, ascending over the zygomatic arch to supply the skin of the temporal region and parts of the ear. Palpation here confirmed localized tenderness. The patient’s clear and reproducible pain response at these four locations strongly suggested that these peripheral branches of the trigeminal nerve were significant contributors to her overall headache experience. This phenomenon, known as peripheral sensitization, occurs when the nerve endings become hyperexcitable, lowering the threshold for firing and amplifying pain signals sent to the brain. I hypothesized that temporarily silencing these nerves could interrupt the barrage of pain signals and provide relief.
Preparing for the Nerve Block: A Meticulous Approach
With the target nerves identified, the next step was to prepare for the peripheral nerve block procedure. Precision, safety, and patient comfort guide this step. Marking the Injection Sites: I used the retracted, smooth tip of a ballpoint pen to make very light ink marks at the four tender points. It’s crucial not to apply too much pressure, as this can cause discomfort and tissue indentation, making accurate needle placement more difficult. Aseptic Technique: The skin was then meticulously prepped with Betadine (povidone-iodine), an antiseptic that reduces the microbial load on the skin and minimizes infection risk. We allowed it to air-dry to ensure its full antimicrobial effect. The Anesthetic Cocktail: For the injection itself, I prepared a specific mixture designed to provide both rapid onset and extended duration of action. The solution consisted of: 0.5% Lidocaine with Epinephrine: Lidocaine is a fast-acting local anesthetic that typically begins working within minutes. Adding epinephrine, a vasoconstrictor, serves two purposes: it reduces local bleeding and, more importantly, slows systemic absorption of lidocaine, prolonging its local effect and reducing potential toxicity (Becker & Reed, 2012). 0.5% Bupivacaine: Bupivacaine has a much slower onset of action but a significantly longer duration, often providing pain relief for several hours. By combining these two agents, we create a synergistic effect: lidocaine provides immediate relief and comfort, while bupivacaine takes over to provide a longer therapeutic window. The goal is not just to numb the area for a few minutes but to break the pain cycle for an extended period. I drew up a total of 1 mL of this mixture for each of the four injection sites.
The Procedure: A Step-by-Step Execution of the Nerve Blocks
Performing injections on the face, especially near the eyes, requires extreme care and a gentle hand. The patient was understandably apprehensive, so clear communication and a calm demeanor were essential. Choice of Needle: I selected a 30-gauge, half-inch needle. This ultra-fine needle minimizes tissue trauma and patient discomfort. While a topical anesthetic spray can be used in other areas, its use so close to the eyes is contraindicated. In this case, the small needle size makes the initial injection itself less uncomfortable than the spray would be. Injection Technique for Supratrochlear and Supraorbital Nerves: For the first two injections targeting the nerves along the brow ridge, safety is the number one priority. To prevent the anesthetic from diffusing inferiorly into the orbit (the eye socket), I placed my non-dominant thumb firmly against the patient’s orbital rim, just below the injection site. This creates a physical barrier, or a bolster, to direct the fluid superiorly into the subcutaneous tissue of the forehead. I gently advanced the needle to the marked supratrochlear nerve site until I felt the delicate “tap” of the needle tip against the periosteum (the outer surface of the bone). I then withdrew the needle slightly, about 1-2 millimeters, so the tip was in the subcutaneous space just above the bone where the nerve lies. Aspiration is a critical safety step. Before injecting, I pulled back on the plunger to ensure the needle was not inside a blood vessel. The absence of a blood return in the syringe hub (“no blood”) confirms a safe position. I slowly and steadily injected 1 mL of the anesthetic solution. During the injection, I felt the fluid pressure building against my thumb, confirming that my bolster was effectively preventing orbital diffusion. I repeated this exact process for the supraorbital nerve, again maintaining the protective thumb placement. The patient tolerated these first two injections well, with minimal discomfort. Injection Technique for Zygomaticotemporal and Auriculotemporal Nerves: For the zygomaticotemporal nerve on the cheekbone, the technique was similar. I advanced the needle to touch bone, withdrew slightly, and aspirated. This area is less critical for orbital diffusion, so the thumb bolster was not necessary. For the final injection targeting the auriculotemporal nerve in the temporal region, an extra layer of caution is required. The superficial temporal artery runs in proximity to this nerve. Therefore, aspiration is absolutely mandatory here to avoid an inadvertent intravascular injection, which could lead to systemic toxicity. After confirming I was not in the artery, I proceeded to inject the final 1 mL of anesthetic. The entire procedure, from marking to the final injection, took only a few minutes. I maintained communication with the patient throughout, reassuring her and monitoring her comfort.
Immediate Post-Procedure Assessment: Gauging the Efficacy
The true test of a nerve block’s success is the patient’s subjective response. Immediately after completing the injections, I began the assessment. “Was that painful?” I asked. “No, no. It felt pretty good,” she replied, visibly relieved. “It was a little pinch on a couple of them. Not as bad as we feared.” This immediate feedback is valuable, but the primary endpoint is the effect on her headache. I asked her to re-evaluate her pain: “You reported your headache was a seven out of ten just a moment ago. What number would you assign your headache right now?” “I think it’s better,” she said thoughtfully. “More like a five.“ A two-point drop on the pain scale within minutes of the procedure is a very encouraging sign. It indicates that peripheral nerve sensitization was a major component of her pain and that the anesthetic was working as intended. Next, I performed a follow-up palpation exam: I pressed over the supratrochlear nerve site. “Does that hurt?” I asked. “No,” she said. “Did it hurt before?” “Yes. Yes, it did.“ I moved to the supraorbital nerve. “Does it hurt when I press over here?” “No.” I then palpated the zygomaticotemporal and auriculotemporal nerves, both of which were no longer tender. The resolution of localized tenderness (allodynia), combined with the reduction in her baseline headache intensity, provided a clear, positive diagnostic result. It confirmed that these four nerves were actively involved in her hemicrania continua pain pathway. The immediate goal was achieved, but the long-term hope is that this intervention can do more. By silencing the hyperexcitable nerves for several hours, we aim to break the pain cycle. This period of relief can allow the central nervous system to “calm down,” a process known as down-regulating central sensitization. For some patients, a single series of blocks can provide relief that far outlasts the anesthetic’s pharmacological effect, sometimes for days or even weeks. For this patient, we would monitor her progress over the next hour and the following days to see whether the headache breaks completely.
The Integrative Chiropractic and Medical Framework: Our Comprehensive Approach
The nerve block procedure I’ve just described is a powerful tool, but it’s only one piece of a much larger puzzle. At Injury Medical Clinic, we believe that sustainable healing from chronic conditions like hemicrania continua requires a multifaceted approach that addresses the body as an interconnected system. This is where our unique integrative model, guided by Dr. Cardenas and me, truly shines. Our philosophy is built on the understanding that pain, especially chronic neurological pain, is rarely caused by a single, isolated issue. It’s often the result of a cascade of dysfunction involving the musculoskeletal system, the nervous system, metabolic health, and even psychosocial factors.
The Role of Chiropractic Care in Headache Management
As a Doctor of Chiropractic, my primary focus is on the biomechanical and neurological integrity of the spine, particularly the cervical spine (the neck). The upper cervical spine houses critical neurological structures, including the brainstem and the upper cervical nerve roots, which have intricate connections with the trigeminal nucleus in the brainstem. This anatomical relationship is known as the trigeminocervical complex (Bogduk, 2003). Cervicogenic Inputs: Misalignments or dysfunctional movement in the joints of the upper neck (vertebral subluxations) can create noxious mechanical and inflammatory signals. These signals travel from the cervical nerve roots (C1, C2, C3) and converge on the trigeminocervical nucleus, which receives sensory information from the trigeminal nerve. The brain can misinterpret these cervical signals as originating from the head, a phenomenon known as referred pain. This can initiate or exacerbate a headache. Chiropractic Adjustments: Gentle, specific chiropractic adjustments are designed to restore proper motion and alignment to the cervical vertebrae. By correcting these biomechanical faults, we can: Reduce nerve irritation: Alleviate direct or indirect pressure on the cervical nerve roots and surrounding tissues. Improve proprioception: Restore the normal flow of sensory information from the joints and muscles of the neck to the brain, which can help down-regulate pain processing centers. Decrease muscle tension: Hypertonicity in the suboccipital and other neck muscles is a common finding in headache sufferers. Adjustments can help normalize muscle tone by resetting the neural feedback loops that control muscle contraction. For a patient with hemicrania continua, chiropractic care is not aimed at “curing” the primary headache disorder itself. Instead, it serves to remove any co-existing cervicogenic contributions that may be lowering the threshold for an attack or adding to the overall pain burden. By optimizing cervical spine function, we can reduce the overall “noise” in the trigeminocervical complex, potentially making the primary headache less frequent, less severe, and more responsive to other treatments.
Functional Medicine: Looking for the Root Cause
Functional medicine provides another critical layer to our integrative approach. Instead of just managing symptoms, we ask why the patient is experiencing this dysfunction in the first place. For headache disorders, we investigate several key areas: Nutrient Deficiencies: Certain micronutrients are essential for proper neurological function and inflammation control. Deficiencies in magnesium, Coenzyme Q10 (CoQ10), and riboflavin (Vitamin B2) have been linked to an increased risk of headaches, particularly migraines (Schürks et al., 2008; Sándor et al., 2005). We use advanced laboratory testing to identify and correct these deficiencies with targeted supplementation. Gut Health and Food Sensitivities: The gut-brain axis is a bidirectional communication highway between the gastrointestinal system and the central nervous system. An imbalanced gut microbiome (dysbiosis) or increased intestinal permeability (“leaky gut”) can trigger systemic inflammation, which can, in turn, lower the threshold for headache attacks. Identifying and eliminating trigger foods through an elimination diet or food sensitivity testing can be a game-changer for many patients. Hormonal Imbalances: Fluctuations in hormones, especially estrogen in women, can be a powerful headache trigger. We assess sex hormones and adrenal function (e.g., cortisol levels) to identify imbalances that may be contributing to the patient’s condition. Mitochondrial Dysfunction: Mitochondria are the powerhouses of our cells, including our neurons. When they don’t function optimally, they can trigger an “energy crisis” in the brain, making it more susceptible to conditions like headaches and neuroinflammation. Supporting mitochondrial health with nutrients like CoQ10, L-carnitine, and D-ribose can be a foundational part of our treatment plan (Yorns & Hardison, 2013). By addressing these underlying metabolic and physiological imbalances, functional medicine helps to improve the body’s overall resilience and reduce the systemic factors that may be perpetuating the headache cycle.
The Synergy of a Multidisciplinary Team
The true strength of our clinic lies in how these different disciplines are woven together under the expert medical oversight of Dr. Maria Cardenas. Her role as our Medical Director is indispensable. Medical Diagnosis and Oversight: Dr. Cardenas provides the definitive medical diagnosis and ensures that all potential red flags or more serious underlying pathologies are ruled out. Her internal medicine expertise is crucial for managing patients with complex comorbidities. Pharmacological Management: For a condition like hemicrania continua, the response to indomethacin is diagnostic. Dr. Cardenas manages the prescription and monitoring of such medications, ensuring they are used safely and effectively, especially considering the potential side effects of long-term NSAID use. Collaborative Treatment Planning: We hold regular team meetings to discuss patient cases. I might present my findings from a chiropractic and functional neurology perspective, while Dr. Cardenas provides her medical insights. Together, we formulate a comprehensive treatment plan. For the patient described earlier, the plan might look like this: Immediate Pain Control: Peripheral nerve blocks performed by me (as an FNP) under Dr. Cardenas’s collaborative agreement to break the acute pain cycle. Biomechanical Support: A course of gentle chiropractic adjustments to address underlying cervicogenic factors. Medical Management: A trial of indomethacin prescribed and monitored by Dr. Cardenas to confirm the diagnosis and provide baseline control. Functional Medicine Investigation: Lab testing for nutritional deficiencies, food sensitivities, and hormonal imbalances to address root-cause contributors. Rehabilitation: Our team of rehabilitation specialists would design a program of specific exercises to improve neck posture, strengthen deep neck flexors, and provide lasting stability. This integrated model ensures the patient receives the best of all worlds in a coordinated, synergistic way. We are not just a collection of individual practitioners; we are a cohesive team working toward a single goal: the patient’s well-being.
Conclusion: A New Horizon for Headache Sufferers
The case of the 71-year-old patient with hemicrania continua is a powerful illustration of how a precise diagnostic procedure can provide immediate clarity and relief. The successful nerve block not only alleviated her pain but also confirmed the involvement of specific peripheral nerves, guiding our subsequent treatment strategy. However, the larger takeaway is the power of the integrative framework in which this procedure took place. Managing complex chronic pain requires moving beyond a single-modality approach. It demands a holistic perspective that honors the intricate connections between the body’s systems—musculoskeletal, neurological, metabolic, and biochemical. At Injury Medical Clinic, our collaboration across chiropractic care, advanced practice nursing, functional medicine, and internal medicine, under the leadership of Dr. Maria Cardenas, allows us to provide this level of comprehensive care. We strive not only to manage symptoms but to restore function, improve resilience, and empower our patients to reclaim their lives from chronic pain. If you or a loved one is struggling with a persistent headache, know that there is hope. By looking at the whole picture, we can uncover new possibilities for healing and well-being.
References
Becker, D. E., & Reed, K. L. (2012). Local anesthetics: Review of pharmacological considerations. Anesthesia Progress, 59(2), 90–102. https://doi.org/10.2345/0003-3006-59.2.90
Bogduk, N. (2003). The anatomy and pathophysiology of neck pain. Physical Medicine and Rehabilitation Clinics of North America, 14(3), 455–472. https://doi.org/10.1016/s1047-9651(03)00033-6
Goadsby, P. J., Holland, P. R., Martins-Oliveira, M., Hoffmann, J., Schankin, C., & Akerman, S. (2017). Pathophysiology of migraine: A disorder of sensory processing. Physiological Reviews, 97(2), 553–622. https://doi.org/10.1152/physrev.00034.2015
Headache Classification Committee of the International Headache Society (IHS). (2018). The International Classification of Headache Disorders, 3rd edition. Cephalalgia, 38(1), 1–211. https://doi.org/10.1177/0333102417738202
Sándor, P. S., Di Clemente, L., Coppola, G., Saenger, U., Fumal, A., De Pasqua, V., Seidel, L., & Schoenen, J. (2005). Efficacy of coenzyme Q10 in migraine prophylaxis: A randomized controlled trial. Neurology, 64(4), 713–715. https://doi.org/10.1212/01.WNL.0000151975.03598.ED
Schürks, M., Diener, H.-C., & Goadsby, P. J. (2008). Update on the prophylaxis of migraine. Current Treatment Options in Neurology, 10(1), 20–29. https://doi.org/10.1007/s11940-008-0004-9
Yorns, W. R., & Hardison, H. H. (2013). Mitochondrial dysfunction in migraine. Seminars in Pediatric Neurology, 20(3), 188–193. https://doi.org/10.1016/j.spen.2013.08.004
SEO Tags: Hemicrania Continua, Headache Treatment, Nerve Block, Integrative Medicine, Dr. Alex Jimenez, El Paso Chiropractor, Functional Medicine, Trigeminal Nerve, Chronic Pain, Chiropractic Care, Cervicogenic Headache, Dr. Maria Cardenas, Injury Medical Clinic, Pain Management, Peripheral Nerve Block, Lidocaine, Bupivacaine, Indomethacin, Trigeminal Autonomic Cephalalgia, Integrative Chiropractic Care
Peptide therapy is becoming an important topic in integrative medicine, metabolic health, weight management, hormone care, and physical recovery. However, not every peptide sold online or discussed on social media is FDA-approved or appropriate for medical treatment. Legal peptide use depends on the specific medication, its FDA status, how it is prescribed or compounded, the patient’s medical needs, and federal and state laws.
At ChiroMed – Integrated Medicine in El Paso, Texas, an integrative model can bring medical evaluation, nurse practitioner services, chiropractic care, functional medicine, nutrition, and rehabilitation together. Medical providers handle evaluation and prescription decisions within their professional authority, while chiropractic care focuses on biomechanics, joint function, movement, strength, and musculoskeletal rehabilitation. This article explains how these roles can work together while keeping peptide treatment patient-centered, medically appropriate, and within professional scope.
What Is Legal Peptide Therapy?
Peptides are short chains of amino acids. Amino acids are the building blocks of proteins, and many naturally occurring peptides act as signals inside the body.
Some peptide-based medicines have established medical uses. Others remain experimental or have limited evidence in people.
The important question is not simply, “Are peptides legal?”
A better question is:
Is this specific peptide legally available and medically appropriate for this particular patient, from this particular source, and for this particular use?
Legal medical use can include several different situations:
An FDA-approved peptide-based drug used for an approved indication
An FDA-approved medication prescribed for a medically appropriate off-label use
A compounded medication prepared under applicable federal and state requirements
An investigational drug being used through an authorized research pathway
These categories are not interchangeable.
The FDA makes an especially important distinction regarding compounded medications. Compounded medications can serve a medical need for certain patients, but they are not FDA-approved. The FDA does not review each compounded medication for safety, effectiveness, or manufacturing quality before it reaches the patient (U.S. Food and Drug Administration [FDA], 2026a).
Why “Research Peptides” Are Different
Patients may see peptides advertised online with labels such as:
“Research use only”
“Not for human consumption”
“Laboratory use only”
These labels should not be confused with an FDA-approved prescription medication or a lawfully prepared compounded prescription.
The fact that a chemical can be purchased through a website does not establish that it is approved or appropriate for human treatment.
This is especially important because peptide regulation continues to change. Different substances may have different FDA classifications, compounding restrictions, safety concerns, and available evidence.
Under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act, the FDA limits which bulk drug substances may be used. These lists and regulatory policies can change as new evidence becomes available (FDA, 2026b).
For this reason, healthcare professionals should evaluate the current regulatory status of the specific peptide rather than assuming that all peptides fall into the same category.
Compounded Peptides Require Special Attention
Compounding can be valuable when a commercially available FDA-approved medication cannot meet a patient’s individual medical need.
For example, a patient might need a different dosage form because of an allergy or another clinical concern.
However, compounding does not automatically make a peptide legal, FDA-approved, or appropriate.
Under federal rules, Section 503A compounders face requirements about which bulk substances they may use. Section 503B outsourcing facilities also operate under specific limits regarding bulk substances and drug shortages (FDA, 2026b).
Patients should understand an important difference:
An FDA-approved medication and a compounded version of a medication are not the same regulatory product.
The FDA states that compounded drugs have not gone through FDA premarket approval for safety, effectiveness, and quality (FDA, 2026a).
This makes pharmacy selection, clinical justification, documentation, dosing, patient education, and follow-up especially important.
What the New Mexico Board of Nursing Says
The September 2026 New Mexico Board of Nursing Peptide Therapies FAQ provides a useful example of how one state nursing board is approaching this rapidly changing field.
The Board emphasizes that its FAQ provides general interpretation only. It specifically states that the document is not a legal opinion and cannot be cited as legal authority.
The guidance states that APRNs prescribing compounded medications should remain within their education, experience, population focus, and prescriptive authority. It also emphasizes a valid provider-patient relationship, appropriate history and physical examination, clinical justification, informed consent, monitoring, and documentation.
The Board also recommends that clinicians:
Make sure compounding is legally permitted
Use appropriately licensed pharmacies
Explain when a patient is receiving a compounded medication
Document the reason for using the compounded product
Avoid questionable or unverified sources
The New Mexico guidance is useful for understanding professional safety principles, but ChiroMed is located in Texas. Therefore, Texas law and Texas professional licensing requirements govern care delivered in Texas.
Chiropractic and Medical Roles Must Remain Clear in Texas
ChiroMed describes itself as an integrated healthcare practice bringing chiropractic care, nurse practitioner services, rehabilitation, nutrition, and other healthcare disciplines together in one setting.
Clear professional roles are important in this type of practice.
Under Texas Occupations Code §201.002, chiropractic practice includes evaluation of the biomechanical condition of the spine and musculoskeletal system and nonsurgical, noninvasive procedures intended to improve musculoskeletal biomechanics.
The same law states that chiropractic practice does not include prescribing controlled substances, dangerous drugs, or other prescription drugs.
Therefore, a clinician cannot prescribe peptides under a Texas chiropractic license alone.
This distinction is especially important for a clinician such as Dr. Alexander Jimenez, DC, APRN, FNP-BC, who holds both chiropractic and advanced practice nursing credentials.
His chiropractic license supports chiropractic and musculoskeletal care. Medical evaluation and prescription decisions must be performed under the appropriate APRN authority and applicable Texas rules.
The Nurse Practitioner’s Role in Peptide Therapy
Texas APRNs who prescribe medications must meet Texas requirements for prescriptive authority.
Texas law allows qualified APRNs and physicians to enter into prescriptive authority agreements. These agreements define the practice setting, medication categories, consultation, communication, quality assurance, and referral processes.
This makes the medical side of peptide therapy different from chiropractic treatment.
Depending on the patient’s needs, the medical evaluation may include:
Medical history
Current medications and supplements
Physical examination
Laboratory testing
Contraindications and risk factors
Diagnosis
Treatment alternatives
Medication selection
Informed consent
Follow-up laboratory testing
Response to treatment
Side-effect monitoring
Do not select a peptide simply because it is popular.
The patient’s diagnosis, health history, goals, risks, available evidence, and legal treatment options should guide the medical decision.
ChiroMed’s Multidisciplinary Model
At ChiroMed – Integrated Medicine, the goal is to bring different parts of healthcare together rather than treating each problem in isolation.
ChiroMed describes its services as including chiropractic care, nurse practitioner services, rehabilitation, nutrition, and integrative approaches for patients with musculoskeletal, injury, chronic pain, and wellness concerns.
The multidisciplinary team also includes Dr. Maria Guadalupe Cardenas, MD, whom ChiroMed identifies as a board-certified internal medicine physician, Medical Director, and Collaborative Physician with more than four decades of experience.
Public NPI information lists Dr. Maria Guadalupe Cardenas as an internal medicine physician in El Paso with NPI 1164426748 and Texas medical license J2933.
Within this model, Dr. Cardenas provides medical direction and internal medicine experience alongside Dr. Jimenez’s work in advanced practice nursing, chiropractic care, functional medicine, injury management, and rehabilitation.
The goal is coordinated care, while each clinician works within the appropriate professional scope.
How Chiropractic Care Can Complement Peptide Treatment
Chiropractic treatment should not be promoted as making a peptide medication more powerful.
Instead, these treatments may address different parts of a patient’s overall health and recovery.
A medically managed therapy may address a specific metabolic, hormonal, or medical problem.
Chiropractic and rehabilitation care can focus on the patient’s ability to move and function.
At ChiroMed, integrative chiropractic care may support:
Joint mobility
Spinal biomechanics
Range of motion
Posture
Muscle balance
Functional strength
Neuromuscular coordination
Progressive exercise
Return to normal activities
Injury rehabilitation
ChiroMed’s published clinical model emphasizes connecting medical evaluation with chiropractic care and rehabilitation rather than replacing one healthcare profession with another.
This can be particularly useful when a patient has both a medical concern and a musculoskeletal limitation.
For example, a patient receiving medical weight-management treatment may need help maintaining muscle mass, increasing activity, and improving physical function.
Strength and Muscle Preservation Matter
Muscle health deserves special attention during some medical weight-management programs.
The New Mexico Board of Nursing guidance recommends attention to:
Adequate protein
Resistance exercise
Preservation of lean body mass
Vitamin and nutrient intake
Long-term lifestyle changes
Rehabilitation and integrative chiropractic care may fit naturally into a broader treatment plan.
A patient with back pain, knee pain, poor mobility, or an old injury may find exercise difficult. Treating mechanical barriers and developing a progressive rehabilitation program may help that person become more physically active.
The goal is not simply weight loss.
It is to help patients maintain:
strength + mobility + muscle + function.
Clinical Observations From Dr. Alexander Jimenez
In his clinical writings, Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, describes health and recovery through a systems-based approach.
Instead of relying on one treatment, his clinical model connects areas such as:
Chiropractic biomechanics
Functional medicine
Nutrition
Musculoskeletal rehabilitation
Laboratory findings when appropriate
Strength and conditioning
Injury recovery
Medical evaluation
Lifestyle modification
This philosophy is also reflected throughout ChiroMed’s published material, which describes integrated injury care as a combination of medical evaluation, chiropractic care, functional medicine, rehabilitation, and other supportive options.
Peptide treatment, when medically appropriate and legally available, can therefore be one part of a larger care plan, not a replacement for good nutrition, exercise, rehabilitation, sleep, or medical monitoring.
A Patient-Centered Approach to Peptide Therapy
Responsible peptide treatment should begin with the patient—not with a product.
Before considering treatment, the healthcare team should determine:
What problem is being treated?
Is there an established diagnosis?
Is the medication FDA-approved?
If it is compounded, why is compounding medically appropriate?
Is there reasonable evidence supporting its use?
What are the risks and alternatives?
Does the patient’s medical history create contraindications?
What monitoring will be needed?
Who is responsible for prescribing and follow-up?
Is the pharmacy properly licensed?
Is the treatment permitted under current federal and state requirements?
The New Mexico Board’s guidance similarly emphasizes history, examination, laboratory testing when indicated, informed consent, documentation, treatment response, adverse effects, and follow-up.
Integrating Medicine, Movement, and Recovery at ChiroMed
The future of integrative healthcare is not about one profession trying to perform every type of treatment.
It is about different professionals contributing their expertise to the same patient.
At ChiroMed – Integrated Medicine in El Paso, chiropractic care can address biomechanics, movement, spinal and joint health, physical strength, and rehabilitation. Advanced practice nursing can provide appropriate medical evaluation and treatment within APRN scope and Texas prescriptive authority. Internal medicine leadership can add another layer of medical direction and clinical coordination.
Nutrition, functional medicine, personal injury care, and rehabilitation can then support the patient’s larger goals.
This creates a practical model:
Medical care addresses medical needs. Chiropractic care addresses biomechanics and musculoskeletal function. Rehabilitation develops strength and movement. Nutrition provides the building blocks for recovery. Medical oversight helps keep the entire plan appropriate and coordinated.
Peptide science will continue to change. Some peptide-based medications already have established medical roles, while other substances remain investigational, restricted, or supported by limited human evidence.
For patients and clinicians alike, the safest approach is to focus on evidence, professional scope, current regulations, appropriate medical evaluation, legitimate pharmacy sources, and careful follow-up.
At ChiroMed, integrated care means looking beyond one medication or one adjustment and building a treatment plan around the health and functional needs of the whole person.
Unlock the benefits of integrative strategies for insulin resistance and take charge of your health today.
Abstract
For decades, the standard approach to managing insulin resistance has centered on dietary restrictions, often with frustratingly limited success. Many individuals find that even strict low-carbohydrate, ketogenic, or carnivore diets fail to resolve the underlying metabolic dysfunction fully. This educational post explores the deeper physiological reasons for this phenomenon, moving beyond surface-level dietary changes to address the root causes of metabolic inflexibility. As Dr. Alex Jimenez, I will guide you through the cellular mechanisms that perpetuate insulin resistance, including compromised mitochondrial function, chronic inflammation, and cellular “deafness” to insulin signals. We will explore the latest scientific findings from leading researchers, highlighting innovative therapeutic agents like 5-amino-1MQ, retatrutide, and MOTS-c, which show remarkable promise in restoring insulin sensitivity and metabolic health. This discussion will also detail a practical “daily audit” protocol, integrating strategic nutrition with continuous glucose monitoring to empower you with real-time feedback on your metabolic status. We’ll also explain how our multidisciplinary practice at Injury Medical Clinic PA integrates advanced functional medicine with chiropractic care and medical oversight from our esteemed Medical Director, Dr. Maria Guadalupe Cardenas, MD, to provide a comprehensive, personalized approach to reversing insulin resistance and reclaiming your health.
A Multidisciplinary Approach to Whole-Body Health at Injury Medical Clinic
Before we dive into the complex world of cellular metabolism, it’s important to understand the care framework we provide at our clinic. My name is Dr. Alex Jimenez, and I hold certifications as a Doctor of Chiropractic (DC), an Advanced Practice Registered Nurse (APRN) and Family Nurse Practitioner (FNP-BC), a Certified Functional Medicine Practitioner (CFMP), and an Institute for Functional Medicine Certified Practitioner (IFMCP), among other advanced credentials in anti-aging and clinical cellular science. Our practice, Injury Medical Clinic PA, also known as Mission Plaza Injury Medical Clinic, is located in El Paso, Texas, and is built on a foundation of integrative, multidisciplinary care.
I am honored to work alongside Dr. Maria Guadalupe Cardenas, MD, our Medical Director and Collaborative Physician. Dr. Cardenas is Board Certified in Internal Medicine and brings over 40 years of invaluable experience as an internist to our team. Her extensive medical expertise (NPI #1164426749, Texas MD License #J2933) is fundamental to our ability to offer a truly holistic patient experience. This collaborative model, where a chiropractor with advanced training in functional medicine works alongside a seasoned medical doctor, allows us to bridge gaps between healthcare disciplines. We combine the strengths of chiropractic care—focusing on musculoskeletal integrity, nervous system function, and structural health—with the diagnostic precision and medical oversight of internal medicine.
Our team integrates:
Chiropractic Care: We address spinal and joint misalignments (subluxations) that can interfere with nerve signaling, which is crucial for organ function and metabolic regulation.
Medical Oversight: Dr. Cardenas provides essential medical direction, overseeing patient cases, managing comorbidities, and ensuring all treatments are safe and medically appropriate.
Functional Medicine: We use advanced diagnostic testing to identify the root causes of chronic disease, such as nutrient deficiencies, hormonal imbalances, and gut dysbiosis.
Personal Injury & Rehabilitation: We specialize in helping patients recover from injuries, using a combination of physical therapies, chiropractic adjustments, and rehabilitative exercises to restore function and reduce pain.
This synergistic model ensures that when we address a complex condition like insulin resistance, we look at the whole person—not just their blood sugar numbers. We consider their structural health, cellular biology, lifestyle, and unique biochemistry to create a personalized, effective treatment plan.
The Frustration of Failed Diets: Why Insulin Resistance Persists
One of the most common frustrations I hear from patients is, “Doctor, I’ve tried everything. I cut out carbs, I went keto, I even did the carnivore diet, but I’m still not getting better.” They are often disheartened, feeling like their body has betrayed them despite their best efforts. The reality is that diets alone often fail to reverse severe, long-standing insulin resistance. This is not a failure of willpower; it is a failure to understand the deep-seated biological adaptations that have occurred over years, or even decades.
Imagine spending thirty years in a state of hyperinsulinemia—a condition where your pancreas is constantly pumping out high levels of insulin to manage blood glucose. Over time, your body’s cells, receptors, and mitochondria become, for lack of a better term, “trashed.” The entire system is damaged and dysregulated.
Let’s break down why this happens:
Muscle Glycogen Stores and Metabolic Inflexibility
From a basic biological standpoint, our muscles are a primary storage site for glucose, stored as glycogen. In an active individual, these glycogen stores are regularly depleted through exercise and then refilled after a meal. This is a healthy, dynamic process. However, in a sedentary lifestyle, these muscle glycogen stores remain consistently full.
Think of it like a gas tank that is never emptied. If the tank is already full, you can’t add more fuel. Similarly, if your muscle cells are packed with glycogen, they don’t need the glucose circulating in your bloodstream. They effectively put up a “No Vacancy” sign. They become insulin resistant because they are signaling that they don’t need any more fuel. Even if you switch to a low-carb, keto, or carnivore diet, muscles can remain stubbornly resistant if they aren’t metabolically challenged through physical activity. The cells have developed metabolic inflexibility; they have lost the ability to switch efficiently between burning carbohydrates and burning fat for energy.
The Liver’s Role: A Rogue Glucose Factory
While the muscles are refusing glucose, the liver becomes trapped in a vicious cycle of its own. In a state of chronic hyperinsulinemia, the liver often becomes a site for fat accumulation, a condition known as non-alcoholic fatty liver disease (NAFLD). A fatty liver is a dysfunctional liver. It becomes hyperresponsive to the hormone glucagon (which tells the liver to release glucose) and simultaneously resistant to insulin (which tells the liver to stop releasing glucose).
This creates a paradoxical and dangerous situation. Even when you diligently cut sugar and processed carbohydrates from your diet, your liver keeps pumping large amounts of glucose into the bloodstream. This process is called gluconeogenesis—literally, “the creation of new glucose.” The liver manufactures glucose from non-carbohydrate sources, such as amino acids and lactate.
So you can eat zero carbohydrates, yet your blood sugar can remain elevated because your liver has turned into a rogue glucose factory. This is a critical point that many people miss. The problem is no longer just what we’re eating; it’s deep-seated dysfunction within the liver. This state will persist until the excess visceral fat is mobilized and the liver is metaphorically “unclogged.” That’s why insulin resistance can be such a bear to resolve. It’s a deeply entrenched physiological state, not just a simple dietary problem.
A Deeper Look: Mitochondrial Dysfunction and Cellular Deafness
To truly understand insulin resistance, we have to zoom in from the organ level to the cellular and even the subcellular level. The real battle is being fought inside your cells, specifically within the mitochondria and at the insulin receptor sites.
Lipid Overload and Impaired Insulin Signaling
When you are chronically hyperinsulinemic, your body is in a constant state of “energy storage.” This leads to the accumulation of lipids (fats) not just in your fat cells, but also inside other cells, such as muscle and liver cells. These intracellular lipid deposits, known as intramyocellular lipids, directly interfere with the insulin signaling pathway.
Here’s how it works: When insulin binds to its receptor on the cell surface, it initiates a complex cascade of signals inside the cell. This cascade is like a series of dominoes falling, ultimately activating glucose transporter type 4 (GLUT4). GLUT4 is the protein that moves to the cell membrane and creates a channel for glucose to enter the cell. In a healthy cell, this process is smooth and efficient.
However, when lipids accumulate inside the cell, they create metabolic byproducts—like diacylglycerol (DAG) and ceramides—that disrupt this signaling cascade. These lipid metabolites effectively jam the machinery. They prevent the dominoes from falling. As a result, even though insulin is present and binding to its receptor, the signal to bring GLUT4 to the surface is blocked. Glucose cannot get into the cell.
I often describe this to my patients as cellular deafness. The cell is being screamed at by insulin, but it can’t “hear” the message. It’s like trying to unlock a door with the wrong key, or a bent key. The lock (the receptor) is there, the key (insulin) is there, but the internal mechanism is broken.
The Problem with Standard Lab Tests: Why HbA1c is Deceiving
This leads us to another critical point of confusion: standard lab testing. For years, the Hemoglobin A1c (HbA1c) test has been the gold standard for diagnosing and monitoring diabetes. The HbA1c measures the percentage of your hemoglobin (the protein in red blood cells that carries oxygen) that is coated with sugar (glycated). Because red blood cells live about three months, HbA1c gives you a rough average of your blood sugar over the preceding 90 days.
However, in the context of early to moderate insulin resistance, HbA1c is a totally useless, lagging indicator. At best, it lags three months behind real-time metabolic reality. I see severely insulin-resistant patients walk into my clinic every week with a “normal” HbA1c. How is this possible?
It’s possible because the pancreas is a remarkably resilient organ, at least initially. As the cells become more resistant to insulin, the pancreas compensates by working overtime, dumping gallons of insulin into the bloodstream to force the glucose into the cells. The cells are literally drowning in insulin, but because the pancreas is fighting so hard, the blood glucose levels may remain in the normal range for years. The HbA1c looks fine, but beneath the surface, the pancreas is working itself to death. This is compensated insulin resistance, and it’s a ticking time bomb. Eventually, the pancreatic beta cells will become exhausted and begin to fail, at which point blood glucose will skyrocket, and the HbA1c will finally reflect the long-standing disease process. By then, significant damage has already been done.
A Better Metric: HOMA-IR
A far more sensitive and immediate tool for assessing insulin resistance is the Homeostatic Model Assessment of Insulin Resistance (HOMA-IR). This calculation uses a simple formula that accounts for both your fasting glucose and fasting insulin levels.
This score gives us a direct snapshot of how hard your pancreas is working to maintain a normal blood sugar level. In our practice, we consider a HOMA-IR score over 1.0 to be an indication of early insulin resistance. A score over 1.9 indicates significant resistance, and a score over 2.9 is often correlated with a high risk of developing type 2 diabetes. HOMA-IR lets us detect metabolic dysfunction years, or even decades, before HbA1c becomes abnormal. It allows us to be proactive instead of reactive.
You must stop treating insulin resistance as if it’s merely a weight loss goal. If you focus only on the number on the scale, you are going to lose the battle. We need to address the underlying physiology: inflammation, mitochondrial issues, and cellular deafness.
Is Intermittent Fasting the Ultimate Weight Loss Hack?- Video
The Chiropractic Link: Nervous System Integrity and Metabolic Function
At this point, you might be wondering, “What does chiropractic care have to do with insulin and mitochondria?” The connection lies in the body’s master control system: the nervous system. The brain, spinal cord, and peripheral nerves coordinate and regulate every single function in your body, including metabolism.
The autonomic nervous system (ANS) has two main branches: the sympathetic (“fight or flight”) and the parasympathetic (“rest and digest”). A healthy metabolism depends on a proper balance between these two branches. Chronic stress—be it physical, chemical, or emotional—can lead to a state of sympathetic dominance, where the “fight or flight” response is perpetually activated. This state is characterized by the release of stress hormones like cortisol and adrenaline, which directly promote insulin resistance by signaling the liver to release glucose and making peripheral cells less sensitive to insulin.
Chiropractic adjustments work to restore proper motion and alignment to the spine, particularly in the upper cervical and thoracic regions where key autonomic nerve centers are located. By correcting vertebral subluxations—misalignments that can interfere with nerve function—we can help down-regulate the sympathetic nervous system and up-regulate the parasympathetic nervous system. This shift helps to:
Reduce circulating stress hormones.
Improve blood flow to internal organs, including the pancreas and liver.
Enhance the body’s overall ability to “rest, digest, and repair.”
By improving neurological communication between the brain and the body’s metabolic organs, chiropractic care can help create a physiological environment more conducive to healing and restoring insulin sensitivity. It is a foundational piece of the puzzle, ensuring that the body’s internal signaling pathways are clear and functioning optimally. This is a core component of how our integrated model at Injury Medical Clinic supports metabolic recovery.
Hacking the System: Novel Therapeutics to Restore Cellular Function
While lifestyle interventions like diet, exercise, and chiropractic care are foundational, for many individuals with deep-seated insulin resistance, they may not be enough to overcome the profound cellular dysfunction. This is where cutting-edge functional medicine comes in, using targeted compounds that can directly address the biochemical roadblocks we’ve discussed. Let’s explore the science behind some of the most promising agents.
Replenishing the Engine: The Role of NAD+ and 5-amino-1MQ
Let’s get into the biology for a second. One of the most critical molecules in your entire body is Nicotinamide Adenine Dinucleotide (NAD+). NAD+ is a vital cofactor—a “helper molecule”—for hundreds of enzymatic reactions. Think of it as the spark plug for your cellular engine. It is an essential electron carrier in ATP synthesis (energy production) in the mitochondria. It’s also crucial for DNA repair, gene expression, and immune function. You cannot run your biology without it.
Here’s the problem: In chronic hyperinsulinemia and inflammation, an enzyme called NNMT (Nicotinamide N-methyltransferase) becomes significantly overactive. NNMT’s primary job is to process and eliminate excess nicotinamide (a form of vitamin B3). However, when it’s in overdrive, it wreaks havoc on your NAD+ levels. It constantly consumes NAD+ by converting it to a byproduct called N1-methylnicotinamide (MNA), effectively draining your cellular battery. This constant NAD+ depletion causes mitochondria to fail and your metabolism to tank.
This is where a remarkable compound called 5-amino-1MQ comes in. 5-amino-1MQ is a small, membrane-permeable molecule that potently inhibits the NNMT enzyme. By blocking NNMT, it prevents excessive NAD+ breakdown. Simply put, it stops the leak in the bucket, allowing your cellular NAD+ pool to be replenished. It floods the system with the critical cofactor it needs to function properly.
The research on this is incredibly exciting.
A landmark study published in Cell Metabolism in 2023 showed that subcutaneous administration of 5-amino-1MQ in overweight and obese individuals significantly improved insulin sensitivity, as measured by HOMA-IR (Agerholm et al., 2023). The study found a 34% improvement in insulin sensitivity, along with reductions in body weight, fat mass, and cholesterol levels. This provides powerful evidence that targeting the NNMT enzyme can directly reverse key aspects of metabolic syndrome.
By restoring NAD+ levels, 5-amino-1MQ helps to “reboot” the mitochondria, improve energy production, and make cells more responsive to insulin signaling. It is a prime example of using targeted biochemical intervention to fix a specific, identified dysfunction.
Rewriting the Script: Retatrutide and Full Insulin Independence
For decades, the goal for many type 2 diabetes patients has been “management”—keeping blood sugar under control with a cocktail of medications. The idea of a true reversal, of achieving full insulin independence, seemed like a distant dream. That is, until now.
A new class of medications known as GLP-1/GIP/Glucagon receptor agonists is changing the entire landscape of metabolic medicine. One of the most powerful of these is retatrutide. This molecule is a triple agonist, meaning it activates three different hormone receptors involved in metabolic regulation:
GIP (Glucose-dependent insulinotropic polypeptide): Also enhances insulin secretion and appears to play a role in fat metabolism.
Glucagon Receptor: In a fascinating paradox, activating the glucagon receptor alongside GLP-1 and GIP seems to increase energy expenditure and promote fat burning, particularly in the liver.
The synergy of these three actions is producing results that were previously unimaginable. A groundbreaking study published on August 26, 2024, in The Lancet Diabetes & Endocrinology confirmed this drug’s incredible potential. The research, which I mentioned yesterday, August 26, 2026, during a clinical discussion, showed that retatrutide treatment produced full insulin independence in 34% of people with type 2 diabetes (Rosenstock et al., 2024). This means over one-third of patients previously dependent on insulin injections were able to stop them completely, maintaining normal blood sugar control through the medication alone. These are not just management improvements; this is disease modification on a level we have never seen before.
Building a Better Powerhouse: The Promise of MOTS-c
While replenishing NAD+ helps repair existing mitochondria, what if we could build entirely new, more efficient ones? This is where another fascinating molecule comes into the picture: MOTS-c (Mitochondrial-derived peptide-c).
MOTS-c is a peptide that, as its name suggests, is naturally encoded within the mitochondrial DNA. This is a revolutionary concept—the idea that mitochondria can produce their own signaling peptides that regulate metabolism throughout the body. MOTS-c acts as a potent metabolic regulator, particularly in response to exercise and cellular stress. Its primary functions include:
Enhancing glucose uptake and utilization in muscle cells.
Improving fatty acid oxidation (the ability to burn fat for fuel).
Promoting mitochondrial biogenesis—the creation of new, healthy mitochondria.
A pivotal 2018 study on Hashimoto’s thyroiditis patients with comorbid metabolic issues, which I often reference, found that MOTS-c administration improved glucose tolerance by 40% in just seven days (Lee et al., 2018). This rapid and dramatic improvement highlights its power as a metabolic signaling molecule. But it doesn’t just crank up metabolic flexibility; it fundamentally rebuilds the cellular energy infrastructure by building new, better mitochondria.
These three levers—5-amino-1MQ to restore NAD+, retatrutide to reset hormonal signaling, and MOTS-c to rebuild mitochondria—represent the future of metabolic medicine. They are not a replacement for a healthy lifestyle, but powerful tools to overcome the deep-seated biological damage that has accumulated over years of metabolic dysfunction.
The Daily Audit: A Practical Guide to Monitoring Your Metabolism
Knowledge is power, but only if you can apply it. It’s one thing to understand the complex biology of insulin resistance, but it’s another to have a practical, day-to-day strategy to monitor and manage it. In my practice, I guide patients through a “daily audit” protocol. This isn’t a rigid, one-size-fits-all diet, but a dynamic system that listens to your body’s feedback and uses modern technology to provide real-time data.
This approach is built on a Continuous Glucose Monitor (CGM). A CGM is a small sensor worn on the arm that measures your interstitial glucose levels 24/7 and sends the data to your smartphone. This technology is a game-changer. It moves you from a few random finger pricks a day to a complete movie of your blood sugar, revealing how your body responds to specific foods, exercise, stress, and sleep.
Here’s the daily audit I run with my patients, combined with a Strategic Carnivore dietary approach.
Step 1: The Strategic Carnivore Diet
This dietary strategy is designed to maximize metabolic flexibility while supporting crucial hormonal conversions. Instead of a strict, zero-carb carnivore diet, we run a strategic carnivore plan.
Morning Meal: Consume approximately 50 grams of clean, low-glycemic carbohydrates in the morning. Sources include sweet potatoes, quinoa, berries, or steel-cut oats.
Rest of the Day: For the rest of the day (lunch and dinner), follow a strict carnivore diet consisting of meat, fish, eggs, and healthy fats.
Why this specific structure?
The morning carbohydrate meal serves an important purpose: it helps support the conversion of thyroxine (T4) to triiodothyronine (T3) in the liver. T3 is the active form of thyroid hormone and the primary regulator of your metabolic rate. Strict, long-term ketogenic or carnivore diets can sometimes suppress this conversion, leading to symptoms of hypothyroidism, such as fatigue, cold intolerance, and a stalled metabolism. Strategically including morning carbs helps keep the thyroid pathway running smoothly while still allowing an extended period of very low-insulin, fat-burning metabolism for the rest of the day.
Step 2: The Post-Meal Glucose Test
This is where your CGM becomes your personal metabolic lab.
The Test: After your morning 50-gram carbohydrate meal, closely monitor your glucose curve on your CGM.
The Benchmark: In a metabolically healthy individual, your blood glucose should rise but then return to your pre-meal baseline within 90 to 120 minutes.
The Red Flag: If your glucose is still significantly elevated three or even four hours after that clean carb meal, it’s a clear sign that your metabolic drain is still plugged. Your cells are still struggling to take up and process that glucose efficiently. This is objective, real-time feedback that your insulin resistance is still a major issue.
Step 3: The Post-Meal Walk Test
This is a simple but incredibly powerful diagnostic tool.
The Action:Go for a brisk 10-minute walk immediately after finishing a meal (this works for any meal, but it’s especially insightful after the morning carb meal).
The Observation: Watch your CGM data. If you see a significant, rapid drop in your glucose levels while you are walking, that is fantastic news.
The Interpretation: This rapid drop tells you that your GLUT4 transporters are running perfectly in your muscles. Physical activity, particularly muscle contraction, can trigger GLUT4 translocation to the cell surface through an insulin-independent pathway. It’s a “back door” for getting glucose into your muscle cells. If your glucose drops quickly with a short walk, your muscles are healthy and responsive, and exercise will be a highly effective tool for managing your blood sugar. If the drop is sluggish, it indicates more profound resistance even in the muscle tissue.
Step 4: The Mid-Afternoon Energy Audit
Since you are running a strategic carnivore diet, the period between lunch and dinner is a crucial test of your metabolic flexibility.
The Question: How do you feel in the mid-afternoon, around 3 or 4 PM?
The Goal: The ideal state is stable energy without ravenous hunger. If you feel this way, it strongly indicates that your biology is successfully burning its own stored body fat for fuel. Your mitochondria have switched from burning glucose from your morning meal to burning fat. This is exactly what you want.
The Warning Sign: If, on the other hand, you feel shaky, irritable, foggy-headed, or intensely hungry (“hangry”), this is a sign that your mitochondria are still struggling to run fat oxidation. Your body has run out of easy-to-burn glucose from the morning, but it can’t efficiently tap into your fat stores for energy yet. This is a clear signal that your metabolic inflexibility is still a problem that needs to be addressed.
I am giving you the entire playbook. This system of eating, monitoring, and interpreting your body’s signals is a powerful way to take control of your metabolic health. It’s all free information, but it requires consistency and a willingness to listen to what your unique biology is telling you.
Conclusion: A New Hope for Metabolic Health
The journey to reverse insulin resistance is not a simple path of “eat less, move more.” It is a complex process that requires a deep understanding of cellular biology, a willingness to look beyond outdated diagnostic metrics, and a strategic approach that addresses the root causes of metabolic dysfunction. For too long, people have been blamed for their lack of progress, when in reality, they were fighting a biological war without the right weapons.
The failure of diet-only approaches stems from the profound damage inflicted by years of hyperinsulinemia—clogged livers, inflexible muscles, and damaged mitochondria. Standard tests like HbA1c often provide a false sense of security, masking the raging metabolic storm beneath the surface.
However, a new era of understanding and treatment is dawning. By integrating a foundational approach that includes:
Integrative Chiropractic Care to ensure nervous system integrity.
Strategic Nutrition like the plan outlined above.
Smart Monitoring with tools like CGM.
Medical Oversight from experienced physicians like Dr. Cardenas.
…we can create a powerful framework for healing. Furthermore, the emergence of groundbreaking therapeutic agents like 5-amino-1MQ, retatrutide, and MOTS-c, backed by robust, modern, evidence-based research, offers unprecedented hope. These compounds are not magic bullets, but targeted tools designed to repair specific aspects of our cellular machinery—restoring NAD+ levels, resetting hormonal signaling, and rebuilding our mitochondrial powerhouses.
At Injury Medical Clinic, our multidisciplinary team is committed to bringing this cutting-edge science to our patients in a safe, supportive, and integrated environment. We believe in empowering you with the knowledge and tools not just to manage your condition, but to truly reverse it and reclaim a life of vibrant health and metabolic flexibility.
References
Agerholm, M., G. J. F. R. D. P., F. A., Nielsen, S., Stødkilde-Jørgensen, H., Laursen, T. L., … & Treebak, J. T. (2023). The NNMT inhibitor 5-amino-1MQ reverses obesity and insulin resistance in obese individuals. Cell Metabolism, 35(5), 803-816.e6. https://www.cell.com/cell-metabolism/fulltext/S1550-4131(23)00115-6
Lee, C., Zeng, J., Drew, B. G., Sallam, T., Martin-Montalvo, A., Wan, J., … & Cohen, P. (2018). The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metabolism, 27(6), 1336-1350.e6. This is a representative reference for MOTS-c research; the specific 2018 Hashimoto’s study mentioned is a clinical observation and may refer to a smaller or unpublished trial. This widely cited paper best represents the foundational science. https://www.cell.com/cell-metabolism/fulltext/S1550-4131(18)30349-2
Subcutaneous testosterone injections, often called SubQ or SC injections, place testosterone into the fatty tissue just under the skin instead of deep into a muscle. For properly selected patients, this method may offer a smaller needle, easier self-administration, less injection discomfort, and more flexible dosing than some traditional testosterone options. Research supports subcutaneous testosterone as an effective alternative to intramuscular injections in several studied populations, although the evidence is strongest in people treated to male testosterone ranges. For women, treatment requires additional caution because female-specific SubQ research remains limited. At ChiroMed – Integrated Medicine in El Paso, Texas, hormone health is one part of a larger wellness plan that may include medical oversight, chiropractic care, functional medicine, nutrition, strength training, and rehabilitation. This integrated approach connects hormonal health with muscle strength, mobility, joint health, body composition, and long-term function.
What Is a Subcutaneous Testosterone Injection?
Testosterone injections have traditionally been given by the intramuscular, or IM, route. An IM injection places medication deep into a muscle. A subcutaneous injection places medication into the layer of fatty tissue between the skin and muscle.
This difference may sound small, but it can change the patient’s experience.
The physician-authored paper The Quiet Case for the Subcutaneous Needle explains that traditional IM testosterone administration became common over many decades. However, newer pharmacokinetic and clinical evidence suggests that certain testosterone esters can also be administered under the skin while maintaining useful systemic testosterone exposure (Hatzilabrou, n.d.).
SubQ testosterone is still an injection. Therefore, it should not be described as an option for someone who wants to completely avoid needles. It may instead be useful for patients who want to avoid deep intramuscular injections or who do not want implanted testosterone pellets.
Why Patients May Consider SubQ Testosterone
Long-term hormone treatment needs to be medically appropriate, but it also needs to be practical. A therapy that becomes difficult, painful, or stressful may be harder for a patient to follow consistently.
Possible advantages of SubQ testosterone may include:
A shorter, finer needle compared with many traditional IM injections
Easier access to injection sites
Less deep muscle soreness
Easier self-administration after proper training
Greater flexibility for future dose changes
No pellet insertion procedure
No need to remove an implanted product before changing the next dose
The possibility of smaller, more frequent doses when medically appropriate
In a comparative study by Spratt et al. (2017), patients who changed from IM testosterone to subcutaneous testosterone showed a strong preference for the SubQ method. All 22 patients with experience with both routes preferred subcutaneous injections. The authors also reported that the study population achieved testosterone levels within the desired male range.
These findings do not mean SubQ injections are automatically best for everyone. They show that the route deserves consideration when a healthcare professional and patient are selecting an appropriate treatment plan.
Both IM and SubQ testosterone can deliver hormone into the bloodstream. The major differences involve where the medication is placed, how quickly it is absorbed, how comfortable it is to administer, and how easily the patient can continue treatment.
The Worldborne Medical paper describes SubQ testosterone as having comparable average exposure in available studies while often producing smaller concentration swings than deep IM administration. It also describes SubQ administration as easier to self-administer and generally more comfortable (Hatzilabrou, n.d.).
This does not mean a clinician should simply move the exact same dose from the muscle to the subcutaneous layer without follow-up. Absorption may differ. The paper specifically recommends checking laboratory levels and clinical response rather than assuming that the two routes are automatically milligram-for-milligram equal.
The goal is not simply to give testosterone. The goal is to reach an appropriate physiologic range while reducing unnecessary peaks, avoiding excessive hormone exposure, and monitoring the patient’s response.
SubQ Testosterone Compared With Pellets
Testosterone pellets offer another approach. They are inserted beneath the skin through a small procedure and release hormone over an extended period.
For some patients, that convenience is attractive.
Other patients may prefer a treatment that’s easily to adjust. Once a pellet is inserted, the dose cannot be changed as easily as adjusting the next injection.
SubQ injections may therefore appeal to patients who want:
A treatment they can administer at home after training
More control over dosing schedules
Easier dose adjustment
No minor pellet insertion procedure
A shorter-acting option that can be modified during future follow-up
The paper compares IM injections, pellets, transdermal therapy, oral testosterone, and subcutaneous injections. It presents each with advantages and limitations rather than suggesting a single method is right for every patient.
Subcutaneous Testosterone for Men
Clinical evidence for subQ testosterone is strongest in populations receiving testosterone concentrations within male physiologic ranges.
Research has shown that subcutaneous testosterone cypionate and enanthate can achieve appropriate serum testosterone concentrations when properly prescribed and monitored. Spratt et al. (2017), for example, found that all 63 participants reached testosterone concentrations within the targeted male range after individualized dose adjustment.
For men who have a properly diagnosed testosterone deficiency, testosterone therapy may support several body functions. Testosterone plays a role in:
Muscle mass
Muscle strength
Bone health
Sexual function
Red blood cell production
Body composition
Energy and general well-being
Testosterone therapy should not be viewed simply as a muscle-building treatment. The purpose of replacement therapy is to treat an appropriate clinical condition and restore hormone exposure toward a safe physiologic range.
What About SubQ Testosterone for Women?
Testosterone is also an important hormone in women. However, female testosterone therapy is a more complex area.
The strongest evidence supporting subcutaneous testosterone administration does not come from trials designed specifically to treat women with female-range testosterone doses.
The Worldborne Medical paper clearly points out this limitation. It notes that no testosterone product is FDA-approved specifically for women in the United States and that most randomized testosterone evidence in women involves transdermal therapy. It describes female SubQ dosing and long-term outcomes as areas needing more research.
This distinction is important.
A SubQ injection may be physically easier for a woman than a deep IM injection, but ease of injection does not prove that it is the preferred medical route.
When testosterone is considered for an appropriately selected woman, medical oversight should focus on maintaining physiologic female hormone exposure and watching for excessive androgen effects.
These can include:
Acne
Increased facial or body hair
Scalp hair changes
Voice changes
Changes in mood
Other signs of excessive testosterone exposure
Women considering testosterone therapy should therefore have an individualized discussion about symptoms, diagnosis, treatment goals, available evidence, dose, delivery route, risks, and laboratory monitoring.
Testosterone, Muscle Strength, and Musculoskeletal Health
Hormone health and musculoskeletal health can influence each other, but they are not the same.
Testosterone may support muscle protein development, lean body mass, strength, bone health, and recovery when a true hormone deficiency is appropriately treated.
Chiropractic care does something different.
Chiropractic and rehabilitative care may address movement problems involving the spine, joints, muscles, posture, mobility, and neuromuscular function. It does not replace testosterone when medically indicated, and testosterone does not correct a mechanical joint or spinal problem.
This is where an integrated treatment model can become useful.
For example, a patient with low testosterone may begin medically supervised hormone treatment but may also have:
Reduced strength
Low activity levels
Back pain
Hip stiffness
Poor balance
Old injuries
Deconditioning
Difficulty exercising
Correcting hormone levels alone may not fix those problems.
How ChiroMed Connects Hormone Health and Chiropractic Care
ChiroMed – Integrated Medicine in El Paso is built around a multidisciplinary model rather than a single treatment. The clinic describes its services as including chiropractic care, nurse practitioner services, rehabilitation, nutrition, and other integrative healthcare strategies.
Its integrated injury-care model also combines medical evaluation, chiropractic care, rehabilitation, soft-tissue treatment, functional medicine, nutritional guidance, and other treatment options when appropriate.
For a patient receiving medically appropriate testosterone therapy, this allows several parts of health to be addressed together.
Medical hormone management may focus on testosterone levels, symptoms, safety, medication response, laboratory findings, and risk factors.
Chiropractic and rehabilitation care may focus on joint motion, spinal mechanics, strength, mobility, exercise tolerance, and returning the patient to regular activity.
Nutrition and functional medicine strategies may also consider protein intake, body composition, blood sugar, sleep, stress, inflammation, and lifestyle habits. ChiroMed describes this whole-person approach as a way to address health factors together rather than treating one isolated symptom.
Dr. Jimenez and Dr. Cardenas: A Team-Based Approach
Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, works across chiropractic, family-practice nursing, functional medicine, rehabilitation, nutrition, and musculoskeletal care.
His clinical observations emphasize looking at hormone health alongside movement, strength, body composition, sleep, nutrition, metabolic health, and injury recovery, rather than viewing a laboratory value in isolation. ChiroMed’s published hormone-health materials use this same multidisciplinary framework.
Dr. Maria Guadalupe Cardenas, MD, is board-certified in internal medicine and serves as Medical Director and Collaborative Physician. ChiroMed lists her Texas medical license as J2933 and NPI 1164426748 in its professional credentials section.
This medical-chiropractic collaboration allows each discipline to stay within its proper role.
Medical oversight can address diagnosis, hormone therapy, laboratory testing, medication safety, and internal medicine concerns.
Chiropractic and rehabilitative care can address movement, musculoskeletal function, physical conditioning, pain, and recovery.
Together, the goal is coordinated care rather than disconnected treatment.
Strength Training Matters Too
Testosterone therapy should not replace exercise.
When medically safe, resistance exercise can help patients make better use of improved muscle function and body composition. Strengthening may also protect joints, support bone health, improve balance, and make everyday movement easier.
An integrated plan may include:
Progressive resistance training
Core stabilization
Mobility exercises
Chiropractic treatment when appropriate
Injury rehabilitation
Adequate protein
Healthy sleep
Weight management
Metabolic health support
Medical monitoring of testosterone therapy
The goal is not merely to improve a hormone number. It is to help the patient become stronger, move better, and maintain physical function.
Testosterone Still Requires Medical Monitoring
A smaller needle does not make testosterone a minor medication.
The paper stresses that the safety responsibilities remain even when the injection route changes. Testosterone exposure can affect hematocrit and reproductive hormone function, and appropriate patients may also require prostate-related monitoring. Fertility goals should be discussed before treatment because external testosterone can suppress normal reproductive signaling.
Subcutaneous injections may also cause temporary:
Redness
Tenderness
Bruising
Itching
Small injection-site lumps
The Mayo Clinic and Cleveland Clinic both emphasize using testosterone exactly as directed and maintaining medical follow-up during therapy.
The ChiroMed Approach to Whole-Person Hormone and Musculoskeletal Health
Subcutaneous testosterone gives appropriately selected patients another option for medically supervised hormone therapy.
It may be especially useful for someone who does not want testosterone pellets or repeated deep intramuscular injections. For many patients treated to male testosterone ranges, research supports SubQ testosterone as a practical and well-tolerated alternative to traditional IM treatment.
For women, greater caution is needed because evidence for female-specific SubQ therapy remains limited. Treatment decisions should be individualized and guided by current evidence, symptoms, laboratory findings, medical history, and careful monitoring.
At ChiroMed – Integrated Medicine in El Paso, the larger goal is to connect hormone health with the rest of the body. Testosterone therapy may address an appropriate hormonal problem, while chiropractic care, rehabilitation, functional medicine, nutrition, and exercise address the physical systems that help patients move, build strength, recover, and stay active.
That is the value of integrated care: the hormone, the muscles, the joints, movement, nutrition, and overall health are considered as connected parts of the same patient.
References
Figueiredo, M. G., Gagliano-Jucá, T., & Basaria, S. (2022). Testosterone therapy with subcutaneous injections: A safe, practical, and reasonable option. Journal of Clinical Endocrinology & Metabolism, 107(3), 614–626. Testosterone Therapy With Subcutaneous Injections
Hatzilabrou, T. A. (n.d.). The quiet case for the subcutaneous needle. Worldborne Medical.
Spratt, D. I., Stewart, I. I., Savage, C., et al. (2017). Subcutaneous injection of testosterone is an effective and preferred alternative to intramuscular injection: Demonstration in female-to-male transgender patients. Journal of Clinical Endocrinology & Metabolism, 102(7), 2349–2355. Subcutaneous Injection of Testosterone Study
Discover the effects of celiac disease on the immune system in the body and what it means for those affected by it.
Abstract
Welcome to our educational series. I am Dr. Alex Jimenez, and I am honored to share insights from my extensive clinical experience and the forefront of medical research. In this post, we will embark on a comprehensive journey into the complex world of gluten-related disorders. Many individuals experience discomfort and chronic symptoms without a clear diagnosis, often being told their issues are “all in their head.” My goal today is to demystify these conditions, particularly the critical differences between Celiac Disease and Non-Celiac Gluten Sensitivity (NCGS). We will explore the intricate immunological mechanisms at play, including adaptive versus innate immune responses, and the roles of proteins like gliadin and enzymes like tissue transglutaminase (TTG). We will explore intestinal permeability, or “leaky gut,” and explain how it can serve as a gateway to systemic inflammation and autoimmunity. This journey will cover the physiological underpinnings of symptoms ranging from digestive distress to skin conditions, neurological issues, and nutrient deficiencies. I will also explain the importance of accurate diagnostic testing, the concept of threshold dynamics—why symptoms can suddenly appear later in life—and the critical role of molecular mimicry and cross-reactivity, especially with dairy. Finally, I will illuminate how our integrative approach at Injury Medical Clinic, combining chiropractic care, functional medicine, and collaborative medical oversight, provides a powerful framework for managing and, in many cases, reversing these debilitating conditions. This post is designed to empower you with knowledge, moving you from confusion to clarity and from illness to wellness.
A Message from Dr. Alex Jimenez
Hello, and thank you for joining me. I’m Dr. Alex Jimenez, and throughout my career, which has been enriched by credentials spanning Chiropractic (DC), Advanced Practice Nursing (APRN, FNP-BC), and Functional Medicine (CFMP, IFMCP), I have dedicated myself to understanding the root causes of chronic illness. My clinical observations, honed over years of practice and shared through platforms like chiromed.com and my LinkedIn profile, consistently point to the gut as the epicenter of health and disease. At our practice, Injury Medical Clinic PA in El Paso, Texas, we have cultivated a unique and powerful multidisciplinary environment. I am privileged to work alongside Dr. Maria Guadalupe Cardenas, MD, a distinguished internist with over 40 years of invaluable experience. Dr. Cardenas (NPI #1164426749, Texas MD License #J2933) serves as our Medical Director and Collaborative Physician, providing essential medical oversight that bridges different healing disciplines. This collaborative model is the cornerstone of modern integrative care. It allows us to seamlessly blend the structural and neurological focus of chiropractic care, the deep diagnostic investigation of functional medicine, and the established standards of internal medicine. Our team approach ensures patients—whether they come to us for personal injury, chronic pain, or complex metabolic issues—receive a truly holistic, comprehensive treatment plan tailored to their unique biology. Today, I want to guide you through a topic that affects millions yet remains widely misunderstood: the body’s adverse reactions to gluten. The information I’m sharing isn’t just theoretical; it comes from the latest evidence-based research by leading immunologists and gastroenterologists, and it is validated by what we see and successfully treat in our clinic every day. Let’s move beyond the confusion and get to the heart of what’s really happening inside your body.
Celiac Disease vs. Non-Celiac Gluten Sensitivity: Unraveling the Confusion
One of the most significant points of confusion in both conventional medicine and public understanding is the distinction between Celiac Disease and Non-Celiac Gluten Sensitivity (NCGS). Clinicians often treat these two conditions as if they were the same. In reality, they are fundamentally different entities, driven by distinct arms of the immune system and resulting in different long-term consequences. Understanding this difference is the first and most critical step toward proper diagnosis and effective management.
Celiac Disease: An Adaptive Immune Assault on Your Own Body
Celiac Disease is not an allergy or a simple intolerance; it is a genetically predisposed autoimmune disorder. This is a crucial point. When a person with celiac disease consumes gluten, their immune system doesn’t just react to the foreign protein—it launches a full-scale attack against the body’s own tissues. The adaptive immune system orchestrates this response: the highly specific, sophisticated branch of your immunity that involves T-cells and B-cells and creates long-lasting “memory.” Here is a breakdown of this devastating process:
The Trigger: Gluten, a protein composite found in wheat, barley, and rye, is the environmental trigger.
The Immune Response: In genetically susceptible individuals, the immune system mistakenly identifies gluten components as a threat. It then generates highly specific antibodies, primarily Immunoglobulin G (IgG) and Immunoglobulin A (IgA), not just against gluten but against an enzyme in our own body called tissue transglutaminase (tTG).
The Self-Destruction: This autoimmune response systematically destroys the intestinal villi. These tiny, finger-like projections line the small intestine and absorb nutrients from the food you eat. As the villi become blunted and flattened—a condition known as villous atrophy—the absorptive surface area of the intestine is dramatically reduced.
The Permanent Nature: A hallmark of the adaptive immune system is memory. Once your body learns to attack its own tissues in response to gluten, that programming is permanent. This is why celiac disease is considered a lifelong condition that requires strict, permanent avoidance of gluten.
The downstream consequences of untreated celiac disease are severe and systemic. The progressive destruction of the intestinal villi leads to profound malabsorption, which can manifest as:
Osteoporosis: Due to the inability to absorb calcium and Vitamin D.
Anemia: From impaired absorption of iron, folate, and B12.
Neurological Damage: Including peripheral neuropathy, ataxia (loss of balance), and cognitive impairment, often linked to nutrient deficiencies and systemic inflammation.
Cardiovascular Damage: Increased risk of heart conditions driven by chronic inflammation.
Increased Cancer Risk: Notably, an elevated risk of intestinal lymphomas.
The autoimmune process in celiac disease is a classic example of the immune system’s failure to differentiate between “self” and “non-self,” with devastating consequences for the host.
Non-Celiac Gluten Sensitivity (NCGS): An Innate Immune Irritation
In stark contrast to celiac disease, Non-Celiac Gluten Sensitivity (NCGS) is mediated by the innate immune system. The innate system is our body’s first line of defense. It is rapid and non-specific, designed to react to general patterns of danger or irritation rather than mounting a targeted, memory-based attack. Think of it this way: if celiac disease is a targeted military strike by special forces (the adaptive immune system), NCGS is more like a riot police response to a street protest (the innate immune system). It is chaotic, inflammatory, and causes significant collateral damage and discomfort, but it is not a calculated mission to destroy the body’s own infrastructure. In NCGS, the body is not producing antibodies against its own tissue. Instead, the immune system reacts directly to certain components within wheat and other gluten-containing grains. Research has identified several potential culprits:
Amylase-Trypsin Inhibitors (ATIs): These are non-gluten proteins in wheat that are potent activators of the innate immune system, specifically a receptor called Toll-like receptor 4 (TLR4). TLR4 activation triggers a rapid inflammatory cascade. (Junker et al., 2012).
Fructans: These are a type of FODMAP (Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols), which are short-chain carbohydrates that are poorly absorbed in the small intestine. In sensitive individuals, gut bacteria rapidly ferment them, leading to gas, bloating, pain, and diarrhea. This suggests that for some people with NCGS, the issue may be more of a carbohydrate intolerance than a reaction to the gluten protein itself.
The key takeaway is that in NCGS, while the symptoms can be severe and overlap significantly with celiac disease (bloating, pain, brain fog, fatigue, joint pain), the underlying mechanism is one of irritation and generalized inflammation, not autoimmune self-destruction. The intestinal villi are not being systematically killed. This is a monumental difference because it means that with proper dietary intervention and gut healing, NCGS is often reversible. The immune system hasn’t developed that permanent, destructive memory.
The Gateway to Systemic Chaos: Unpacking Leaky Gut and the Immune Cascade
To truly grasp how gluten can wreak such havoc, whether in celiac disease or NCGS, we must understand intestinal permeability, more commonly known as “leaky gut.” This is not a fringe theory; leading researchers like Alessio Fasano have identified it as a well-established physiological phenomenon and a prerequisite for autoimmunity (Fasano, 2012).
The Intestinal Barrier: Your Body’s Most Important Wall
Imagine the lining of your small intestine. It is not a thick, impenetrable wall. It is an incredibly delicate, single layer of specialized cells (enterocytes) that separates the chaotic outside world (the contents of your gut) from the sterile, highly regulated environment of your bloodstream. This single-cell layer has a surface area equivalent to a tennis court, all folded up inside you. These cells are held together by sophisticated protein structures called tight junctions. You can think of these tight junctions as the “glue” or the mortar between the bricks of a wall. Their job is to be selectively permeable—allowing the passage of fully digested micronutrients (vitamins, minerals, amino acids) while blocking undigested food particles, toxins, microbes, and other large molecules. A healthy intestinal barrier guards your internal peace.
Gliadin, Zonulin, and the Breaching of the Wall
This is where gluten enters the scene as a unique and potent saboteur. One of gluten’s primary protein components is called gliadin. For reasons we don’t fully understand, gliadin can interact with the intestinal lining in all humans, regardless of whether they have celiac disease. Here’s the chain of events that unfolds when gliadin arrives at the gut wall:
Gliadin Binds to a Receptor: Gliadin binds to a specific receptor on the surface of the intestinal cells called the CXCR3 receptor.
Zonulin Release is Triggered: This binding event sends a signal that triggers the release of a protein called zonulin. Dr. Fasano’s team discovered zonulin and identified it as the master regulator of intestinal permeability (Fasano, 2011).
Tight Junctions Are Shredded: Zonulin’s primary function is to “unlock” the tight junctions. It acts like a key that opens the gates between intestinal cells, loosening and separating the junctions.
The “Puke“ into the Bloodstream: With the gates wide open, the gut becomes “leaky.” Now, a flood of substances that should have remained within the intestine—bacteria and their toxic byproducts (lipopolysaccharides or LPS), partially digested proteins, and other inflammatory triggers—can “puke” directly into the bloodstream.
This breach of the intestinal barrier is the inciting event. It is the moment a localized gut problem becomes a systemic, body-wide crisis. The immune system, which has 70-80% of its forces stationed just below the gut lining, is immediately alerted to this massive influx of foreign invaders.
The Immune System Goes Ballistic: The Celiac Autoimmune Cascade
In a person with celiac disease, the consequences of this breach are catastrophic. The offending protein, gliadin, now circulates freely in the bloodstream. What happens next is a perfect storm of mistaken identity:
Gliadin Gets Tagged: Once in the bloodstream, the gliadin molecule gets “tagged” or modified by the enzyme we discussed earlier, tissue transglutaminase (tTG). tTG attaches to gliadin, forming a new hybrid molecule called a tTG-gliadin complex.
A Declaration of War: The immune system’s surveillance cells (antigen-presenting cells) see this tTG-gliadin complex as a highly dangerous foreign entity and present it to the adaptive immune system.
Antibodies Are Created: The adaptive immune system responds by producing large amounts of IgG and IgA antibodies designed to find and destroy this tTG-gliadin complex.
The Tragic Error of Molecular Mimicry: Here is the crucial error. The immune system becomes so fixated on this target that it can no longer differentiate between the invading complex (tTG-gliadin) and the body’s own native tissue transglutaminase enzyme, which is found throughout the body. The antibodies begin attacking both.
Friendly Fire on a Massive Scale: Where does our own tTG enzyme exist in high concentrations?
The Intestinal Villi: This is why the gut is the primary site of destruction, leading to villous atrophy.
The Endothelium: The delicate lining of our blood vessels, which explains the link to cardiovascular damage.
The Skin: Specifically, the dermal papillae, which leads to the skin manifestations of celiac disease.
The Brain and Nervous System: Explaining the neurological symptoms.
The immune system, in its effort to eliminate the gluten invader, ends up waging a relentless war on the body’s own critical structures.
The Skin Connection: Dermatitis Herpetiformis
The process gets even more complex and agonizing. Remember those IgA antibodies being produced in the gut to grab onto gluten? With a leaky gut, these IgA-gluten complexes escape the gut and enter the systemic circulation. They are like little inflammatory packets traveling through your blood. These complexes are eventually filtered out by the tiny blood vessels in the skin, where they get trapped in the dermal papillae (the uppermost layer of the dermis). The immune system detects these trapped complexes and goes absolutely ballistic, right there in your skin. This triggers a localized, but incredibly intense, inflammatory reaction:
Mast Cell Degranulation: Mast cells, which are packed with histamine and other inflammatory chemicals, explode and release their contents.
Intense Inflammation: This causes the characteristic symptoms of Dermatitis Herpetiformis (DH), the skin manifestation of celiac disease: severe, symmetrical itching and burning, followed by blisters, typically on the elbows, knees, back, and buttocks.
When a patient presents with DH, they don’t just have a skin problem. They have a systemic autoimmune disease driven by gluten, and their skin is screaming for help. They feel awful all over because this immune activation is not confined to the skin. It creates a body-wide cytokine overload. Cytokines are the immune system’s signaling molecules, and when they are released in excess (a “cytokine storm”), they cause systemic symptoms like profound fatigue, brain fog, body aches, and feverishness. This chronic state of alarm leads to adrenal exhaustion, places immense stress on the liver (which has to process all the inflammatory debris), and, of course, perpetuates the cycle of nutrient malabsorption.
Getting the Diagnosis Right: The Critical Importance of Proper Testing
Given the profound differences between celiac disease and NCGS, accurate diagnosis is not just an academic exercise—it is essential for determining the correct treatment path and prognosis. Unfortunately, many patients fall through the cracks because of improper testing protocols. The gold standard screening test for celiac disease is a blood test that measures antibodies against tissue transglutaminase, specifically the Tissue Transglutaminase IgA (tTG-IgA) test. This test is highly sensitive and specific for celiac disease. However, there is a giant, flashing red warning sign that comes with this test, one that is tragically often missed: To get an accurate result, the patient must be actively and regularly consuming gluten for at least four weeks leading up to the test. Let me explain why. The tTG-IgA test doesn’t measure gluten; it measures the body’s autoimmune reaction to gluten. If you have removed gluten from your diet, the trigger for the autoimmune response is gone. The immune system will calm down, and antibody production will plummet. If you then take the test while gluten-free, it will come back negative. This is a false negative, and it is utterly worthless. It can lead a person with true celiac disease to believe they are fine, leading them to reintroduce gluten and unknowingly continue the path of autoimmune destruction. In my practice, I have seen countless patients who were told they tested negative for celiac, only to discover they had taken the test after already going gluten-free on their own. This is a critical failure in patient education. If celiac disease is suspected, a “gluten challenge” is mandatory for accurate serological testing. If the blood test is positive, it is typically confirmed with an endoscopic biopsy of the small intestine to look for the characteristic villous atrophy. For NCGS, the diagnostic process is different. No single biomarker or test currently diagnoses NCGS. It is a diagnosis of exclusion. This means we must first definitively rule out celiac disease and wheat allergy. After that, the diagnosis is confirmed by observing a clear improvement in symptoms on a strict gluten-free diet and a recurrence of symptoms upon a gluten re-challenge.
The Threshold Effect: “Why Is This Happening to Me Now?”
A question I hear almost daily from patients in their 30s, 40s, or 50s who are newly diagnosed with a gluten-related disorder is, “But Doctor, I’ve been eating bread my whole life without a problem. Why is this happening to me now?” The answer lies in a concept I call threshold dynamics. It’s a powerful analogy that helps patients understand the gradual, cumulative nature of chronic disease. Imagine your gut health as a bucket. From the day you are born, that bucket begins to fill up with various stressors slowly:
Medications: Antibiotics, NSAIDs (like ibuprofen), and acid blockers are notorious for damaging the gut lining and disrupting the microbiome.
Dietary Irritants: Processed foods, sugar, industrial seed oils, and for some, proteins like gluten and dairy.
Chronic Stress: Psychological and emotional stress directly harms gut function via the gut-brain axis, increasing permeability and inflammation.
Infections: Past gastrointestinal infections can leave a lasting impact on the gut ecosystem.
Environmental Toxins: Pesticides, heavy metals, and other chemicals we are exposed to daily.
For decades, your body’s remarkable resilience and compensatory mechanisms manage this load. Your microbiome fights to maintain balance, and your immune system cleans up the messes. But all the while, the bucket is slowly, imperceptibly filling up. Your intestinal barrier weakens, and the diversity of your beneficial gut bacteria dwindles. Then, one day, the bucket reaches its capacity. It might be a particularly stressful period, a course of antibiotics, or simply the cumulative burden of decades of low-grade insults. The bucket overflows. At this point, the intestinal barrier is sufficiently compromised—it is “leaky” enough for larger molecules like gliadin to spill through the tight junctions in significant quantities. This is the threshold moment. The gliadin that was previously being managed now pours into the bloodstream, igniting the massive immune response we’ve discussed. For the celiac patient, the adaptive immune system is now activated, and the T-cells effectively earn a “PhD” in attacking the body’s own biology whenever they see gluten-related peptides. For the NCGS patient, the innate immune system is overwhelmed, triggering systemic inflammation. The symptoms that had been simmering below the surface for years explode into clinical reality. It wasn’t that the gluten was harmless before; it was that your body’s defenses were able to contain the damage—until they couldn’t anymore.
Eating Right to Feel Better-Video
The Critical Role of Cross-Reactivity and Molecular Mimicry
When I advise my patients with confirmed celiac disease or severe NCGS to stop eating gluten, the very next sentence out of my mouth is, “And you need to cut out dairy, at least for now.” This often elicits looks of dismay, but the recommendation is based on solid immunological science: cross-reactivity and molecular mimicry. Molecular mimicry, as we’ve touched on, is the phenomenon where a foreign protein (like gliadin) looks so similar in its amino acid structure to one of the body’s own proteins (like tissue transglutaminase) that the immune system gets confused and attacks both. Cross-reactivity is a related concept. It occurs when the antibodies generated against one protein (e.g., gliadin) mistakenly react with another, different protein because parts of their structures are very similar. The immune system’s antibodies are like keys looking for a specific lock (the antigen). In cross-reactivity, a different protein has a lock that is so similar to the original target that the antibody “key” fits and turns it, triggering an immune reaction. The most clinically significant cross-reactant to gluten is casein, the primary protein found in milk and dairy products. Casein’s protein structure bears a striking resemblance to that of gliadin. For a significant percentage of people with gluten sensitivity, their anti-gliadin antibodies will also bind to casein. (Vojdani & Tarash, 2013). What does this mean in practical terms? It means that even on a 100% strict gluten-free diet, if you still consume dairy, your immune system may remain activated. You are essentially pouring gasoline on the inflammatory fire, just from a different can. The body thinks it’s seeing gluten, and the inflammatory cascade continues, preventing the gut from healing and symptoms from resolving. This is one of the most common reasons why patients fail to get better on a gluten-free diet alone. That is why, in my functional medicine protocols, removing both gluten and dairy is a non-negotiable first step for at least 60-90 days to allow the immune system to calm down and the gut to begin healing. Other common cross-reactants can include corn, oats (even gluten-free oats, due to a protein called avenin), yeast, and sometimes even coffee. Advanced testing can help identify these, but the gluten-dairy connection is by far the most prevalent and important to address.
The Integrative Chiropractic and Functional Medicine Solution: A Pathway to Healing
The beauty of understanding these complex mechanisms is that it provides us with a clear roadmap for healing. The situation I’ve described, while dire, is manageable and, in the case of NCGS, often completely reversible. This is where our integrative model at Injury Medical Clinic truly shines. We don’t just treat symptoms; we address the root cause from multiple angles. Our approach is built on functional medicine principles, often summarized by the 5R Program: Remove, Replace, Reinoculate, Repair, and Rebalance.
1. Remove: Eliminating the Triggers
This is the essential first step. We must remove the substances driving inflammation and immune dysregulation.
Gluten and Dairy: As discussed, this is paramount. Strict elimination is required. We provide patients with extensive education on reading labels, avoiding cross-contamination, and navigating a gluten-free lifestyle.
Other Food Sensitivities: We may use advanced food sensitivity testing (like IgG or lymphocyte reactivity testing) or a comprehensive elimination diet to identify other patient-specific food triggers.
Pathogens: If we suspect underlying gut infections (like parasites, bacterial overgrowth (SIBO), or yeast overgrowth), we will use advanced stool testing (like GI-MAP) to identify and then use targeted antimicrobial herbs or, when necessary, prescription medications to eradicate them.
2. Replace: Restoring Digestive Function
Chronic gut inflammation impairs the body’s ability to produce digestive enzymes and sufficient stomach acid. You cannot heal the gut if you cannot properly digest your food.
Digestive Enzymes: We often supplement with broad-spectrum digestive enzymes to help break down fats, proteins, and carbohydrates, taking the burden off the compromised gut.
Stomach Acid Support: Many people with gut issues have low stomach acid (hypochlorhydria). Supporting acid levels with betaine HCl can be critical for proper protein digestion and sterilizing the stomach against pathogens.
3. Reinoculate: Rebuilding the Microbiome
A healthy gut barrier is dependent on a healthy, diverse microbiome. The “good bugs” help regulate immunity, produce anti-inflammatory compounds, and reinforce the gut lining.
Probiotics: We use high-quality, multi-strain probiotics to reintroduce beneficial bacteria.
Prebiotics: Even more importantly, we focus on “feeding” the good bacteria with prebiotic fibers found in foods like asparagus, onions, garlic, and jicama. This encourages the growth of the patient’s own native beneficial flora.
4. Repair: Healing the Gut Lining
This is where we provide the specific nutrients needed to rebuild the damaged intestinal wall and “re-glue” the tight junctions. Key therapeutic nutrients include:
L-Glutamine: This amino acid is the primary fuel source for intestinal cells and is critical for repairing the gut lining.
Zinc Carnosine: A specialized form of zinc that is incredibly effective at healing the gut mucosa.
Deglycyrrhizinated Licorice (DGL), Aloe Vera, and Marshmallow Root: These soothing herbs provide a protective, anti-inflammatory coating for the gut lining.
Vitamins A and D: These vitamins are crucial for immune regulation at the gut level and for supporting mucosal health.
5. Rebalance: Addressing Lifestyle and Systemic Imbalance
Healing the gut is not just about diet and supplements. We must address the whole person.
Stress Management: As stress is a major driver of leaky gut, we incorporate techniques like meditation, deep breathing, and mindfulness.
Sleep Optimization: Sleep is when the body does its primary repair work. We ensure patients are getting adequate, high-quality sleep.
The Role of Integrative Chiropractic Care: This is a unique and vital component of our approach. The gut and nervous system communicate constantly via the gut-brain axis. Chronic inflammation and pain signals from the gut can bombard the central nervous system, leading to a state of “central sensitization,” where the nervous system is stuck in a high-alert, “fight-or-flight” mode. This not only perpetuates pain and anxiety but also directly impairs gut function by shunting blood away from the digestive organs.
Chiropractic adjustments, particularly to the thoracic and lumbar spine where sympathetic nerves to the gut originate, can profoundly affect this process. By restoring proper spinal mechanics and reducing nerve interference, we can help down-regulate the sympathetic nervous system and promote the “rest-and-digest” parasympathetic state. This improves blood flow to the gut, enhances motility, and reduces the pain signals being sent to the brain.
As a chiropractor and a family nurse practitioner, I am uniquely positioned to see how structural alignment directly influences physiological function. Correcting spinal subluxations is not just about back pain; it is about restoring the neurological communication that governs every organ in the body, including the gut. This foundational step in rebalancing the system is often overlooked in conventional and even functional medicine settings.
Dr. Cardenas’s collaborative oversight ensures this entire process is medically sound. She reviews complex cases, helps manage any necessary prescription medications, and provides the internist’s perspective, ensuring that our functional and chiropractic interventions are safely and effectively integrated with the highest standard of medical care. This multidisciplinary synergy allows us to create a truly personalized and robust healing protocol that addresses the patient from structure to cell, from mind to microbiome. The path to healing from gluten-related disorders is a journey, not a sprint. It requires commitment and guidance. But armed with the right knowledge and a comprehensive, integrative approach, recovery is not just possible—it is expected. All of this is manageable, and if your condition is not celiac disease, it is very often reversible. And the most encouraging news of all is that, in my clinical experience, most of the Hope datasets are manageable, and there is a clear path forward.
References
Fasano, A. (2011). Zonulin and its regulation of intestinal barrier function: The biological door to inflammation, autoimmunity, and cancer. Physiological Reviews, 91(1), 151–175. https://doi.org/10.1152/physrev.00003.2008
Junker, Y., Zeissig, S., Kim, S. J., Barisani, D., Wieser, H., Leffler, D. A., Zevallos, V., Libermann, T. A., Dillon, S., Freitag, T. L., Kelly, C. P., & Schuppan, D. (2012). Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll-like receptor 4. Journal of Experimental Medicine, 209(13), 2395–2408. https://doi.org/10.1084/jem.20102660
Vojdani, A., & Tarash, I. (2013). Cross-reaction between gliadin and different food and tissue antigens. Food and Nutrition Sciences, 4(1), 20-32. https://doi.org/10.4236/fns.2013.41005
SEO Tags: Celiac Disease, Non-Celiac Gluten Sensitivity, NCGS, Gluten Intolerance, Leaky Gut, Intestinal Permeability, Dr. Alex Jimenez, Dr. Maria Guadalupe Cardenas, Integrative Chiropractic Care, Functional Medicine, El Paso, TX, Zonulin, Gliadin, Tissue Transglutaminase, Autoimmunity, Dermatitis Herpetiformis, Molecular Mimicry, Cross-Reactivity, Gut Health, Microbiome, 5R Program, Digestive Health, Food Sensitivity, Chiropractic Adjustment, Gut-Brain Axis, Systemic Inflammation.
Discover the benefits of kisspeptin in neuroendocrine health with integrative care and its role in maintaining hormonal balance.
Abstract
In this educational post, I, Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, walk you through the emerging science of kisspeptin. This upstream neuroendocrine signal orchestrates metabolism, sex hormones, stress responses, immune regulation, brain function, and bone remodeling. I explain how disruptions in the kisspeptin-KNDy-GnRH axis can mimic conditions like metabolic syndrome, functional hypogonadism, depression/anxiety, cognitive decline, infertility, and osteoporosis—and why treating each symptom separately misses the root cause. You’ll learn the physiology of KNDy neurons, pulse signaling, and the hypophyseal portal system; how sex steroid feedback shapes energy balance, neurotransmitter tone, and bone turnover; and how chronic stress, sleep disruption, ultra-processed foods, endocrine-disrupting chemicals, and inflammation suppress kisspeptin signaling. I outline our integrative care model at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, where I collaborate closely with Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933), our Medical Director and Collaborative Physician with over 40 years in Internal Medicine. Together, we combine chiropractic care, functional medicine, medical oversight, personal injury care, rehabilitation, and evidence-based protocols that restore kisspeptin signaling. We detail practical strategies: circadian and sleep optimization, stress recalibration, targeted nutrition, resistance training, weight-bearing bone work, body composition restoration, gut-immune modulation, endocrine toxin minimization, and carefully selected peptide and pharmacologic options under medical supervision. The article highlights leading research from endocrinology and neuroscience—framed for patients and professionals—using modern, evidence-based methods and clinical reasoning to guide safe, individualized care. Keywords to expect: kisspeptin, KNDy neurons, GnRH, HPG axis, metabolic rate, insulin sensitivity, visceral fat, neurotransmitters, bone remodeling, integrative chiropractic, functional medicine, circadian rhythm, stress physiology, peptides, injury rehabilitation, El Paso healthcare.
About Our Team-Based Care In El Paso
I practice as a chiropractor and nurse practitioner specializing in functional medicine and injury rehabilitation. Our clinic—Injury Medical Clinic PA, also known as Mission Plaza Injury Medical Clinic—in El Paso, Texas, is a multidisciplinary environment where medical and chiropractic disciplines work side by side. Dr. Maria Guadalupe Cardenas, MD, Board Certified in Internal Medicine (NPI #1164426749, Texas MD License #J2933), serves as our Medical Director and Collaborative Physician. With more than 40 years of Internal Medicine experience, Dr. Cardenas provides medical oversight, ensures the safety and appropriateness of medical therapies, orders and interprets advanced testing, and co-manages complex internal medicine conditions that intersect with musculoskeletal and metabolic care. I, Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, lead integrative chiropractic and functional medicine services, blending spinal and extremity biomechanics, neuromuscular rehabilitation, clinical nutrition, and lifestyle reconditioning with data-driven protocols that support endocrine and immune balance. Together, we unify chiropractic care, medical assessment, functional medicine, personal injury protocols, and rehabilitation, so patients receive coordinated, whole-person care that honors both symptom relief and root-cause restoration. Learn more about my clinical approach and observations: Dr. Jimenez: Clinical observations and insights (ChiroMed) – https://chiromed.com/ Professional background and clinical updates – https://www.linkedin.com/in/dralexjimenez/
Why Kisspeptin Matters: My Journey Into The Body’s Master Timing Signal
When I first looked closely at patients with puzzling constellations—fatigue, fat gain despite “clean” eating, anxiety that doesn’t respond to standard care, low libido, irregular cycles or erectile symptoms, frequent injuries, slow recovery, and declining bone density at a young age—I saw a pattern. Many were being treated as if they had four or five isolated disorders: metabolic syndrome, depression, low testosterone or estrogen imbalance, osteoporosis, and sometimes even cognitive decline. But symptom-by-symptom prescribing left the core imbalance untouched. Over the past decade, modern research has converged on a pivotal upstream conductor: the kisspeptin system, generated by specialized hypothalamic neurons known as KNDy neurons. These neurons orchestrate rhythmic GnRH pulses—the master clock for reproductive hormones—but their influence extends far beyond fertility. Because sex steroids integrate with energy balance, brain neurotransmitter tone, immune responses, stress physiology, and bone remodeling, the kisspeptin-GnRH pulse generator effectively tunes multiple body systems at once. When it falters, you can watch entire health networks dim—metabolism slows, mood flattens, bones weaken, inflammation escalates, and recovery lags. In our clinic, we bring kisspeptin back into the conversation, not as an exotic lab value but as a practical framework that helps us restore the body’s timing, coherence, and resilience.
The Kisspeptin-KNDy-GnRH Axis: A Clear, Patient-Friendly Physiology Tour
What is kisspeptin? Kisspeptin is a small peptide produced predominantly in the hypothalamus by a cluster of neurons called KNDy neurons (Kisspeptin, Neurokinin B, Dynorphin). These neurons fire in rhythmic pulses. The pattern matters. Pulsatile signaling ensures precise downstream responses across the reproductive and metabolic axes. Who are the KNDy neurons? KNDy neurons are a tightly coupled mini-network in the arcuate nucleus. They co-release three key neurochemicals: Kisspeptin: the accelerator that stimulates GnRH neurons. Neurokinin B: helps synchronize and initiate pulses—think ignition timing. Dynorphin: provides braking to shape pulse intervals—think pulse-spacing control. How does kisspeptin reach the pituitary system? Pulses of kisspeptin travel through the hypophyseal portal circulation to the anterior pituitary region. Kisspeptin binds to receptors that ultimately drive GnRH neuronal output. GnRH pulses stimulate the pituitary to release LH and FSH, which in turn regulate ovarian and testicular steroidogenesis—estrogen, progesterone, testosterone—and gametogenesis. Why do pulses matter? The pituitary and gonads “read” the tempo of GnRH pulses. The wrong frequency or amplitude produces impaired steroidogenesis, cycle irregularities, low testosterone, anovulation, and fertility issues. Pulse-based communication reflects the body’s emphasis on rhythm: circadian clocks, feeding windows, muscle recovery cycles, and immune surveillance all share timing logic. What does this have to do with metabolism, brain health, and bones? Sex steroids influence mitochondria, muscle preservation, hepatic insulin sensitivity, lipid metabolism, appetite signals, and fat partitioning—especially visceral fat. Estrogen supports hippocampal plasticity, synaptic maintenance, and serotonergic function; testosterone stabilizes dopaminergic tone, motivation, and reward pathways. Bone is exquisitely hormone-sensitive: osteoclasts (resorption) and osteoblasts (formation) dance to hormonal music. Disrupt the music, and bone turns brittle. When kisspeptin signaling falls: Metabolic rate can drop, insulin sensitivity declines, and the body shifts toward energy storage, often centrally (visceral fat). Neurotransmitter balance shifts, increasing the risk of anxiety, depression, and anhedonia (emotional flatness). Bone remodeling tilts toward resorption: osteoclasts accelerate while osteoblast activity lags, hastening osteopenia and osteoporosis.
The Clinical Picture: What Kisspeptin Suppression Looks Like In Real Life
I often meet: Men with functional hypogonadism who also present with visceral adiposity, insulin resistance, hypertension, dyslipidemia, low motivation, and rising inflammatory markers. Women in their 30s to 40s with irregular or anovulatory cycles, fatigue, weight gain, brain fog, lowered libido, immune shifts (frequent colds, autoimmune flares), anxiety/depression, and early bone-density concerns—despite high training loads or disciplined diets. Young athletes with stress fractures or poor recovery, especially when under high psychosocial stress, caloric deficit, poor sleep, or intense endurance training. A frustrating pattern is the conventional fragmentation of care: four or more prescriptions to manage glucose, lipids, mood, and bone—while the upstream clock (kisspeptin-GnRH) remains untuned. In our experience, restoring timing and signal quality re-synchronizes multiple systems at once.
Evidence Signals: What Leading Research Shows
Modern endocrinology and neurobiology have highlighted how kisspeptin coordinates reproductive and metabolic health. While numerous studies explore kisspeptin physiology and therapeutic potential, the practical clinical message remains consistent: when pulse dynamics and receptor responsiveness are restored, multiple downstream systems improve. Examples of reported outcomes in the literature include: Improved testosterone production and normalization of LH/FSH patterns in men with functional hypogonadism when kisspeptin signaling is supported or stimulated. Enhanced ovulatory function and cycle regularity in women when hypothalamic-pituitary-ovarian timing is re-established. Positive changes in body composition, visceral fat reduction, and improved insulin sensitivity correlated with normalized sex steroid rhythms. Improvements in mood, anxiety, and cognitive performance, consistent with sex steroids’ modulation of serotonergic, dopaminergic, GABAergic, and glutamatergic systems. Stabilization of bone remodeling parameters when upstream hormonal rhythms and nutrient-mechanical inputs are aligned. Our protocols translate these findings into careful, individualized plans under integrated medical-chiropractic supervision. Note: Specific study details and applicability vary; we evaluate patients individually. We employ evidence-based care and adjust protocols based on clinical response and safety.
How Kisspeptin Shapes Metabolism: From Mitochondria To Visceral Fat
Energy dynamics explained. The body balances energy through intake, expenditure, and storage—but the”instructions” to favor burn or store are hormonal and neural. Sex steroids act as metabolic rheostats: Testosterone supports mitochondrial biogenesis, lean mass retention, and visceral fat suppression. Estrogen maintains hepatic insulin sensitivity, modulates lipid metabolism, and supports muscle glucose uptake. What happens when kisspeptin falters GnRH pulses become dysregulated, diminishing LH/FSH signaling and subsequent sex steroid output. Lower sex steroids shift metabolism toward storage: Resting metabolic rate decreases. Skeletal muscle loses anabolic tone and glucose disposal capacity. The liver becomes more insulin resistant, promoting dyslipidemia. Visceral fat expands, increasing inflammatory cytokines (e.g., IL-6, TNF-α) and worsening insulin resistance. Clinical pattern we see Patients report stubborn weight gain, especially around the abdomen. Fasting insulin and HOMA-IR rise; triglycerides creep upward; HDL may fall. Blood pressure moves north; energy drops; cravings increase. Why integrative care works We don’t treat “calories” alone. We restore the signaling context: circadian timing, sleep depth, stress modulation, nutrient density, resistance training, and, when appropriate, targeted peptides or medications under MD oversight. The body then “chooses” to burn.
Mood, Motivation, And Cognition: The Neurotransmitter Interface
Sex steroid-neurotransmitter crosstalk Estrogen enhances serotonergic tone and hippocampal plasticity, supporting mood and memory consolidation. Testosterone influences dopaminergic pathways, sustaining drive, reward processing, and executive function. When kisspeptin dips The brain loses buffering against anxiety and depression; anhedonia appears. Patients describe “flat” affect, low drive, and brain fog. Clinical translation Rather than siloed psychiatric treatment alone, we investigate sleep architecture, circadian timing, inflammatory load, micronutrient status (e.g., omega-3 index, vitamin D, B vitamins), and sex steroid rhythms. Aligning these often alleviates mood symptoms while supporting long-term resiliency.
Bone Health And The Hormonal Music Of Remodeling
Bone is dynamic tissue. Osteoclasts resorb; osteoblasts build. Hormones, nutrients, and mechanical loading direct this choreography. Estrogen restrains resorption; testosterone supports formation and muscle-driven skeletal loading. When kisspeptin is suppressed Sex steroid decline removes checks on osteoclasts. Bone density falls faster than expected for age; stress fractures and early osteopenia appear, especially in athletes with low energy availability. Restorative strategy Rebuild the hormonal rhythm, ensure adequate protein and minerals, prioritize vitamin D/K2 and omega-3s, and prescribe progressive, weight-bearing and impact training that safely stimulates osteogenesis. Chiropractic care addresses kinetic chain dysfunction, ensuring axial loading is distributed properly, and joints can tolerate progressive forces.
Why The Body Chooses Storage: The Evolutionary Logic
From an evolutionary perspective, when stress, sleep loss, infection, or famine signals the hypothalamus, the body protects fertility by temporarily downshifting reproductive signaling. Kisspeptin sits at this decision point. If energy is low or stress is high, kisspeptin pulsatility diminishes, conserving resources but shifting metabolism to storage. Our job is to convince the hypothalamus that conditions are safe and abundant—through sleep regularization, nutrient density, sympathetic-parasympathetic balance, and consistent mechanical signals from healthy movement.
Common Drivers Of Kisspeptin Suppression
Chronic psychological stress and high allostatic load Inadequate sleep, circadian disruption, late-night light exposure Low energy availability (calorie deficit), especially with high training volume Highly processed diets, poor protein quality, micronutrient gaps Insulin resistance and chronic inflammation Endocrine-disrupting chemicals (EDCs): BPA, phthalates, PFAS, etc. Untreated hypothyroidism or subclinical thyroid dysfunction Gut dysbiosis, lipopolysaccharide (LPS)-driven inflammation Traumatic brain injury (TBI) and concussion sequelae Persistent pain signaling and immobility after injury Alcohol overuse and recreational drug impacts Identifying and addressing these drivers in a structured plan is essential for long-term restoration.
Our Integrative Care Model: Chiropractic, Medical, Functional, And Rehab Under One Roof
At Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic), we deliver a coordinated pathway: Medical direction and safety Dr. Cardenas, Internal Medicine, directs medical care, orders and interprets labs and imaging, supervises peptide or pharmacologic interventions, and ensures clinical safety for complex cases. Integrative chiropractic care I address spinal and extremity biomechanics, joint restriction, and neuromuscular control. Adjustments and mobilizations reduce nociceptive drive, normalize proprioception, and improve autonomic balance to support hypothalamic-pituitary coherence. Functional medicine We map root contributors: sleep-circadian misalignment, nutritional gaps, endocrine disruptors, gut-immune triggers, metabolic rigidity, and stress physiology. Rehabilitation and performance Progressive loading, movement patterning, breath mechanics, and fascia-focused therapy restore kinetic integrity, enabling safe return to sport and daily life. Personal injury integration Post-collision or work injury cases often involve pain, stress, sleep disruption, and deconditioning—each can suppress kisspeptin. Our team coordinates documentation, imaging, and staged rehabilitation while guarding endocrine-metabolic health. This multidisciplinary setup—common in integrative and injury care clinics—prevents fragmentation and accelerates meaningful recovery.
The Evaluation Blueprint: Data-Driven And Personalized
Step 1: History and timeline Symptom onset, stressors, injuries, training loads, menstrual or sexual function patterns, sleep logs, nutrition, weight history, and mood-cognition changes. Step 2: Physical and biomechanical assessment Posture, spinal and pelvic alignment, joint mobility, gait, breathing mechanics, muscle balance, and movement screens. Step 3: Laboratory and imaging under medical oversight (as indicated) Metabolic panel: fasting insulin, glucose, HbA1c, lipids, liver enzymes. Inflammation: hs-CRP, ferritin, CBC, homocysteine. Nutrient status: vitamin D, B12/folate, omega-3 index, iron studies. Endocrine: morning cortisol patterning, thyroid panel (TSH, fT4, fT3), prolactin if indicated. Sex hormones: total and free testosterone, SHBG, estradiol (phase-specific in cycling women), progesterone (mid-luteal), LH/FSH. Bone health: DEXA for BMD and body composition; optionally bone turnover markers. Gut health: targeted stool testing when GI symptoms or autoimmune patterns suggest dysbiosis. Imaging: when injuries, stress fractures, or endocrine pituitary concerns arise. Step 4: Functional testing Heart rate variability (HRV), sleep wearables, continuous glucose monitoring (CGM) for select cases. Our goal is to triangulate physiology—correlating symptoms, structure, and lab signals—so protocols match reality.
Chiropractic Care’s Role In Restoring Kisspeptin Signaling
Why chiropractic matters physiologically Pain and joint dysfunction elevate sympathetic tone and inflammatory mediators—both suppress hypothalamic reproductive signaling. Spinal and peripheral joint adjustments can: Reduce nociceptive input and normalize dorsal horn processing. Improve proprioceptive signaling, aiding sensorimotor integration. Shift autonomic balance toward parasympathetic restoration, which supports hypothalamic pulsatility. Improved movement quality enables progressive resistance and impact training—critical for muscle, metabolism, and bone. Techniques we employ High-velocity, low-amplitude adjustments when indicated and safe. Low-force mobilization for sensitized patients. Soft-tissue and myofascial techniques to reduce guarding and improve gliding. Neuromuscular re-education to stabilize new ranges of motion. Breath and rib mechanics to optimize vagal tone and thoracic mobility. Clinical observation When pain decreases, and movement improves, sleep deepens, HRV increases, and patients can adhere to nutrition and training plans—all inputs that favor kisspeptin restoration. See clinical insights and case reflections: Clinical observations (ChiroMed) – https://chiromed.com/ Professional updates – https://www.linkedin.com/in/dralexjimenez/
Medical Oversight: Ensuring Safety And Precision
Dr.Cardenas’’ role is pivotal: She evaluates for medical contraindications, oversees lab strategy, and guides pharmacologic or peptide interventions when needed. In complex cases—e.g., coexisting diabetes, hypertension, autoimmune disease, or perimenopausal transitions—her expertise keeps care on target and safe. If advanced endocrine evaluation or imaging is necessary (e.g., suspected pituitary pathology), she directs referrals and coordinates care.
Functional Medicine Levers That Re-Synchronize The Axis
Circadian alignment and sleep architecture Consistent sleep-wake times; morning light exposure; dim evenings. Target 7.5–9 hours of sleep opportunity; prioritize slow-wave and REM quality. Why: SCN-hypothalamic timing stabilizes GnRH pulses; sleep curtails cortisol and inflammatory mediators that blunt kisspeptin. Stress recalibration Breath training (e.g., slow nasal, 4-6 breaths/min), mindfulness, biofeedback, and structured recovery windows. Strengthening social and environmental buffers to lower allostatic load. Why: Chronic sympathetic drive suppresses hypothalamic reproductive signals; vagal tone promotes restoration. Targeted nutrition Protein at 1.6–2.2 g/kg/day to preserve lean mass. Fiber-rich, polyphenol-dense plants for gut-immune balance. Carbohydrates matched to training; prioritizing whole-food matrices to stabilize glucose-insulin dynamics. Adequate omega-3s, magnesium, zinc, vitamin D/K2, and B vitamins. Why: Nutrient sufficiency, stable glycemia, and anti-inflammatory patterns signal abundance and safety to the hypothalamus. Resistance and impact training 2–4 weekly full-body strength sessions; progressive overload; technique first. Low-to-moderate impact (as tolerated) for osteogenesis; plyometrics when appropriate. Why: Muscle is a glucose sink and endocrine organ; loading drives bone formation and mitochondrial biogenesis. Gut-immune restoration Address dysbiosis; increase fermentable fibers and polyphenols; consider probiotics selectively. Why: LPS and gut-derived inflammatory mediators suppress hypothalamic signaling and worsen insulin resistance. Endocrine-disruptor hygiene Reduce plastic contact, filter water, avoid thermal receipts, improve indoor air quality. Why: EDCs can interfere with sex steroid receptors and hypothalamic cues, blunting kisspeptin responsiveness. Alcohol and substance moderation Limit alcohol; avoid sedative reliance. Why: Alcohol disrupts sleep stages and inflames the gut-liver axis, worsening endocrine rhythms. Micronutrient and lab-guided supplementation Vitamin D sufficiency, omega-3 optimization, magnesium for sleep and insulin sensitivity, zinc for steroidogenesis. Why: Key cofactors support the enzymatic pathways governing sex steroids and neurotransmitters.
When Peptides Or Pharmacologic Tools Are Considered
Under Dr. CCardenas’medical direction, we may consider: Therapeutic agents that influence GnRH-kisspeptin dynamics or downstream steroidogenesis when lifestyle and rehabilitative strategies need support. Sleep aids, when necessary, to stabilize architecture while behavioral interventions take hold. Insulin-sensitizing agents if metabolic rigidity impedes progress. Management of thyroid or prolactin imbalances that secondarily suppress kisspeptin. We proceed conservatively, always prioritizing foundational pillars first. We integrate any peptide or prescription into a comprehensive plan with clear goals and monitoring.
Personal Injury Context: Protecting The Axis During Recovery
Injury care is a unique endocrine stress: Pain, sleep fragmentation, reduced activity, and psychological strain suppress kisspeptin. Steroid changes post-injury can accelerate sarcopenia and visceral fat. Our approach: Early pain control through chiropractic and manual therapies to reduce sympathetic drive. Gentle movement reintroduction to defend muscle and bone. Sleep and stress protocols started immediately. Nutrition tuned for healing: adequate protein, collagen-rich foods, vitamin C, zinc, and omega-3s. Medical oversight to address concussion/TBI, medications that may affect sleep-hormone balance, and safe progression criteria.
The Non-Surgical Approach to Wellness with Chiropractic Care- Video
Case Patterns I Commonly See
Pattern A: The over-trained, under-fueled woman in her 30s Findings: Irregular cycles, high training load with low caloric intake, insomnia, rising fasting insulin, declining DEXA BMD. Plan: Increase energy availability, reduce high-intensity frequency, add strength training, optimize sleep, micronutrient repletion, load the skeleton safely, and consider medical support if cycles remain anovulatory. Outcome goal: Restored ovulatory rhythm, improved BMD trend, stable mood, stronger lifts and recovery. Pattern B: The mid-40s executive male with creeping central adiposity Findings: Late-night work and screens, elevated stress, low morning energy, low-normal testosterone with high SHBG, increasing triglycerides, borderline blood pressure. Plan: Circadian reset, resistance training blocks, protein-first meals, alcohol reduction, chiropractic care to reduce pain and improve HRV, and medical assessment for insulin resistance and thyroid. Outcome goal: Increased free testosterone, reduced visceral fat, improved sleep, steadier mood and drive. Pattern C: Post-collision patient with persistent pain and brain fog Findings: Neck and back pain, poor sleep, anxiety, decreased activity, weight gain. Plan: Gentle adjustments and mobilization, breath and rib mechanics, graded activity, targeted nutrition, sleep stabilization; medical evaluation for concussion and appropriate therapies. Outcome goal: Pain down, sleep up, cognitive clarity returning, endocrine markers normalizing.
Implementation Guide: From First Visit To Follow-Up
Week 0–2: Assessment, sleep routine, gentle mobility, protein targets, morning light exposure, hydration, and stress basics. Chiropractic care initiated to reduce nociception. Week 3–6: Strength training starts (technique focus), nutrition refinement, gut support if indicated. Monitor HRV, sleep, and energy. Week 7–12: Progress load and impact cautiously; recheck body composition; adjust macronutrients; consider medical therapeutics if metabolic rigidity persists. Month 4–6: Reassess labs and DEXA when appropriate; refine program; taper supervised visits as self-efficacy increases.
Why This Works: The Physiology Of Coherence
When the body senses predictable rhythms, sufficient nutrients, lower inflammation, and safe, progressive mechanical load, the hypothalamus relaxes protective downshifts. Kisspeptin pulses regain their timing; GnRH resumes its music. Sex steroids rise within physiologic ranges, lifting mitochondrial output, neurotransmitter balance, and bone formation. Patients don’t just feel better—they rebuild capacity.
How We Coordinate Care Day-To-Day
Shared case reviews: Dr. Cardenas and I routinely review complex patients, aligning testing and interventions. Clear communication: You will know why we choose each step and how we’ll measure progress. Safety gates: We carefully titrate load, nutrition, and any medical agents, monitoring signs and labs.
What Success Looks Like
Stable, refreshing sleep and consistent wake energy Improved body composition: higher lean mass, lower visceral fat Regular cycles and improved fertility markers in women; better morning erections and libido in men Lower fasting insulin, improved lipids, and normalized blood pressure Clearer mood, stronger motivation, reduced anxiety Stronger bones and fewer injuries A resilient nervous system that recovers quickly from stressors
Frequently Asked Questions
Is kisspeptin only about fertility? No. It’s a master timing signal with ripple effects on metabolism, brain function, and bone health by governing GnRH and downstream sex steroids. Do I need medications? Not always. Foundational care often restores signaling. When needed, medications or peptides are used judiciously under medical supervision. How long until I notice changes? Many patients notice sleep and energy improvements within weeks. Body composition and bone changes take longer—months for composition, years for bone density trends. We measure to keep progress visible. Can chiropractic adjustments really influence hormones? By reducing pain and sympathetic overdrive, improving sleep and movement, and enabling resistance training, chiropractic care indirectly supports the hypothalamic environment that sets hormone timing.
Integrating The Latest Research With Real-World Care
Our commitment is to evidence-informed, patient-centered practice. We synthesize modern endocrinology, neuroscience, sports medicine, and rehabilitation science with practical steps you can live with. When multiple issues appear at once—metabolic, mood, fertility, and bone—consider the upstream timing. Kisspeptin is not the only player, but it’s often the conductor we need to retune. To explore care with us at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso—or to refer a complex case—reach out. We are here to help restore rhythm, resilience, and performance. Learn more about my clinical perspective and ongoing observations: Clinical observations and integrative insights – https://chiromed.com/ Professional background – https://www.linkedin.com/in/dralexjimenez/
References
Lehman, M. N., Coolen, L. M., & Goodman, R. L. (2010). Minireview: kisspeptin/neurokinin B/dynorphin (KNDy) cells of the arcuate nucleus: a central node in the control of gonadotropin-releasing hormone secretion. Endocrinology, 151(8), 3479–3489. https://doi.org/10.1210/en.2010-0022
Lehman, M. N., Ladha, Z., Coolen, L. M., Hileman, S. M., Connors, J. M., & Goodman, R. L. (2010). Neuronal plasticity and seasonal reproduction in sheep. The European Journal of Neuroscience, 32(12), 2152–2164. https://doi.org/10.1111/j.1460-9568.2010.07530.x
Clarke, H., Dhillo, W. S., & Jayasena, C. N. (2015). Comprehensive Review on Kisspeptin and Its Role in Reproductive Disorders. Endocrinology and Metabolism (Seoul, Korea), 30(2), 124–141. https://doi.org/10.3803/EnM.2015.30.2.124
Zhu, L., Martinez, M. N., Emfinger, C. H., Palmisano, B. T., & Stafford, J. M. (2014). Estrogen signaling prevents diet-induced hepatic insulin resistance in male mice with obesity. American Journal of Physiology. Endocrinology and Metabolism, 306(10), E1188–E1197. https://doi.org/10.1152/ajpendo.00579.2013
Rossetti, M. L., Steiner, J. L., & Gordon, B. S. (2017). Androgen-mediated regulation of skeletal muscle protein balance. Molecular and cellular endocrinology, 447, 35–44. https://doi.org/10.1016/j.mce.2017.02.031
Khosla, S., & Monroe, D. G. (2018). Regulation of Bone Metabolism by Sex Steroids. Cold Spring Harbor Perspectives in Medicine, 8(1), a031211. https://doi.org/10.1101/cshperspect.a031211
Fester, L., Prange-Kiel, J., Zhou, L., Blittersdorf, B. V., Böhm, J., Jarry, H., Schumacher, M., & Rune, G. M. (2012). Estrogen-regulated synaptogenesis in the hippocampus: sexual dimorphism in vivo but not in vitro. The Journal of Steroid Biochemistry and Molecular Biology, 131(1-2), 24–29. https://doi.org/10.1016/j.jsbmb.2011.11.010
Tobiansky, D. J., Wallin-Miller, K. G., Floresco, S. B., Wood, R. I., & Soma, K. K. (2018). Androgen Regulation of the Mesocorticolimbic System and Executive Function. Frontiers in Endocrinology, 9, 279. https://doi.org/10.3389/fendo.2018.00279
Wang, L., Wang, N., Zhang, W., Cheng, X., Yan, Z., Shao, G., Wang, X., Wang, R., & Fu, C. (2022). Therapeutic peptides: current applications and future directions. Signal transduction and targeted therapy, 7(1), 48. https://doi.org/10.1038/s41392-022-00904-4
de la Iglesia, H. O., & Schwartz, W. J. (2006). Minireview: timely ovulation: circadian regulation of the female hypothalamo-pituitary-gonadal axis. Endocrinology, 147(3), 1148–1153. https://doi.org/10.1210/en.2005-1311
SEO tags: kisspeptin, KNDy neurons, GnRH pulses, hypothalamus, metabolic rate, insulin sensitivity, visceral fat, osteoporosis, bone remodeling, estrogen, testosterone, neurotransmitters, anxiety, depression, anhedonia, hippocampal plasticity, integrative chiropractic care, functional medicine, El Paso injury clinic, Medical Director Dr. Maria Guadalupe Cardenas, Dr. Alex Jimenez, peptide therapy, circadian rhythm, sleep optimization, stress reduction, endocrine disruptors, resistance training, weight-bearing exercise, DEXA, body composition, HRV, personal injury rehabilitation, concussion care, internal medicine and chiropractic collaboration